SlideShare a Scribd company logo
1 of 28
Download to read offline
Evaluating mHealth
Adoption Barriers:
Human Behaviour
Vodafone mHealth Solutions
Insights Guide
mhealth.vodafone.com
Vodafone mHealth Solutions 3
Vodafone mHealth Solutions Insights Guide
Welcome
!"#$%&"'(%'%)*'+*,('-".#(/'0"1.("'2)1#3$.(3%4'5'(/"'
64,37/(,'8)39":';)*'.3&'3,'(%'2*%<39"',%&"'"<39"4$"=
1.,"9',(3&)#),'(/.('>3##'"4$%)*.7"'.##'(/%,"'>%*?347'
in the different areas of healthcare to consider the
344%<.(3%4'%22%*()43(3",'(/.('.*"'4%>'.<.3#.1#"'(%'(/"&:'
!"'1"#3"<"'(/.('*".#'2*%7*",,'$.4'%4#@'1"'343(3.("9'>/"4'
.##',(.?"/%#9"*,'#%%?'1"@%49'(*.93(3%4.#'/%*3A%4,'.49'
share ideas that challenge the status quo so that together
>"'$.4'39"4(3B@'4">'>.@,'%B'.99*",,347'$)**"4('3,,)",:'
C/"'%2343%4,'"D2*",,"9'34'(/3,'
9%$)&"4('.*"'4%('%)*,'1)('(/"@'.*"'
(/%,"'%B'349"2"49"4('"D2"*(,'>/%,"'
<3">,'>"'*",2"$('5'"<"4'3B'>"'9%4E('
.#>.@,'.7*""'>3(/'(/"&:'6'(/.4?'
(/"&'B%*'(/"'(3&"'.49'"BB%*('(/"@'
/.<"'34<",("9'34'"D2#%*347'(/3,'(%23$:'
6'1"#3"<"'(/"@'/.<"'3&2%*(.4('(/347,'
(%',.@'(/.(',/%)#9'1"'%B'34("*",('(%'
.4@%4"'$%4$"*4"9'>3(/'(/"'#%47=("*&'
B)()*"'%B'(/"'/".#(/$.*"'349),(*@:
!"'/%2"'(/3,'9%$)&"4('$.4'%BB"*'@%)'
,%&"'34,37/(,'(/.('>3##'2*%<39"'(/"'
3&2"(),'(%'7"4"*.("'2%,3(3<"'$/.47":'
6('3,'(/"'+*,('%B'.',"*3",'.49'>"'#%%?'
B%*>.*9'(%'/".*347'@%)*'*",2%4,"'(%'
our ideas in the months to come.
FD"#'G"&"(A
Head of Vodafone mHealth Solutions
C/"'H%9.B%4"'-".#(/'0"1.("',"*3",'3,'2.*('%B'%)*'$%4(34)347'$%&&3(&"4('
(%'(/%)7/('#".9"*,/32'34'/".#(/$.*":'6('1*347,'(%7"(/"*',"43%*'2/.*&.I'2)1#3$'
.49'2*3<.("'/".#(/',(.?"/%#9"*,'(%'#".*4I',/.*"'.49'9"1.("'%4'3,,)",'.49'4">'
(/34?347'1*%)7/('B%*>.*9'1@'*"4%>4"9'(/%)7/('#".9"*,'.49'349),(*@'"D2"*(,:
Vodafone mHealth Solutions 4
Vodafone mHealth Solutions Insights Guide
Table of contents
3 Welcome
4 C.1#"'%B'$%4("4(,
5 J$%2"'.49'9"+43(3%4,
6 !/.('2.(3"4(,'.49'/".#(/$.*"'2*%B",,3%4.#,',.@
8 F4'%<"*<3">'%B'&-".#(/'%22%*()43(@
10 K<.#).(347'1"/.<3%)*'(%'&.*?"("9'
mHealth services
14 F9%2(347'("$/4%#%7@L')49"*,(.49347'(/"'
$/.##"47",'B%*'/".#(/$.*"'2*%B",,3%4.#,
16 M49"*,(.49347'/".#(/'2,@$/%#%7@'
.49'(/"',$3"4$"'%B'1"/.<3%)*
26 Vodafone mHealth Solutions
26 References
Vodafone mHealth Solutions 5
Vodafone mHealth Solutions Insights Guide
Scope and !"#$%&%'$(
N''&-".#(/L'.22#3$.(3%4'%B'&%13#"'.49'
4"(>%*?'("$/4%#%73",'(%'3&2*%<"'
/".#(/$.*"'%)($%&",'%*'"B+$3"4$3",O'
P%*'(/"',$%2"'%B'(/3,'*"2%*(I'>"'
B%$),'%4'2.(3"4('.49'/".#(/$.*"'
2*%B",,3%4.#'$"4(*"9'&-".#(/',"*<3$",'
including remote care and healthcare
2*%B",,3%4.#'&%13#3,.(3%4
N''&-".#(/',"*<3$",L'34$#)9",'.4@',%B(>.*"I'
/.*9>.*"I'.49',"*<3$",'*"Q)3*"9'(%'&.?"'
(/"'"49=(%="49'&-".#(/',%#)(3%4
N''R.(3"4(,L'34$#)9",'1%(/'$%4,)&"*,'
3:":'S/".#(/@T'3493<39).#,I'.49'2"%2#"'
>3(/'.'#%47'("*&'%*'.$)("'$%493(3%4'
N''-UR,L'/".#(/$.*"'2*%B",,3%4.#,'34$#)9347'
4)*,",I'2*3&.*@'.49',"$%49.*@'$.*"'
9%$(%*,I',2"$3.#3,(,I'.49'2/.*&.$3,(,:'
C/"'7)39"'>3##'B%$),'%4'1"/.<3%)*,'>3(/34'(/"'&.()*"'
&.*?"(,'.49'&.34(.34'(/"'B%##%>347'9"+43(3%4,'(/*%)7/%)('
(/"'*"2%*(L
Vodafone mHealth Solutions 6
Vodafone mHealth Solutions Insights Guide
What patients and
healthcare professionals say
V",)#(,',/%>'.'7"4)34"'34("*",('34'),347'
&%13#"'("$/4%#%7@'(%'3&2*%<"'2.(3"4('$.*"'
.49'34$*".,"'"B+$3"4$3",:'-%>"<"*'<"*@'
*".#'$%4$"*4,'"D3,('.*%)49'3(,'*"#3.13#3(@I'(/"'
$%,('%B'3&2#"&"4(.(3%4'.49'(/"'.13#3(@'%B'
2.(3"4(,'(%'),"'3(:'C/"'B%##%>347'$%&&"4(,'
.*"'34$#)9"9'34'(/3,'*"2%*('(%'73<"'(/"'*".9"*'
.4'3493$.(3%4'%B'(/"'*",2%4,",'>"'*"$"3<"9'
%4',2"$3+$'(%23$,:'
W"B%*"'.4.#@,347'(/"'$/.47347'.((3()9",'(%>.*9,'
&-".#(/'343(3.(3<",I'H%9.B%4"'$%&&3,,3%4"9'*",".*$/1
34'%*9"*'(%'1"(("*')49"*,(.49'(/"'$)**"4('.22*%.$/'(%'
/".#(/$.*"'9"#3<"*@'.&%47,('/".#(/$.*"'2*%B",,3%4.#,'
.49'(/"3*'2.(3"4(,:'
Stakeholder Group What they want from mHealth
Specialists C%'/"#2'&.4.7"'9.(.'.49'&.?"'(/"'1",('),"'%B'("$/4%#%7@
GPs C%'"&2%>"*'(/"3*'2.(3"4(,'.49'/"#2'(/"&'&.4.7"'$/*%43$'
diseases
Nurses C%'.$$",,'34,(*)$(3%4.#'34B%*&.(3%4'%*'2.(3"4('9"(.3#,'%4=(/"=7%
Pharmacists C%'/"#2'(/"&'&.4.7"'2.(3"4('2*",$*32(3%4,I'"4,)*"'.$$)*.$@'
.49'/"#2'>3(/'2.(3"4('$%&2#3.4$"
Patients C%'1"(("*'&.4.7"'.49'(*.$?'(/"3*'3##4",,",
Table 1 What HCPs and Patients say
What patients have to say
R.(3"4(,'$.4',""'(/"'1"4"+('%B'&-".#(/'
1"$.),"'3&2*%<"9'.$$",,'(%'34B%*&.(3%4'
"4.1#",'(/"&'(%'1"$%&"'&%*"'.$(3<"#@'
34<%#<"9'34'(/"3*'%>4'$.*":'C/3,'3,'
2.*(3$)#.*#@'(*)"'B%*'(/%,"'>3(/'$/*%43$'
$%493(3%4,',)$/'.,'93.1"(",'%*'/37/'1#%%9'
2*",,)*":'X%13#"'("$/4%#%7@'$.4'/"#2'
them to monitor their condition outside
.'/%,23(.#'"4<3*%4&"4(:'6('&".4,'&%*"'
2"%2#"'$.4'"4Y%@'.'4%*&.#'#3B"'1)('$.4'
*".$(',>3B(#@'(%'*"$"3<"'(*".(&"4(',/%)#9'
the need arise.
Vodafone mHealth Solutions 7
Vodafone mHealth Solutions Insights Guide
What healthcare professionals
have to say
C/"'&.Y%*3(@'%B'/".#(/$.*"'2*%B",,3%4.#,',""'
(/"'.9<.4(.7",'%B'&-".#(/'1)('>3(/34'(/"'
,"$(%*'93BB"*"4('"&2/.,3,'3,'73<"4'(%'93BB"*"4('
"#"&"4(,:'P%*'"D.&2#"I'4)*,",'.49'8R,'.*"'
&%,('$%4$"*4"9'>3(/'3&2*%<347'2.(3"4('
$%&2#3.4$":'8R,'.#,%',""'(/.('&-".#(/'
("$/4%#%7@'$.4'*"9)$"')44"$",,.*@'2.(3"4('
<3,3(,'.49'(/"*"B%*"'$)('$%,(,:'G)*,",'%4'(/"'
%(/"*'/.49'1"#3"<"'(/.('&-".#(/'343(3.(3<",'
&.@'>"##'*"9)$"'.9&343,(*.(3%4'(3&"I'>/3$/'
>3##'34'()*4'.##%>'(/"&'(%',2"49'&%*"'(3&"'
$.*347'B%*'(/"3*'2.(3"4(,:''P34.##@',2"$3.#3,(,'
.49'2/.*&.$3,(,'1"#3"<"'(/.('&-".#(/'
,%#)(3%4,'$.4'3&2*%<"'$%&&)43$.(3%4'
>3(/'8R,',%'(/.('(/"@'$.4',/.*"'93.74%,3,'
.49'#".*4347E,'&%*"'"BB"$(3<"#@:
-"*"'3,'>/.('(/"@'/.<"'(%',.@L'
0",23("'(/3,'"4(/),3.,&'&-".#(/'.9%2(3%4'/.,'4%('1""4',$.#"9'.,'&)$/'
.,'%4"'>%)#9'/.<"'"D2"$("9:'J)1,"Q)"4('"93(3%4,'%B'(/"'H%9.B%4"'64,37/(,'
8)39"'>3##'"D2#%*"'%(/"*'*".,%4,'B%*'(/3,'34'&%*"'9"(.3#'1)('/"*"I'34'(/"'+*,('
%B'(/"',"*3",I'>"'>3##'B%$),'%4'>/.(',%&"'>%)#9'.*7)"'3,'(/"'&.34'1.**3"*'(%'
(.?"')2'5'/)&.4'1"/.<3%)*:'
Improving quality of life
ZFB("*'6'+*,('/.9'&@'+*,('/".*('.((.$?'
B%*'(/"'(/*""'>""?,'1"(>""4'(/"'+*,('
%4"'.49'(/"',"$%49'%4"'6'/.9'(%'(.?"'
&@'1#%%9'2*",,)*"'/.#B'.'9%A"4'(3&",'
.'9.@'.('(/"'9%$(%*E,'%B+$"I'.49'6'$%)#9'
/.<"'Y),('),"9'&@'2/%4"'(%'*"$%*9'3('.('
/%&"'34,(".9E'
U.*93.$'R.(3"4(I'M['
Reassurance
Z64'&@'/%,23(.#'7*%)2I'>"'7"('34'(%)$/'
%<"*'(/"'64("*4"(:'C/"*"E,',%&"%4"'(/"*"'
(%'.4,>"*'@%)*'Q)",(3%4,']'/%)*,'.'9.@I'
either a doctor or a nutritionist. I can do
3('B*%&'/%&"'%*'>%*?I'.49'3('73<",'&"'
2".$"'%B'&349:E'
03.1"(3$'R.(3"4(I'J2.34
Discretion
Z6'9%4E('>.4('%(/"*'2"%2#"'(%'B""#',%**@'
B%*'&"'1"$.),"'6E&'.'93.1"(3$I',%'6'9%4E('
>.4(I'3B'6'(.?"'%)('.'$"##'2/%4"I'"<"*@%4"'
(%'?4%>'Z%/I'(/"'2%%*'7)@'3,'.'93.1"(3$:E'
03.1"(3$'R.(3"4(I'J%)(/'FB*3$.
Caring for patients
Z6('>%)#9'1"'43$"'(%'1"',.('>3(/'(/"'
2.(3"4('.49'/.<"'.'2/%4"'(%'*"73,("*'
>/.('@%)E*"'9%347I'>/.('@%)E<"'9%4"I'
and have that recorded and logged.
6(',/%)#94E('1"'.'4)*,347'Y%1I',/%)#9'3(^
'6('(.?",'.1%)('(>%'/%)*,'.'9.@'
>*3(347'(/"'4%(",:E
G)*,"I'M[:
Improved communication
between professionals
Z&-".#(/'>3##'1"'.4'.99"9'<.#)"'1"$.),"'
(/"'7"4"*.#'2*.$(3(3%4"*'>3##'#".*4'.1%)('
93BB"*"4('2.(/%#%73",'1@'*"$"3<347'
34B%*&.(3%4'B*%&'(/"',2"$3.#3,"9'9%$(%*:E'
J2"$3.#3,(I'J2.34
C/"'B%##%>347'Q)%(.(3%4,'.*"'"D.&2#",'%B'(/"'&.34'1"4"+(,'>/3$/'>"*"'/37/#37/("9:
Vodafone mHealth Solutions 8
Vodafone mHealth Solutions Insights Guide
An overview of
mHealth opportunity
C/"'&-".#(/'&.*?"('3,',(3##'<"*@'@%)47'
/%>"<"*'3('3,'$#".*'(/.('(/"'%22%*()43(@'B%*'
("$/4%#%7@'9*3<"4'/".#(/$.*"'3,'(/*3<347'
as a result of a changing healthcare
"4<3*%4&"4(:'V"&%("I'34("##37"4('
&%43(%*347'.49'93.74%,3,'B%*'"D.&2#"I'/.,'
(/"'2%("4(3.#'(%'"4/.4$"'Q).#3(@'%B'#3B"I'
3&2*%<"'/".#(/$.*"'"B+$3"4$@'.49'%BB,"('
1)*7"%4347'/".#(/$.*"'$%,(,'B*%&'.'7*%>347I'
.7"347'.49'34$*".,347#@'%1","'2%2)#.(3%4:
64'.'>.@I'>"'.*"'<3$(3&,'%B'%)*'%>4',)$$",,'
.49'1@'*"9)$347'(/"'$.),",'%B'9".(/'&.4@'
&%*"'2"%2#"'.*"'4%>'#3<347'34(%'.7"'1.49,'
(/"'>%*#9'/.,4E('"D2"*3"4$"9'1"B%*"'5'>/"*"'
(/"@'4""9'&%*"'$.*"'5'.49'&%*"'"D2"4,3<"'
$.*":'-".#(/$.*"',"*<3$",'.*%)49'(/"'>%*#9'
.*"'(/"*"B%*"')49"*'2*",,)*"'(%'34$*".,"'(/"'
Q).#3(@'%B'$.*"'(%'2.(3"4(,'.('.'(3&"'>/"4'
(/"'7#%1.#'2%2)#.(3%4'3,'.7347I'(/"'1)*9"4'
of chronic disease is rising and the economic
$%493(3%4,'.*"'$/.##"47347:'64'K)*%2"I'B%*'
"D.&2#"I'(/"'%<"*=_`,I'>/%,"'/".#(/$.*"'
$%,('1)*9"4'3,'B%)*'(3&",'(/.('%B'@%)47"*'
.7",I'>3##'.$$%)4('B%*'.('#".,('`a'%B'
(/"'2%2)#.(3%4'1@'b]b
:'F#%47,39"'(/3,I'
)4/".#(/@'#3B",(@#"'$/%3$",',)$/'.,'
,&%?347'.49'2%%*'93"(I'(/"'34$*".,347'*3,?'
%B'.49'$%4$"*4'.*%)49'(/"'2%("4(3.#'3&2.$('
%B'2.49"&3$'93,".,",I'(/"'#3&3("9'4)&1"*'
.49')4"<"4'93,(*31)(3%4'%B'/".#(/$.*"'
>%*?"*,I'2%%*'9*)7'93,(*31)(3%4'.49'(/"'
#"47(/@'9"<"#%2&"4('$@$#",'%B'4">'
&"93$34",'.*"'$%&134347'(%'&.?"'(/"'
$%,('%B'/".#(/$.*"'.#&%,(')4,),(.34.1#"'
2.*(3$)#.*#@'34'&.()*"'&.*?"(,:'
64'.993(3%4I'&.4@'/".#(/$.*"'2*%<39"*,'34'
9"<"#%2"9'&.*?"(,'.*"'"4$)&1"*"9'1@'
#"7.$@'34B*.,(*)$()*",'(/.('/.<"'1""4')4.1#"'
(%'.9.2('(%'&""('(/"'$/.47347'4""9,'%B'
(/"'<"*@'2"%2#"'(/"@'>"*"'9",374"9'(%'
2*%("$(:'J&.##'>%49"*'(/.('&.4.7"&"4('
$%4,)#(.4(,'X$[34,"@'2*"93$('(/.('3B'#"B('.,'3('
3,I'/".#(/$.*"'$%,(,'$%)#9'*".$/'cb'2"*'$"4('
%B'80R'1@'b]b:'C/"';KU0'3,'4%('B.*'1"/349'
>3(/'$%,(,'*".$/347'cb'2"*'$"4('%B'(/"'
&"93.4'80R'1@'bdb:'64'"&"*7347'&.*?"(,'
,)$/'.,'FB*3$.'>/"*"'.9)#('&%*(.#3(@'*.(",'.*"'
%<"*']bb'2"*'eIbbb'2%2)#.(3%4,I'.#%47,39"'
$%,(I'#.$?'%B'34B*.,(*)$()*"I'#3&3("9'.$$",,'(%'
(*".(&"4(,'.49'2%%*'Q).#3(@'&"93$34",'
.*"'(/"'$%*"'/".#(/$.*"'2*%1#"&,:'
f%%?347'./".9'3('3,'/%2"9'(/.(',&.*("*'
("$/4%#%73",'>3##'/"#2'(%'3&2*%<"'
$%&&)43$.(3%4,'1"(>""4'2.(3"4(,I'
/".#(/$.*"'2*%<39"*,'.49'(/%,"'(/.('2.@'.49'
&.4.7"'(/"',@,("&:'F,'.'*",)#('(/3,'/.,'(/"'
2%("4(3.#'(%'3&2*%<"'2.(3"4('B*""9%&'.49'
349"2"49"4$"I'*"9)$"'(/"'%<"*.##'$%,('.49'
3&2*%<"'2.(3"4('$.*":'C/3,'<3">'3,',)22%*("9'
1@'X$[34,"@'(/.('",(3&.(",'(/.('(/"'("#"=
/".#(/'%*'&-".#(/'349),(*@'>3##'1"'>%*(/'
%<"*'MJ'g`b'13##3%4'1@'(/"'"49'%B'(/"'9"$.9":
F'&.Y%*'7#%1.#'$/.##"47"'3,'/%>'(%'#%%?'
.B("*'%)*'"#9"*#@'.49'(/"'$/*%43$.##@'3##:'
X.4@'1"#3"<"'(/.('*%1%(3$'.,,3,("9'$.*"'
.49'*"&%("'&%43(%*347'>3##'%BB"*'<3.1#"'
,)22%*(:'C%9.@'7*%>347'4)&1"*,'%B'2)1#3$'
.49'2*3<.("'%*7.43,.(3%4,'/.<"'&%<"9'%4'
B*%&'1.,3$',@,("&,'%B'4)*,"'<3,3(,'.49'.*"'
.#*".9@'2*%<39347'("#"=/".#(/'1.,"9',)22%*('
(%'&%43(%*'<3(.#',374,'(/*%)7/'9.(.'#34?,I'
73<"'.9<3$"'%<"*'(/"'2/%4"'.49'.##%>'
*"&%("'3&.7347:'C"D('1.,"9',)22%*('%B'
&)#(32#"'2.(3"4(,'/.,'.#,%'2*%<"9'/37/#@'
"BB"$(3<"'B*%&'1%(/'(/"*.2")(3$'.49'
"$%4%&3$'2"*,2"$(3<",'34'&.4@'$%)4(*3",'
B*%&'(/"'R/3#32234",'(%'J%)(/'FB*3$.I'
8"*&.4@'(%'W*.A3#:
By Dr Tim JonesI'P%)49"*'.49'R*%7*.&&"'03*"$(%*'%B'
P)()*"'F7"49.I'.'7#%1.#'%2"4'B%*",37/('343(3.(3<"'
Vodafone mHealth Solutions 9
Vodafone mHealth Solutions Insights Guide
64'(/"'4"D('9"$.9"'("#"&"93$34"'
$%44"$(3<3(@'>3##'2*%<39"']hd'&"93$.#'
9.(.',/.*347'1"(>""4'2.(3"4(,'.49'
/".#(/$.*"'2*%B",,3%4,'>3(/'<39"%'#34?,I'
>".*.1#"'&%43(%*347'"Q)32&"4('.49'34=
/%&"',"4,%*,'(*.$?347'&%<"&"4(I'1%9@'
("&2"*.()*"'.49'%(/"*'<3(.#',374,:'C/"'
$%4,"Q)"4$"'%B'(/3,'>3##'1"'(/.('2.(3"4(,'
>3##'1"'.1#"'(%'*"(.34'(/"3*'349"2"49"4$"'
B%*'#%47"*'.49',%'1"(("*'"4Y%@'#3B"'%)(,39"'
(/"'&.34,(*".&'$.*"',@,("&:'J%&"'
commentators as a result envisage a
,#%>=9%>4'34'(/"'*"$"4('7*%>(/'%B'4)*,347'
/%&",'.,'.'7*".("*'2*%2%*(3%4'%B'(/"'"#9"*#@'
remain at home. While some suggest that
(/3,'34'()*4'$%)#9'&".4'34$*".,"9'2/@,3$.#'
3,%#.(3%4I'(/"'.&13(3%4'B%*'%(/"*,'3,'(%'),"'
("$/4%#%7@I'2.*(3$)#.*#@'&%13#"'("$/4%#%7@I'
(%'2*"<"4('2"%2#"'B*%&'B""#347'#%4"#@:'64'.'
>%*#9'>/"*"'%4'.<"*.7"'B.&3#@',)22%*('B%*'
(/"'%#9"*'7"4"*.(3%4'>3##'$%4(34)"'(%'9"$#34"'
.49'(/"'$%,('%B'2*%<39347'2"*,%4.#'$.*"*,'
>3##'$%4(34)"'(%'*3,"I'"#9"*#@'2.(3"4(,'.49'
(/%,"'>3(/'#%47'("*&'$/*%43$'93,".,",'.*"'
34$*".,347#@'#3?"#@'(%',""',%&"',("2'$/.47",'
34',)22%*('%<"*'(/"'4"D('B">'@".*,:'
In addition to automated care there is
7"4"*.#'$%4,"4,),'(/.('1"(("*'),"'%B'
2.(3"4('9.(.'3,'<3(.#'(%'3&2*%<"'"B+$3"4$3",'
5'2.*(3$)#.*#@'B%*'(/%,"'>3(/'%4=7%347I'
$/*%43$'$%493(3%4,',)$/'.,'93.1"(",:'C"$/=
,.<<@'93.1"(3$',)BB"*"*,'.#*".9@'1"4"+('
B*%&'.'7*%>347'4)&1"*'%B'&%13#"'2/%4"'
.22#3$.(3%4,'(/.('$.4'/"#2'*"$%*9'.49'(*.$?'
3493<39).#'&".,)*",I'93"('.49'2"*B%*&.4$"'
.49'(/"*"'.*"'34$*".,347'4)&1"*,'%B',@,("&,'
(/.('.##%>'(/"',/.*347'%B'9.(.'1"(>""4'
2.(3"4(,'.49'(/"3*'9%$(%*,:'W)3#9347'%4'(/3,I'
,"<"*.#'%*7.43,.(3%4,',)22%*('(/"'4%(3%4'
(/.('2""*=(%=2""*'.49'"D2"*('2.(3"4('7*%)2,'
&.@'/.<"'.,'&)$/'34i)"4$"'%4'3493<39).#'
1"/.<3%)*'.,'(/"'&%*"'(*.93(3%4.#'2.(3"4(=
/".#(/$.*"'2*%B",,3%4.#'*"#.(3%4,/32I',%'
"D2"$('(%',""'&%*"'2.(3"4('9.(.'1"$%&347'
&%*"'<3,31#"'.49'&%*"',/.*".1#"'.$*%,,'
2#.(B%*&,'.49',@,("&,'34'@".*,'(%'$%&":
6B'>"'$.4')(3#3,"'(/"'%22%*()43(@'(/.('(/"'
)13Q)3(@'%B'&%13#"'$%&&)43$.(3%4'%BB"*,I'
>"'$.4'1"(("*'B.$3#3(.("'(/"'9"#3<"*@'%B'&%*"'
"B+$3"4('.49'"BB"$(3<"'/".#(/$.*":'dba'%B'(/"'
,3D'13##3%43
'&%13#"',)1,$*31"*,'34'(/"'>%*#9'
(%9.@'#3<"'34'9"<"#%2347'$%)4(*3",'>/"*"'
(/"'4""9'B%*'(/"'2*%<3,3%4'%B'$.*"',"*<3$",'.('
2%34('%B'4""9'3,'7*".(",(:'
KD2"*3"4$"'/.,',/%>4'),'(/.('(/"*"'3,'.'
7*".('>3##3474",,'(%'),"'&%13#"'("$/4%#%7@'
>/"*"'(/"'7"4"*.#'2*%<3,3%4'%B'1.,"#34"'
/".#(/$.*"'3,'>".?",(:'C/"*"B%*"'3('3,'2"*/.2,'
)4,)*2*3,347'(%',""'(/.('(/","'2.*(,'%B'
(/"'>%*#9I')4"4$)&1"*"9'.,'(/"@'.*"'1@'
#"7.$@'34B*.,(*)$()*",I'/.<"'9"&%4,(*.("9'
.4'.13#3(@'(%'1"'43&1#"'34'(/"3*'.9%2(3%4'
%B'4">',%#)(3%4,'(/.('$.4'9"#3<"*'9"$"4('
2"*B%*&.4$"'.('.'#%>'$%,(:'649""9'(/"'
"&"*7347'>%*#9'/.,'1"$%&"'.'$.,"',()9@'
for healthcare innovation.
F'7%%9'"D.&2#"'%B'/%>'&.()*"'&.*?"(,'
.*"'#".*4347'B*%&'%(/"*,'$.4'1"'B%)49'
34'6493.'>/"*"'G.*.@.4.'-%,23(.#'/.,'
),"9'.'$%&134.(3%4'%B'1),34",,'&%9"#'
.49'2*%$",,'344%<.(3%4'(%'#%>"*'(/"'$%,('
%B'$.*93.$',)*7"*@'.49'34'9%347',%'/.,'
*"<%#)(3%43,"9'(/"'.$$",,I'<%#)&"'.49'*".$/'
%B'3(,'B.$3#3(3",'(%'1"$%&"'%4"'%B'(/"'B.,(",('
7*%>347'/".#(/$.*"'1),34",,",'34'(/"'>%*#9:'
F$$%*9347'(%'(/"'!JjI'j.$?'f">34I'UK;'%B'(/"'
F&"*3$.4'U%##"7"'%B'U.*93%#%7@I'(/"'#.*7"'
4)&1"*'%B'2.(3"4(,'2.,,347'(/*%)7/'(/"'
G.*.@.4.'B.$3#3(3",'.##%>,'3493<39).#'9%$(%*,'
(%'B%$),'%4'%4"'%*'(>%',2"$3+$'(@2",'%B'
$.*93.$',)*7"*3",'.49',%'9"<"#%2'2.*(3$)#.*'
,?3##,:'SG.*.@.4.'/.,'4%('%4#@'1"$%&"'(/"'
1",('2#.$"'(%'/.<"'/".*(',)*7"*@'1)('3('/.,'
.#,%'1"$%&"'(/"'7%=(%'B.$3#3(@'B%*'.##'.,23*347'
$.*93.$',)*7"%4,'7#%1.##@T:'
j.$?'f%*9I'UK;'%B'G.<37"43$,I'.)(/%*'%B'(/"'
343(3.#'2"*,2"$(3<"'%4'-".#(/'B%*'(/"'P)()*"'
F7"49.'R*%7*.&&"'%1,"*<"9'(/.(I'S%4'(/"'
2*%<3,3%4347'%B'/".#(/$.*"I'34"*(3.',""&,'
(%'1"'(/"'7*".(",('B%*$"T'.49'>"4('%4'(%'
2*"93$('(/.('S(/"'4"D('9"$.9"'3,'4%('(%'1"'
.'(3&"'%B'$/.47"'1)('34,(".9'.'(3&"'(/.('
,(*",,%*,'%4'(/"',@,("&'1"$%&"'
2*%7*",,3<"#@'"<39"4(O'34$*".,"9'1)*9"4,'
%B'9"&%7*.2/@'.49'$/*%43$'3##4",,'>3##'
*"&.34')4.1.("9T:'6WX'34'(/"3*'J&.*("*'
R#.4"('.4.#@,3,'1)3#9,'%4'(/3,'1@',.@347I'
SC/"'2*%1#"&,'>3(/'%)*'/".#(/$.*"',@,("&'
.*"'>"##'?4%>4'.49'>"##'9%$)&"4("9'5'.49'
"49#",,#@'9"1.("9:'!/.(E,'4%(',%'.22.*"4('
3,'(/.('&.4@'%B'(/"&'.*3,"'1"$.),"'%)*'
/".#(/$.*"',@,("&'3,4E(I'34'B.$(I'.',@,("&:T'
The need to address the rationale for this
34"*(3.'3,'2*",,347'.49'3(',""&,'$#".*'(/.('
&%13#"'("$/4%#%7@'/.,'.'?"@'*%#"'(%'2#.@'
in facilitating change.
Z!"'.*"'34'.'2"*B"$(',(%*&:'k%)E<"'7%('/".#(/$.*"'*"B%*&O'@%)E<"'7%('.4'"$%4%&3$'
9%>4()*4:::'>"'/.<"'.',/%*(.7"'%B'2*%<39"*,:'!"'/.<"'.'2*",,)*"'(%'.9%2('"#"$(*%43$'
*"$%*9,:'!"E<"'7%('.4'.7347'2%2)#.(3%4:'F49'@"(I'.('(/"',.&"'(3&"'>"'/.<"'(/","'
"&"*7347'4">'34B%*&.(3%4I'$%&&)43$.(3%4'("$/4%#%73",'(/.('$.4'/"#2'),'4.<37.("'
(/.('2"*B"$(',(%*&:E'
0.#"'F#<"*,%4I'R*",39"4('%B'(/"'F&"*3$.4'C"#"&"93$34"'F,,%$3.(3%4
!/"(/"*'34'(/"'9"<"#%2347'
"$%4%&3",'%*'34'(/"'!",('&%13#"'
("$/4%#%7@'/.,'.',3743+$.4('
*%#"'(%'2#.@:'6('$.4'9*.&.(3$.##@'
3&2*%<"'(/"'"B+$3"4$@'%B'
/".#(/$.*"'9"#3<"*@'&%9"#,I'B*%&'
,3&2#"'("D('&",,.7"'*"&349"*,I'
(%'3&2*%<347'$%&2#"D',)22#@'
$/.34'2*%$",,",'34'*"&%("'.*".,:'
6('3,'.#,%'>"##',)3("9'(%'3&2*%<347'
2.(3"4('$.*"I'%BB"*347'&"93$.#'
2*%B",,3%4.#,'(/"'.13#3(@'(%'$%##"$('
*".#=(3&"'93.74%,3,'B%*'$#343$.#'
(*3.#,I'73<347'$/*%43$'93,".,"'
sufferers the chance to live more
$%&B%*(.1#@'.49'349"2"49"4(#@'
.('/%&"'.49'2*%<39347'/".#(/$.*"'
>%*?"*,'.$$",,'(%'34B%*&.(3%4',%'
(/.('(/"@'$.4'(*".('&%*"'2.(3"4(,'
&%*"'"BB"$(3<"#@:'
''H%9.B%4"'&-".#(/'J%#)(3%4,''eb
Vodafone mHealth Solutions Insights Guide
Evaluating behaviour
to marketed mHealth
services
F,'&-".#(/'343(3.(3<",'"<%#<"'B*%&'23#%('(%'
&.34,(*".&I'(/3,',"$(3%4'39"4(3+",',%&"'
$%&&%4'.((*31)(",'%B'(/"'&%*"',)$$",,B)#'
343(3.(3<",'%2"*.(347'(%9.@'.$*%,,'.'4)&1"*'
%B'$%)4(*3",'34'(/"'9"<"#%2"9'>%*#9:'
A rapidly evolving space, favouring
the newcomer
&-".#(/'$%&134",'(/"'&%13#"I'6C'.49'
/".#(/$.*"'349),(*3",I'>/3$/'.##'/.<"'
93BB"*"4('2#.@"*,I'2.@"*,I'$)#()*",I'$#%$?'
,2""9,'.49'.((3()9",'(%>.*9,',"$)*3(@I'
2*3<.$@'.49'Q).#3(@:'C/3,'9@4.&3$'.*".'
B.<%)*,'4">$%&"*,I'.49'349""9'&%,('%B'
(/"'$%&2.43",'*"B"*"4$"9'34'(/3,',"$(3%4'
.*"'<"4()*"=1.$?"9',(.*(=)2,'>3(/'*.239#@'
7*%>347'),"*'1.,",'.49',(*%47'$.,/'2%,3(3%4,:'
A space that covers both healthcare
and wellness
C/"'$#".*",('93,(34$(3%4'1"(>""4'
93BB"*"4('$%&2.43",'3,'1"(>""4'/".#(/'
$.*"'.49'>"##4",,O'(/"'B%*&"*'("49'(%'1"'
*"7)#.(%*@=.22*%<"9'&"93$.#'9"<3$",'.49'
,"*<3$",'),"9'1@'9%$(%*,I'>/3#"'(/"'#.(("*I'
,)$/'.,'$.#%*3"'$%)4("*,I'+(4",,'1)993",'
.49',#""2'&%43(%*,I'.*"'(.*7"("9'
at consumers. Wellness solutions
7"4"*.##@'),"'1"/.<3%)*'$/.47"'(%'
9"#3<"*'>"##4",,'7%.#,'l,)$/'.,'#%>"*347'
$.#%*3",I'%*'3&2*%<347'.'`?'*)4'(3&"m'
>/3#"'/".#(/$.*"',%#)(3%4,'.*"'%B("4'9.(.'
7.(/"*"*,'.,'2.*('%B'.'#.*7"*'$#343$.#'
2*%$",,'l,)$/'.,'/".*('&%43(%*,'.49'&%13#"'
XV6,'lX.74"(3$'V",%4.4$"'6&.7347mm:'
Tools for chronic disease management
,)$/'.,'93.1"(",I'/@2"*("4,3%4'.49'
.,(/&.'("49'(%'9*.>'B*%&'1%(/'$.&2,I'
.49'*"2*","4(',%&"'%B'(/"'&%,('"D$3(347'
%22%*()43(3",'B%*'#%>"*347'$%,(,'.49'
3&2*%<347'2.(3"4('%)($%&",:'
C/"'.((*31)(",'#3,("9'/"*"'.*"'$.("7%*3,"9'
.$$%*9347'(%'.9%2(3%4I'"47.7"&"4('.49'
3&2.$('l.#,%',""'+7)*"em:'C/","'>%4E('
.22#@'"Q).##@'(%'.##'$%&2.43",I'/%>"<"*'
&.4@',)$$",,B)#'$%&2.43",'"D/313('(/"'
&.Y%*3(@'%B'(/","'.((*31)(",:'
By Stephen Johnston, Founder and CEO of Fordcastle LLC
>/3$/'/"#2,'9"<"#%2'$%&2.43",'(%'1)3#9'%22%*()43(@'
.*%)49'&%13#"'("$/4%#%7@I'/".#(/$.*"'.49'#%47"<3(@'
Figure 1 The common attributes of
successful mHealth services
IMPACTENGAGEMENT
ADOPTION
Simplicity
Empatheticdesign
Comprehensiveness
Interactive
Customerdelight
Uservalue
Joined-upsolutions
Clincalandeconomicresults
Vodafone mHealth Solutions 11
Vodafone mHealth Solutions Insights Guide
F9%2(3%4'
1. Simplicity
8%%7#"E,'F49*%39'.49'F22#"E,'3;J'/.<"'
&.9"'7*".(',(*39",'.('&.?347'$%&2#"DI'
&)#(3=B".()*"9',&.*(2/%4",',3&2#"I'.49'
/.<"'1""4'*">.*9"9'>3(/'.'$%&134"9'_na'
&.*?"(',/.*"'7#%1.##@'34'oc'bee4
:'-%>"<"*I'
(/"'&.Y%*3(@'%B'9"<3$",'34'2"%2#"E,'/.49,'
34'9"<"#%2"9'$%)4(*3",'.*"',(3##'Z9)&1EI'.49'
/".#(/$.*"'2.(3"4(,'34'2.*(3$)#.*'.*"'#3?"#@'
(%'1"'#",,'("$/',.<<@'(/.4'.<"*.7":'649""9I'
%4"'*"$"4(',()9@'B%)49'(/.('%4#@'`a'%B'
2.(3"4(,'>3(/'$/*%43$'93,".,",'>"*"'64("*4"('
users at all5
'l#"('.#%4"'&%13#"'64("*4"('),"*,mI'
>"##'1"#%>'(/"'.<"*.7"'.9)#('2"4"(*.(3%4'
%B'dna6
.
C"D('&",,.7347',"*<3$",'.*"'"BB"$(3<"'.('
9"#3<"*347'1.,3$',"*<3$",I',34$"'(/"@'>%*?'%4'
.#&%,('"<"*@'2/%4"'.49'(/"'*"$323"4('*".9,'
p`a'%B'("D('&",,.7",'>3(/34'B%)*'&34)(",'
of receiving.
H%D3<.I'B%)49"9'34'bbeI'2*%<39",'
C"D(]W.1@'(/.('9"#3<"*,'(/*""'("D(,'.'>""?'
(%'2*%,2"$(3<"'&%(/"*,'.B("*'(/"@'*"73,("*'
(/"3*'13*(/'9.("'),347'.',/%*('$%9":'C/"'("D('
&",,.7",'$%4(.34'"9)$.(3%4.#'$%4("4(I'
*"&349"*,'.49',)*<"@,:'G%>'>3(/'c`?'
,)1,$*31"*,I'(/"',"*<3$"'3,'7*%>347'.('e`?'
),"*,'2"*'&%4(/I'.49',3743+$.4(#@I'%4#@'
cca'%B'.##'),"*,'"<"*'*"73,("*"9'/.<"'
cancelled the service.
C/3,'Z,"('3('.49'B%*7"('3(E'$%4$"2('>%*?,'>"##O'
2.,,3<"',"*<3$",'("49'(%'*"(.34'),"*,'1"(("*'
(/.4'(/%,"'$%4,(.4(#@'*"Q)3*347'9.(.'"4(*@:'
X.4@'$.#%*3"'$%)4("*'.22,'/.<"'i%)49"*"9'
B%*'(/3,'*".,%4I'>/"*".,'>"##4",,'9"<3$",'
,)$/'.,'(/"'!3(/347,'!3=P3'"4.1#"9'1.(/*%%&'
,$.#"I'(/"'P3(13('>".*.1#"'1%9@'&%43(%*'.49'
(/"'q"%',#""2'(*.$?"*'.##'.)(%&.("'9.(.'
$.2()*"'.49'"4(*@'.B("*'343(3.#',"(')2:'
2. Empathetic design
X.*"?'R.>#%>,?3I'B%)49"*'%B'(/"'X%13#"'
M,"*'KD2"*3"4$"'U%4B"*"4$"I'),"9'(/"'("*&'
Z"&2.(/"(3$'9",374E'(%'9",$*31"'(/"'2*%$",,'
%B'"4,)*347'9",374"*,'*".##@'9%'(.?"'(/"'
needs of the end user into consideration.
F('%4"'%B'(/"3*'>%*?,/%2',",,3%4,'%4'
/".#(/$.*"I'2.*(3$32.4(,'34'.'1*.34,(%*&347'
%4'&%13#"'/".#(/'9"<3$",'B%*'(/"'"#9"*#@'
>"*"'73<"4'7#%<",'.49',/.9"9'7#.,,",'(%'
3##),(*.("'(/"'$/.##"47",'B.$"9'>/"4'2"%2#"'
>3(/'<3,).#'.49'2/@,3$.#'3&2.3*&"4(,'/.9'(%'
34("*.$('>3(/'&%13#",:'
C/"'j3(("*1)7'2/%4"'.49',"*<3$"'&.9"'1@'
8*".('U.##'3,'.'&%13#"',%#)(3%4'9",374"9'
>3(/'(/"'4""9,'%B'.7347'),"*,'34'&349'5'>3(/'
#.*7"'?"@,'.49',3&2#"',"*<3$"'%2(3%4,:'C/"@'
offer a medication reminder service for an
.993(3%4.#'&%4(/#@'$/.*7"'(/.('9"#3<"*,'
*"7)#.*'<%3$"'*"&349"*,'(%',)1,$*31"*,'(%'
(.?"'(/"3*'&"93$.(3%4:'
3. Comprehensiveness
P%*',%&"'&-".#(/',%#)(3%4,I'(/"'?"@'(%'
,)$$",,'#3",'34'(/"3*'$%&2*"/"4,3<"4",,:'
P%)49"9'34'eppnI'K2%$*.(",'3,'%4"'%B'(/"'
B">'2)1#3$'$%&2.43",'#3,("9'/"*"'.49'/.<"'
%<"*'.'9"$.9"E,'"D2"*3"4$"'$%##"$(347'.49'
%*7.43,347'$%4("4('B%*'2/@,3$3.4,:'C/"3*'9*)7'
*"B"*"4$"I'"9)$.(3%4.#'.49'$#343$.#',%#)(3%4,'
.*"'34'),"'1@'e:c&'/".#(/$.*"'2*%B",,3%4.#,I'
34$#)9347'%<"*'/.#B'%B'(/"'9%$(%*,'34'(/"'MJI'
>/%'*"#@'%4'3(,'$%&2*"/"4,3<"4",,:
;4'(/"'$%4,)&"*',39"I'(/"'3C*3.7"'.22'(/.('
/.,'1""4'9%>4#%.9"9'.#&%,('(/*""'&3##3%4'
(3&",I',"",')2'(%'%4"'&3##3%4'&%4(/#@'),"*,'
.49'1%.,(,'ebIbbb'l&%,(#@'2%,3(3<"m'*"<3">,'
%4'F22#"E,'F22,(%*":'UK;'R"("*'-)9,%4I'
X0I'/37/#37/(,'3(,'349),(*@=#".9347'$%4("4('
.77*"7.(3%4'$.2.13#3(3",'l34'.993(3%4'(%'
,(*%47'$),(%&"*',)22%*(m'.,'.'?"@',)$$",,'
B.$(%*:'C/"@'2*%<39"'34B%*&.(3%4'.1%)('
,@&2(%&,'.,'>"##'.,'34("7*.(3%4'34(%'
/)49*"9,'%B'2.*(4"*'/".#(/$.*"'2*%<39"*,I'
*",)#(347'34'>/.('3,'"BB"$(3<"#@'1"$%&347'.'
White Pages of consumer health services.
Engagement
4. Interactive
R*%<39347'2"*,%4.#3,"9'B""91.$?'(/.('.##%>,'
users to see the results of their actions
&.?",'B%*'.'&%*"'"47.7347'"D2"*3"4$":'
The Consumer Health Information
U%*2%*.(3%4'lU-6Um'B%)49'(/.('.'Q).*("*'%B'
.##',&.*(2/%4"'.22,'l4%('Y),('/".#(/'.22,m'
>"*"'9*%22"9'.B("*'(/"'+*,('7%I'.49'(/*""=
Q).*("*,'>"*"'4%'#%47"*'),"9'.B("*'(/"'("4(/'
(*@:'V".,%4,'B%*'9*%22347'.4'.22'34$#)9"9'
+49347'.'1"(("*'%4"'lc]:]amI'3(,'#.$?'%B'
S),"*'B*3"49#34",,T'lc:_amI'%*'3('4%('1"347'
"47.7347'"4%)7/'le`:nam:';B'.',)*<"@'%B'
cp`'$%4,)&"*,I'.1%)('nba',.39'(/"@'
>%)#9'1"'&%*"'&%(3<.("9'(%'),"'.4'.22'
(/.('>%)#9'.4.#@,"'9.(.'(/"@'*"$%*9"9'
.49'2*%<39"'B""91.$?7
.
-".#(/$.*"'("$/4%#%7@'$%&2.4@'
!"##0%$I'64$:')49"*,(.49,'(/3,:'
C/"3*'i.7,/32'03.1"(",X.4.7"*®
I'(/"'+*,('
&%13#"'93.1"(",'&.4.7"&"4(',%#)(3%4'(%'
*"$"3<"'P0F'`eb['$#".*.4$"I'2*%<39",'
,3&2#"'.49'2*%<"4I'$#343$.#'.49'1"/.<3%)*.#'
"<39"4$"=1.,"9'7)39.4$"'.1%)('/%>'(%'
&.4.7"'7#)$%,"'#"<"#,I'&"93$.(3%4,I'
.$(3<3(@I'93"('.49',"<"*.#'%(/"*'2.*.&"("*,'
>/3$/'.BB"$('(%(.#'93.1"(",'>"##4",,:'
U%&2.4@'R*",39"4('F4.49'6@"*',"",'3('.,'
.'S&%13#"'<3*().#'$%.$/347',%#)(3%4T'(/.('
2*%<39",'1.,3$'$#343$.#'.49'1"/.<3%)*.#'
,)22%*(I'"BB"$(3<"#@'2*%<39347'.4'34("*.$(3<"'
$%.$/'34'2"%2#"E,'2%$?"(,:
''H%9.B%4"'&-".#(/'J%#)(3%4,''e
Vodafone mHealth Solutions Insights Guide
Z!"E<"',""4'&.4@'2*%7*.&&",'(/.('/.<"'1""4'7*.4('B)49"9:'C/"'7*.4('"49,'.49'(/"'
2*%7*.&&"'"49,:'J%'>"'.,?'2"%2#"'(%'(/34?'.1%)(',),(.34.13#3(@'.49'(%'$%&"')2'>3(/'
.'1),34",,'2#.4'(/.('&.?",',"4,":'!/.(E,'(/"'9.(.'>"'4""9'(%'$%##"$('(%',/%>'(/"'
3&2.$('.49'>/.('.*"'(/"'3493$.(%*,'%B',)$$",,:'k%)E<"'7%('(%'1"'.1#"'(%'9"("*&34"'(/.(:'
C"#"/".#(/'>3##'4%('1"',),(.34"9'%*'.9%2("9')4#",,'>"'$.4',/%>'(/.('3('3&2*%<",'/".#(/'
%)($%&",'.49'*"9)$",'$%,(,:E'
U#343$3.4I'MJ
5. Customer delight, even fun
P)4$(3%4'/.,'7"4"*.##@'(*3)&2/"9'%<"*'
B%*&'34'(/"'/".#(/$.*"'1),34",,I'>/3#"'34'
(/"'$%4,)&"*'"#"$(*%43$,'.49'&%13#"',2.$"'
.'<.,('.&%)4('%B'(3&"'3,',2"4('(/34?347'
.1%)('),"*'"D2"*3"4$":'
C/"'W%,(%4I'XF=1.,"9',(.*(=)2'
P3(4",,[""2"*'/.,'.((*.$("9'_&'),"*,'(%'3(,'
V)4[""2"*',"*<3$"'>3(/%)(',2"49347'.'$"4('
%4'.9<"*(3,347:'P%)49"*'r'UK;'j.,%4'j.$%1,'
(/34?,'(/.('S1)3#9347'.'2*%9)$('2"%2#"'
#%<"T'3,'(/"'?"@'(%'(/3,'%*7.43$'7*%>(/:'64'
.993(3%4I'/"'$3(",'(/"',%$3.#'$%&2%4"4(I'
.$$"#"*.("9'1@'P.$"1%%?'.49'C>3(("*I'.49'
(/"'$%&&)43(@',)22%*(I'.,',)$$",,'B.$(%*,:'
0"#37/('9%",4E('/.<"'(%'1"'*","*<"9'B%*'
>"##4",,'.22,:'C/"'B%)49"*,'%B'HU=1.$?"9'
,(.*(=)2'X.,,3<"'-".#(/'.*"'),"*'"D2"*3"4$"'
"D2"*(,'>3(/%)('/".#(/$.*"'1.$?7*%)49,I'
.49'/.<"'<%>"9'(%'1*347'$),(%&"*'9"#37/('
(%'(/"'+"#9'%B'/".#(/$.*":'C/"@'.*"'$)**"4(#@'
1"(.'(",(347'(/"3*'+*,('2*%9)$(I'.'93.1"(",'
&.4.7"&"4(',%#)(3%4I'.49'UK;'J)(/.'
[.&.#',.@,'(/.(')#(3&.("#@'/"E,'S#%%?347'
B%*'(/"'7*34T'%4'(/"'),"*E,'B.$":'64'.993(3%4I'
344%<.(3<"'2*%Y"$(,'.*"'),347'X3$*%,%B(E,'
[34"$(E,'&%(3%4=,"4,347',%#)(3%4'(%'.,,",,'
".*#@'93,".,"',@&2(%&,8
I'.49'7.&"'
9@4.&3$,'.*"'1"347'),"9'(%'"4$%)*.7"'
&"4(.#'.49'2/@,3$.#'+(4",,I',)$/'.,'>3(/'
-)&.4.E,'U%#%*B.##:
6&2.$(
6. User value
J&.*(',%#)(3%4,'9%'&%*"'(/.4'Y),('
*"2#3$.("'"D3,(347'2*%$",,",'%4',&.##'
,$*""4,I'(/"@'#%%?'B%*'>.@,'34'>/3$/'(/"'
2*%$",,'$.4'1"'9%4"'1"(("*I'9"#3<"*347'
#.,(347'),"*'1"4"+(,'(/.(',3743+$.4(#@'
%)(>"37/'.4@'$%,(,'34$)**"9:'
FA)&3%E,'Z64,(.4('-".*('V.("E'.22'9"#3<"*,'
Y),('>/.('3('2*%&3,",I'(.?347'(/"'/".*('*.("'
B*%&'(/"'+47"*'34'Y),('.'B">',"$%49,:'6('
),",'(/"'2/%4"E,'34=1)3#('$.&"*.'$%&134"9'
>3(/'(/"'#37/('B*%&'(/"'i.,/'(%'(*.$?'$%#%)*'
$/.47",'34'(/"',?34'(/.(',/%>'/".*('*.(":'
C/3,'344%<.(3<"'.22*%.$/I'(%7"(/"*'>3(/'.4'
attractive user interface has resulted in this
.22'1"347'9%>4#%.9"9'eb'&3##3%4'(3&",'1@'
;$(%1"*'bebO'.('gb:pp'.'9%>4#%.9I'(/3,'/.,'
1"$%&"'%4"'%B'&-".#(/E,',)$$",,',(%*3",:'
J%#)(3%4,'(/.('&.?"'B)##'),"'%B'(/"'&)#(3=
B.$"("9'2%>"*'%B'(/"'&%13#"'$.4'9"#3<"*'
even more value to users than those that
Y),('*"2#3$.("'"D3,(347'%Bi34"'2*%$",,",:'
C/3,'3,'",2"$3.##@'3&2%*(.4('>/"4'%4"'
$%4,39"*,'(/"'&@*3.9'%B'"D3,(347'93,(*.$(3%4,'
%4'(/"'2/%4"'(/.('.*"'.#*".9@'$%&2"(347'
B%*'(/"'),"*E,'.(("4(3%4I',)$/'.,'?""2347')2'
>3(/',%$3.#'4"(>%*?,I'$%4,)&347'&"93.'%*'
2#.@347'7.&",:
7. Clinical and economic results
-".#(/=B%$),"9',%#)(3%4,'(/.('$.4',/%>'
1%(/'$#343$.#'.49'"$%4%&3$'1"4"+(,'(%'.##'
2.*(3",'>3##',""'(/"'&%,('*.239')2(.?":'
F3*J(*32'C"$/4%#%73",'9"#3<"*,'4".*'*".#=(3&"'
>.<"B%*&'.49'%(/"*'*"#"<.4('$#343$.#'9.(.'(%'
.'2/@,3$3.4E,',&.*(2/%4":'C/"'$%&2.4@E,'
;W'2*%9)$('/.,'1""4',%',)$$",,B)#'
34'*"9)$347'/)&.4'"**%*,I'(/.(',%&"'
&.#2*.$(3$"'34,)*.4$"'$%&2.43",'34'(/"'
MJ'.*"',)1,393,347'(/"'$%,(,'B%*'9%$(%*,'
(%'),"'3(:'64'.993(3%4I'34("*4.#',()93",'/.<"'
,/%>4'(/.('(/"3*'$.*93%#%7@',%#)(3%4'$.4'
$)(',/%*('(/"'(3&"'B*%&'KXJ'lK&"*7"4$@'
X"93$.#'J"*<3$",m'(%',)*7"*@'1@')2'(%'e`'
&34)(",I'.49'*"9)$",'(/"'.<"*.7"'(3&"'
,2"4('34'/%,23(.#'B%##%>347'.'/".*('.((.$?'
1@'.#&%,('.'9.@:'
F',$3"4(3+$',()9@'*"2%*("9'34'(/"'J"2("&1"*'
bee'"93(3%4'%B'(/"'Y%)*4.#'%B'(/"'F&"*3$.4'
03.1"(",'F,,%$3.(3%4I',/%>,'(/.('!"##0%$E,'
03.1"(",X.4.7"*®
'9"#3<"*"9'.'e:pa'9"$#34"'
%<"*'.'@".*'34'(/"'?"@'93.1"(",'&"(*3$'
lFeU'5'8#@$.("9'/."&%7#%134mI'$%&2.*"9'
(%'b:da'34'(/"'(",('7*%)2:'!3(/'".$/'ea'
34$*".,"'34'(/"'FeU'#"<"#'*"2*","4(347'.'
s]ba'34$*".,"9'*3,?'%B'&3$*%'.49'&.$*%'
<.,$)#.*'$%&2#3$.(3%4,'B%*'93.1"(",'2.(3"4(,I'
.49'.4'.<"*.7"'&%4(/#@'$%,('%B'%<"*'gcbbI'
*",)#(,',)$/'.,'(/","'&.?"'3('&%*"'#3?"#@'
(/.('2/@,3$3.4'.49'*"7)#.(%*,'>3##'*.239#@'
.9%2('.49'"&1*.$"'(/","',"*<3$",:'
Vodafone mHealth Solutions 13
Vodafone mHealth Solutions Insights Guide
8. Joined-up solutions
J)$$",,B)#',"*<3$",'("49'(%'1"'34("7*.("9'
34(%'%(/"*'.,2"$(,'%B'(/"'2.(3"4(E,'#3B"'
.49'(/"'/".#(/$.*"',@,("&:'C/3,'"D2#.34,'
(/"'4""9'B%*'S,%#)(3%4,'.,'%22%,"9'(%'
("$/4%#%73",TI'.$$%*9347'(%'j%"'J&3(/'B*%&'
West Wireless Health Institute.
X3$*%,%B('-".#(/'H.)#(E,'J".4'G%#.4',.@,I'
SC/"'>%*#9'9%",4E('4""9'%4"'&%*"'3,%#.("9'
,3#%'%B'9.(.'B%*'(*.$?347'>/.("<"*:'&-".#(/'
,"*<3$",'/.<"'(%'"D3,('>3(/34'(/"'$%4("D('
%B'(/"'B%*&.#'.49'34B%*&.#'$.*"'(".&:T'
C/"'-".#(/'H.)#('2#.(B%*&'$%44"$(,'cbb'
.22#3$.(3%4,'.49'db'/%&"'$.*"'9"<3$",I'
.49'$%##.1%*.(",'>3(/'.'7*%>347'4)&1"*'
%B'/".#(/$.*"'2*%<39"*,:'
P3(4",,[""2"*'%BB"*,'Y%34"9=)2',%#)(3%4,'
$%&347'B*%&'(/"'>"##4",,'2"*,2"$(3<":'
C/"@'*"$"4(#@'#.)4$/"9'.'-".#(/'8*.2/'FR6'
(/.(',)22%*(,'.4'"$%,@,("&'%B'(/3*9'2.*(@'
9"<"#%2"*,'(/.('34("7*.("'>3(/'(/"'2#.(B%*&'
.49',/.*"'.B+#3.("'*"<"4)",:'R.*(4"*,'
34$#)9"'&.4@'%B'(/"'&%*"'2*%&3,347'
&-".#(/'9"<3$",I',)$/'.,',#""2'(*.$?"*'
q"%I'(/"'!3(/347,'>3*"#",,',$.#"'.49',%$3.#'
7.&347',3("'P3(%$*.$@:'
-".#(/'8*.2/'FR6'/.,'1""4'73<"4'.'1%%,('
,34$"'8%%7#"'2)##"9'(/"'2#)7'%4'3(,'/".#(/'
,"*<3$":'C/"'B.3#)*"'%B'(/3,'343(3.(3<"'>.,'9)"'
(%'&.4@'*".,%4,I'1)('%4"'>.,')49%)1("9#@'
(/"'#.$?'%B'34("7*.(3%4'.49'34$"4(3<",'(%'
"4$%)*.7"'2.*(3$32.(3%4'>3(/'%(/"*'2#.@"*,'
34'(/"'/".#(/',@,("&I'3:":'2/@,3$3.4,'.49'
2.@"*,:'F,'.'*",)#(I'(/"*"'>.,'%4#@'#3&3("9'
1"4"+('(%'(/"'),"*,'B%*'7%347'(%'(/"'"BB%*('
%B')2#%.9347'9.(.'34(%'.',3#%"9',"*<3$":'
C%>.*9,'.4')49"*,(.49347'%B'),"*'.9%2(3%4'1.**3"*,
C/"'.((*31)(",'#3,("9'34'(/3,',"$(3%4'$.4'34i)"4$"'.'4)&1"*'%B'
9"$3,3%4,'(/.('7%'34(%'(/"'$*".(3%4'%B'.'4">'&-".#(/',%#)(3%4I'B*%&'
9",374'%B'(/"'+*,('),"*'"D2"*3"4$"I'(%'(/"'1),34",,'2.*(4"*,/32,'(/.('
4""9'(%'1"'34'2#.$"'B%*'(/"',%#)(3%4'(%'1"'#.,(347#@'"BB"$(3<":'-%>"<"*I'
34'(/"',.&"'>.@I'(/","'.((*31)(",'$.4'.#,%'/"#2'(%'1"(("*')49"*,(.49'
(/"'1.**3"*,'(/.('$)**"4(#@'2*"<"4('>39",2*".9'),"*'.9%2(3%4'5'B.$(%*,'
,)$/'.,'$%&2#"D3(@I'2%%*#@'(/%)7/('%)('9",374,I'.49'93,Y%34("9'
,%#)(3%4,'(/.('9%4E('34("7*.("'34(%'.'2.(3"4(E,'#3B":'
J3743+$.4('%22%*()43(3",'1"$?%4'B%*',.<<@'"4(*"2*"4")*,'>/%'$.4'
,)$$",,B)##@'4.<37.("'1"(>""4'(/"'(>%'>%*#9,I'34$%*2%*.("'&.4@'%B'
(/","'.((*31)(",'.49'34',%'9%347I',(.*('(%'9"#3<"*'%4'&-".#(/E,'2%("4(3.#'
%B'#%>"*347'$%,(,'.49'3&2*%<347'2.(3"4('$.*":'
Vodafone mHealth Solutions 14
Vodafone mHealth Solutions Insights Guide
V"7)#.(%*@'$%&2#"D3(@I'+4.4$3.#'
$%4,(*.34(,I'"4(*"4$/"9'34B*.,(*)$()*",'
.49'2%%*'34<",(&"4('34'("$/4%#%7@'
$%&134"9'>3(/'.'#.$?'%B')49"*,(.49347'
1@'("$/4%#%7@'2*%<39"*,'/.,'&".4('(/.('
9373(.#'344%<.(3%4'34'/".#(/$.*"'/.,'1""4'
,#%>'(%'(.?"'/%#9:'-%>"<"*I'73<"4'$/.47347'
/".#(/$.*"'4""9,'%B'.4'34$*".,347#@'.7"347'
2%2)#.(3%4'.49'(/"'$/.##"47",'2*","4("9'
1@'(/"'$)**"4('"$%4%&3$'$*3,3,I'(/"*"'
3,'*"4">"9'34("*",('34'(/"'2%("4(3.#'%B'
&-".#(/'.49'64("*4"(',%#)(3%4,'(%'/"#2'
*"9)$"'$%,(,I'34$*".,"'"B+$3"4$3",'
and effectiveness.
C/3,',"$(3%4'$%4,39"*,'(/"'2*.$(3$.#'*".,%4,'
1"/349'(/"',#%>"*'(/.4'"D2"$("9'.9%2(3%4'
of digital health technologies and discusses
"D2"*3"4$",'B*%&'%(/"*',"$(%*,'(/.('$%)#9'
2%("4(3.##@'/"#2'$*".("'>39"',$.#"'.9%2(3%4:
Creating a better customer-centric
experience
M49"*,(.49.1#@'2.(3"4(,'.49'2/@,3$3.4,'
>%)#9'2*"B"*'(%'&.4.7"'/".#(/$.*"'
,"*<3$",'34'.',3&2#"'.49',(*.37/(B%*>.*9'
>.@:'-%>"<"*'&.4@'#3B"',$3"4$"'$%&2.43",'
(%'9.("'/.<"'4%('.$?4%>#"97"9'(/3,'.49'
/.<"'34,(".9',"(')2'.'93,2.*.("',"('%B'
34("*B.$",'>/3$/'.*"'(3*",%&":
F$*%,,'#3B"',$3"4$"'$%&2.43",I'(/"'
9"B.)#('.22*%.$/'(%'%4#34"'34("*.$(3%4'3,'
.',(.49.*9',(.(3$'>"1,3("9
'>/"*"'2*%9)$('
34B%*&.(3%4'$.4'1"'B%)49'34'%4"'2#.$"I'
$%&2.4@'34B%*&.(3%4'34'.4%(/"*I'.49'
(/"*"'3,'4%'%1<3%),'%<"*<3">'%B'(/"'<.#)"=
.99"9',"*<3$",'2*%<39"9:'C/3,'3,'.'/)7"'
&3,,"9'%22%*()43(@:
R"*/.2,'#3B"',$3"4$"'%*7.43,.(3%4,',/%)#9'
#%%?'(%'%(/"*',"$(%*,'B%*'7)39.4$":'
F&.A%4E,'>"1,3("'B%*'"D.&2#"'$.4'73<"'
@%)'.#&%,('.4@(/347'@%)'4""9'>3(/'.'
,347#"',".*$/'B)4$(3%4'.49'.'B">'$#3$?,:'
K<"*@'2)*$/.,"'B%##%>,'(/"'"D.$(',.&"'
,3&2#"'2.(("*4'.49'@%)'9%4E('4""9'(%'
+##'%)('@%)*'2.@&"4('%*'9"#3<"*@'9.(.'.'
,"$%49'(3&":'64'.993(3%4I'F&.A%4'),",'
,%$3.#'*"$%&&"49.(3%4,'.49'2*"93$(3<"'
&.*?"(347'(%'/"#2'@%)'.,'.4'3493<39).#'
(%'+49'(/"'(/347,'@%)'9394E('"<"4'?4%>'
@%)'4""9"9'@"(:';4"'(*),(>%*(/@'2.*(4"*'
(/.('?4%>,'@%)*'2*"B"*"4$",'.49',)22%*(,'
@%)'.$$%*9347#@I'.'9*".&'$%&"'(*)":::'
,%'>/@'.*"'#3B"',$3"4$",'$%&2.43",'4%('
"&1*.$347'(/3,^
F9&3(("9#@I'(/"'349),(*@'3,'#".*4347'5'1)('
,#%>#@:'C.?"'B%*'"D.&2#"'(/"'MJ'1.,"9'
9373(.#'/".#(/$.*"'2%*(.#'-".#(/8*.9",:'
6('/"#2,'2.(3"4(,'+49'9%$(%*,'.$$%*9347'
(%'(/"3*'4""9:'f"(E,',.@'@%)'4""9'(%'+49'
.'$.*93%#%73,('$#%,"'(%'G">'k%*?I'(/"4'
@%)'$.4'+49'&%*"'(/.4'`bb'2%,,31#"'Gk'
$.*93%#%73,(,'%4'(/3,'2%*(.#:'-%>'9%'@%)'
?4%>'>/3$/'2/@,3$3.4'>3##'2*%<39"'(/"'
1",('$.*"^'C/*%)7/'/37/=<%#)&"'2.(3"4('
*.(347,I'(/"'2/@,3$3.4,'.*"'*.4?"9'
$%4<"43"4(#@'.49'@%)'$.4'3&&"93.("#@'
+49'(/"'2/@,3$3.4'%B'@%)*'$/%3$":'
)"*%+",%$-./*"0,.1(",.2"$"#&
SC/"'#.,('(>"4(@'@".*,'>"*"'.1%)('
1"$%&347'9373(.#I'(/"'4"D('(>"4(@'@".*,'
>3##'1"'.1%)('1"$%&347'$#"<"*'>3(/'9373(.#TI'
,.@,'U/.3*&.4'%B'F$*%,,'C"$/4%#%7@I'R"("*'
-34,,"4:'C/3,'&37/(',%)49'(*3("'1)('34'%*9"*'
(%'),"'("$/4%#%7@'$),(%&"*,'&),('+*,('
By Fonny Schenck,
UK;'.('F$*%,,'-".#(/I'.4'
international management
$%4,)#(.4$@'B%*'9373(.#'
innovation in life sciences
Adopting technology:
understanding the challenges
for healthcare professionals
Vodafone mHealth Solutions 15
Vodafone mHealth Solutions Insights Guide
)49"*,(.49'3(,'1"4"+(,:'649""9'34'.'>.@'
("$/4%#%73,(,'/.<"'1""4'93,(*.$("9'1@'(/"'
$%4$"2('%B'("$/4%#%7@'5'.49'34,(".9'%B'
>%*?347'(%>.*9,'1"(("*',"*<3$",'/.<"',2"4('
(%%'&)$/'(3&"'(*@347'(%'1)3#9'.'$#"<"*"*'
,@,("&:'F3*J(*32'UK;'F#.4'R%*("#.'"D2#.34"9'
(/3,'34'(/"'$%4("D('%B'K#"$(*%43$'X"93$.#'
V"$%*9,I'KXV,L'SKXV,'.*"'2#.(B%*&,I'C/"'
,.&"'>.@'(/.('@%)*'$%&2)("*'/.,'.4'
t%2"*.(347',@,("&u'5'KXV,'.*"'(/"';J:'
k%)'1"4"+('B*%&'(/"'.22,'(/.('@%)'2)('%4'
(%2'%B'(/"';JI'>/3#"'@%)'9%4E('1"4"+(',%'
much from the OSeb
:T';B'$%)*,"'>3(/%)('
(/"';2"*.(347'J@,("&'(/"'.22,'>%)#9'4%('
>%*?'1)(',(3##I'(/"'2%34('4""9,'(%'1"'&.9":'
&-".#(/'("$/4%#%7@'2*%<39"*,'>%)#9'9%'
>"##'(%'1".*'(/3,'34'&349'>/"4'$%4,39"*347'
2*%9)$('344%<.(3%4,:
Right place, right technology, right
doctor and right patient
64'(/"'B)()*"'/".#(/$.*"'>3##'1"'9"#3<"*"9'
through a multitude of channels and it
3,'$#".*'(/.('&%13#"'9"<3$",'>3##'/.<"'.'
93,(34$('*%#"'(%'2#.@'34'(/3,:'W)('&%13#"'
9"<3$",'.*"'4%('(/"'%4#@'%2(3%4I'%(/"*'
9"<3$",'%*'$/.44"#,',/%)#9'.49'>3##'1"'
),"9'>/"4'&%*"'.22*%2*3.(":
G%('%4#@'9%'$"*(.34'9"<3$",'+('$"*(.34'
$%4("D(,'1"(("*I'(/"',"*<3$",'2*%<39"9'
on these devices should integrate as
,".&#",,#@'.,'2%,,31#"'>3(/'(/"'4%*&.#'
>%*?'2.(("*4,'%B'(/"'/".#(/$.*"'2*%B",,3%4.#'
.49'2.(3"4(:'P.3#)*"'(%'.$/3"<"'(/3,'/.,'34'
(/"'2.,('#"9'(%',3743+$.4('+4.4$3.#'
34<",(&"4('>3(/%)('.4@'&.("*3.#'7.34:
mHealth technologists need to consider
/%>'1",('(%'+('(/"3*',"*<3$"'34(%'(/"'
2.(3"4(,E'9.3#@'#3<",'%*'(/"'2/@,3$3.4,E'
4%*&.#'>%*?i%>:'C/"'?"@'Q)",(3%4'(/"@'
,/%)#9'.,?'3,'/%>'$.4'>"'&.?"'(/"3*'#3<",'
".,3"*I'.49'4%('&%*"'93B+$)#(^'
Understanding pricing and
reimbursement dynamics
C/"'34("*4"('/.,'*.93$.##@'(*.4,B%*&"9'
2*3$347'&%9"#,'.49'&.4@'%*7.43,.(3%4,'
.*"'1.((#347'(%'.9.2('(%'(/3,:'64$*".,347#@'
SB*""&3)&T'&%9"#,'$%&134"9'>3(/'
advertising have great success. There
.*"'.##',%*(,'%B'>.@,'%B'.9%2(347'.'
B*""&3)&'.22*%.$/:'P%*'"D.&2#"I'34'/3,'
1%%?'SP*""L'(/"'P)()*"'%B'.'V.93$.#'R*3$"T'
U/*3,'F49"*,%4'9",$*31",'/%>'2*.$(3$"'
&.4.7"&"4(',%B(>.*"'3,'73<"4'.>.@'1@'
(/"'U.#3B%*43.4'$%&2.4@'R*.$(3$"'P),3%4:'
C/"'2/@,3$3.4,'.*"'73<"4'(/"'B*""'<"*,3%4'%B'
(/"',%B(>.*"'>3(/'.9,'%*'$.4'1)@'.4'.9=B*""'
<"*,3%4'B%*'ebb'MJ0'2"*'&%4(/:'F993(3%4.#'
<.#)"'3,'$*".("9'1@',"##347'.4%43&3,"9'
2.(3"4('$/.*(,'(%'&"93$.#'.,,%$3.(3%4,'
B%*'*",".*$/'2)*2%,",:'ebbIbbb'&"93$.#'
2*%B",,3%4.#,'.*"'$)**"4(#@'),347'(/"'
,"*<3$"'.49'(/"'4)&1"*'3,'7*%>347I'>3(/'
c`b'4">'),"*,'"<"*@'9.@11
.
J(.49.*9'/".#(/$.*"'2*.$(3$"'3,'
,%&">/.('93BB"*"4('(%'(/3,:'64'9"<"#%2"9'
"$%4%&3",'$%&&%4'2*.$(3$"'3,'(%'*"#@'%4'
*"3&1)*,"&"4('B*%&'(/"'7%<"*4&"4(I'34'
>/3$/'$.,"'(/"'("$/4%#%7@'3,'$%4,39"*"9'
l4".*#@m'B*""'B%*'(/"'"49'),"*:'64'&%,('
$%)4(*3",I'9%$(%*,'.*"'2.39'1.,"9'%4'(/"'
4)&1"*'%B'2.(3"4(,'(/"@'(*".('%*'&""('
in the consulting room. If doctors are
*">.*9"9'34'(/3,'>.@'3('3,'<"*@'$#".*'>/@'
(/"@'.*"'*"(3$"4('34'.9%2(347'("$/4%#%73",'
(/.('*"9)$"'B.$"=(%=B.$"'34("*.$(3%4,:'P*%&'
(/.('2"*,2"$(3<"I'349""9L'!/.('(%'(/"&'3,'
(/"'1"4"+('%B'*"&%("'&%43(%*347^'
An interesting recent initiative from
F),(*.#3.')49"*,$%*",'(/"'3&2%*(.4$"'
%B'*"3&1)*,"&"4(h34$"4(3<",'34'(/"'
.9%2(3%4'%B'4">'("$/4%#%73",L',34$"'
j)#@'bee'.49'B%*'(/"'4"D('B%)*'@".*,I'
(/"'F),(*.#3.4'7%<"*4&"4('3,'.$(3<"#@'
2*%&%(347'("#"/".#(/'1@'2*%<39347'1%4),",'
(%'/".#(/$.*"'2*%B",,3%4.#,'(/.('.9%2('
("#"/".#(/'("$/4%#%7@'.49'(/.('2.*(3$32.("'
34'<39"%=$%4,)#(,'>3(/'2.(3"4(,:
U*%,,347'(/"'l&-".#(/m'$/.,&
8"%BB*"@'F:'X%%*"E,'1%%?'SU*%,,347'(/"'U/.,&T'9",$*31",'(/"'7*".(",('
93B+$)#(@'(/.('&.4@'93,*)2(3<"'("$/4%#%73$.#'344%<.(3%4,'B.$"'34'$*%,,347'
(/"'$/.,&'1"(>""4'344%<.(%*,'.49'".*#@'.9%2("*,:'6('3,'$#".*'(/.('(/"'
2*3%*3(3",'%B'9%$(%*,'.49'/".#(/$.*"'>%*?"*,'.*"'<"*@'93BB"*"4('B*%&'(/.('
%B'(/"'("$/4%#%73,(:'C/"'1",(',(3&)#),'(%'(/"'.9%2(3%4'%B'&-".#(/'3,'(%'
()*4'(/"'.1%<"'/)*9#",'34(%'9*3<"*,L'2)((347'(/"'$),(%&"*'.('(/"'/".*('%B'
@%)*'1),34",,I'%BB"*347')4,)*2.,,"9'),"*'1"4"+(,I'9",374347'B%*'(/"'*37/('
),"'$%4("D(I'.49'%BB"*347'.4'.((*.$(3<"'2*3$347'&%9"#:
Vodafone mHealth Solutions 16
Vodafone mHealth Solutions Insights Guide
Understanding health
psychology and the
science of behaviour
Introduction
-.<347'"<.#).("9'.'4)&1"*'%B'&-".#(/'
,"*<3$",'%4'(/"'1.,3,'%B',)$$",,'34'),"*'
.9%2(3%4I'(/3,'#.,(',"$(3%4'%B'(/"'*"2%*('
.3&,'(%'$%4("D().#3,"'(/"'$)**"4(',(.("'
of mHealth through relevant academic
#3("*.()*"'%4'),"*'.9%2(3%4'1"/.<3%)*:
C/"*"'3,'.'7*%>347'$%*2),'%B'#3("*.()*"'
9%$)&"4(347'(/"'9"<"#%2&"4('%B'93BB"*"4('
mHealth technologies. Alongside technical
.,2"$(,I'93,$),,3%4,'"D2#%*"'3,,)",'%B'
93,,"&34.(3%4'.49'3&2#"&"4(.(3%4I'.49'
(/"*"'/.<"'1""4'.'4)&1"*'%B'2*"#3&34.*@'
"<.#).(3%4,'34'("*&,'%B'3&2.$('%4'/".#(/'
%)($%&",I'2.(3"4(',.(3,B.$(3%4'.49'
1"/.<3%)*'$/.47":'!/.('3,'#.*7"#@'.1,"4('
B*%&'(/"'2)1#3,/"9'#3("*.()*"I'/%>"<"*I'
3,'*37%*%),'*",".*$/'%4'(/"'2*%$",,'%B'
)2(.?"'.49'.9%2(3%4'%B'&-".#(/'B*%&'
(/"'2"*,2"$(3<"'%B'1%(/'(/"'2.(3"4('.49'
/".#(/$.*"'2*%<39"*:'64'(/3,',"$(3%4I'
(/"*"B%*"I'>"'.99*",,'(>%'&.34'Q)",(3%4,L
N''!/.('"D3,(347'(/"%*3",'.49'*",".*$/'$.4'
1"'),"9'(%'"D2#.34'.9%2(3%4'1"/.<3%)*'%B'
("$/4%#%73",'%B'/".#(/^'
N''!/.('$%4,(3()("'(/"'&.34'1.**3"*,'(%'
&-".#(/'.9%2(3%4^
Existing theories
-".#(/=*"#.("9'1"/.<3%)*'3,'/37/#@'$%&2#"D'
and efforts to understand and account
B%*'3493<39).#'.49'$%##"$(3<"'1"/.<3%)*'
and its determinants continue across
&)#(32#"'93,$32#34",:'0*.>347'%4'(/"%*"(3$.#'
B*.&">%*?,'B*%&'.4(/*%2%#%7@I'/".#(/'
2,@$/%#%7@I',%$3%#%7@'.49'$)#()*.#'
"239"&3%#%7@I'(/"'B%##%>347'2*","4(,'.'1*3"B'
%)(#34"'%B',"#"$("9'(/"%*3",'%B'1"/.<3%)*'
.,'(/"@'*"#.("'(%'/".#(/$.*"'2*.$(3$",'.49'
/".#(/',@,("&'*",2%4,":
The Health Belief Model
P3*,('9"<"#%2"9'34'(/"'ep`b,'1@',%$3.#'
2,@$/%#%73,(,'-%$/1.)&I'V%,"4,(%$?'.49'
["7"#,eIec
I'(/3,'&%9"#'.(("&2(,'(%'"D2#.34'
.49'2*"93$('/".#(/'1"/.<3%)*,'1@'B%$),347'
%4'(/"'.((3()9",'.49'1"#3"B,'%B'3493<39).#,:'
C/"'&%9"#'3,',(*)$()*"9'.*%)49'B%)*'?"@'
$%4$"2(,'>/3$/'.$$%)4('B%*'.4'3493<39).#E,'
*".934",,'(%'.$(L
N'2"*$"3<"9',),$"2(313#3(@'
N'2"*$"3<"9',"<"*3(@'
N'2"*$"3<"9'1"4"+(,'
N'2"*$"3<"9'1.**3"*,
F993(3%4.#'$%4$"2(,I'$)",'(%'.$(3%4'
.49',"#B="B+$.$@I'>"*"'#.("*'.99"9'(%'
/"#2'(/"'-".#(/'W"#3"B'X%9"#'.99*",,'
/.13().##@')4/".#(/@'1"/.<3%)*,',)$/'.,'
,&%?347I'%<"*".(347'.49'1"347',"9"4(.*@'
l$%493(3%4,'(/.('&-".#(/'("$/4%#%73",'
/.<"'.99*",,"9m:'W"#3"B'.49'/".#(/'
&%(3<.(3%4'.*"',""4'(%'1"'$%493(3%4"9'
1@',%$3%=9"&%7*.2/3$'<.*3.1#",'.49'
(/"'2,@$/%#%73$.#'$/.*.$("*3,(3$,'%B'
(/"'3493<39).#:'C/"'&%9"#'/.,'1""4'
),"9'"D("4,3<"#@'34'9"("*&34347'/".#(/'
2*%&%(3%4'.$(3<3(3",14
:'-%>"<"*I'3('B.3#,'(%'
34$%*2%*.("'B".()*",',)$/'.,'(/"'34i)"4$"'
%B'2*"<3%),'"D2"*3"4$"I'.9<.4(.7",'%B'&.#=
.9.2(3<"'1"/.<3%)*I'1"/.<3%)*.#'34("4(3%4'
.49'2"*$"3<"9'$%4(*%#:
By Dr Juliet BedfordI'P%)49"*'.49'03*"$(%*'%B'F4(/*%#%73$.I'
.'*",".*$/'1.,"9'$%4,)#(.4$@'+*&',2"$3.#3,347'34'(/"'
.22#3"9'.4(/*%2%#%7@'%B'/".#(/$.*"
Vodafone mHealth Solutions 17
Vodafone mHealth Solutions Insights Guide
Theory of Planned Behaviour
F4'"D("4,3%4'%B'(/"'C/"%*@'%B'V".,%4"9'
F$(3%4I'B%*&)#.("9'1@'FYA"4'.49'P3,/1"34'
34'epnb15
I'>/3$/',%)7/('(%'",(3&.("'
(/"'93,$*"2.4$@'1"(>""4'.((3()9"'
.49'1"/.<3%)*I'(/"'C/"%*@'%B'R#.44"9'
W"/.<3%)*'l.#,%',""'+7)*"'m16
'2*"93$(,'
9"#31"*.("'1"/.<3%)*.#'34("4(3%4'),347'
(/*""'$%4,(*)$(,L'1"/.<3%)*.#'1"#3"B,I'
4%*&.(3<"'1"#3"B,'.49'$%4(*%#'1"#3"B,:'
N''W"/.<3%)*.#'1"#3"B,'l.((3()9",'(%>.*9,'
(/"'1"/.<3%)*m'.*"'9"("*&34"9'1@'(/"'
4%(3%4'(/.('.',2"$3+$'1"/.<3%)*'>3##'/.<"'
a concrete consequence.
N''G%*&.(3<"'1"#3"B,'l(/"',)1Y"$(3<"'4%*&m'
.*"'$%4$"*4"9'>3(/'<3">,'.1%)('/%>'
2"%2#"'5'(/"'3493<39).#E,',%$3.#'4"(>%*?'
5'>3##'*"7.*9'(/"'1"/.<3%)*'34'Q)",(3%4I'
2#),'2"*,%4.#'&%(3<.(3%4'(%'B)#+#'(/"'
"D2"$(.(3%4'%B'%(/"*,:'
N''U%4(*%#'1"#3"B,'l2"*$"3<"9'1"/.<3%)*.#'
$%4(*%#m'*"B"*'(%'.4'3493<39).#E,'
2"*$"2(3%4'%B'(/"3*'.13#3(@'(%'2"*B%*&'.'
73<"4'1"/.<3%)*I'1"#3"B'.1%)('.$$",,'(%'
the resources needed in order to
.$(',)$$",,B)##@:'
C/","'2*"93$(%*,'#".9'(%'34("4(3%4I'(/"'
2*"$)*,%*'%B'1"/.<3%)*:'64'7"4"*.#I'(/"'
&%*"'B.<%)*.1#"'(/"'.((3()9"'.49'(/"'
,)1Y"$(3<"'4%*&I'(/"'7*".("*'(/"'2"*$"3<"9'
$%4(*%#I'(/"',(*%47"*'.'2"*,%4E,'34("4(3%4'
(%'2"*B%*&'(/"'1"/.<3%)*'34'Q)",(3%4:'C/"'
.9<.4(.7"'%B'(/"'2*.$(3$.#'.22#3$.(3%4'%B'
(/3,'(/"%*@'3,'(/.('3('(.?",'34(%'.$$%)4('
&%(3<.(3%4.#'.,2"$(,'%B'2"*,%4.#'$%4(*%#'
.49'(/"'34i)"4$"'%B',%$3.#'4"(>%*?,I'1)('
3('$.4'1"'#3&3("9'1@'.4'%<"*="&2/.,3,'%B'
2,@$/%#%73$.#'B.$(%*,'>/3#,(')49"*=<.#)347'
structural forces such as the reduced
.<.3#.13#3(@'%B'*",%)*$",'%*'2%%*'.$$",,:
Healthcare Utilisation Model
0"<"#%2"9'1@'F49"*,%4'.49'G">&.417
34'(/"'epdb,I'(/3,',%$3%=1"/.<3%)*.#'
&%9"#'7*%)2,'(/*""'$#),("*,'%B'B.$(%*,'
(/.('$.4'34i)"4$"'/".#(/'1"/.<3%)*'34'.'
#%73$',"Q)"4$"L'
N'2*"93,2%,347
N'"4.1#347'
N need factors
C/3,'&%9"#'>.,'9"<"#%2"9'(%'34<",(37.("'
(/"'),"'%B'13%&"93$.#'/".#(/',"*<3$",I'
.#(/%)7/'#.("*'<"*,3%4,'>"*"'"D("49"9'
to include other healthcare sectors18
.
6('$"4(*",',2"$3+$.##@'%4'(*".(&"4('
,"#"$(3%4'.49'34$#)9",'1%(/'&.("*3.#'
.49'#%73,(3$.#'B.$(%*,'(/.('.*"'4%('B)##@'
.$$%)4("9'B%*'34'%(/"*'&%9"#,:'[*%"7"*19
"#.1%*.("9'(/"'&%9"#'(%'34$#)9"'/".#(/'
,"*<3$"',@,("&'B.$(%*,I'*"B"**347'(%'(/"'
,(*)$()*"'%B'(/"'/".#(/$.*"',@,("&'.49'3(,'
#34?'(%'(/"',%$3%=2%#3(3$.#'&.$*%="$%4%&@'
34'>/3$/'3('%2"*.(",:'C/"'.9<.4(.7"'%B'
,%$3%=1"/.<3%)*.#'&%9"#,'3,'(/"'<.*3"(@'
%B'B.$(%*,I'%*7.43,"9'34(%'$.("7%*3",I'
(/.('&.?"'34("*<"4(3%4,'B%*'(/"*.2")(3$'
.$(3%4'l%*'#.$?'%B'3(m'B".,31#":'6('2"*&3(,'(/"'
",(.1#3,/&"4('%B'$%**"#.(3%4,'>3(/'7%%9'
2*"93$(.13#3(@I'1)('4%(',2"$3+$.(3%4'%B'
/%>'.49'>/@'(/"'93BB"*"4('B.$(%*,'.BB"$('
(/"*.2")(3$',"#"$(3%4:
Behavioural
attitude
Subjective
norms
Perceived
behavioural
control
Intention Behaviour
Figure 2 Theory of Planned Behaviour
Vodafone mHealth Solutions 18
Vodafone mHealth Solutions Insights Guide
Social Cognitive Theory
P*%&'(/"'ep_b,'%4>.*9,I'W.49)*.b'
has
9"<"#%2"9',%$3.#'$%743(3<"'(/"%*@'(%'
"D2#.34'/%>'2"%2#"'.$Q)3*"'.49'&.34(.34'
$"*(.34'1"/.<3%)*.#'2.(("*4,:'W.,"9'%4'
(/"'".*#3"*'C/"%*@'%B'J%$3.#'f".*4347e'
(/*""'9%&34.4('B.$(%*,'>"*"',""4'(%'
1"'$%4,(.4(#@'34i)"4$347'".$/'%(/"*L'
"4<3*%4&"4('l,%$3.#'.49'2/@,3$.#mI'
2"%2#"'.49'1"/.<3%)*:'
Bandura suggested that individuals are
$.2.1#"'%B'#".*4347'4%('Y),('B*%&'(/"3*'%>4'
"D2"*3"4$",I'1)('<3$.*3%),#@I'B*%&'(/%,"'
.*%)49'(/"&:'[4%>4'.,';1,"*<.(3%4.#'
f".*4347I'(/"'2*%$",,'3,'*"7)#.("9'1@'B%)*'
,)1'B)4$(3%4,L'
N'.(("4(3%4.#'2*%$",,",'
N'*"("4(3%4'2*%$",,",'
N'2*%9)$(3%4'2*%$",,",'
N'&%(3<.(3%4.#'2*%$",,",'
f34?"9'(%'(/3,'3,',"#B="B+$.$@'l1"/.<3%)*.#'
$.2.13#3(@mI'(/"'Z1"#3"B,'34'%4"E,'$.2.13#3(3",'
(%'%*7.43,"'.49'"D"$)("'(/"'$%)*,",'
%B'.$(3%4'*"Q)3*"9'(%'2*%9)$"'73<"4'
.((.34&"4(,E
:'J%$3.#'U%743(3<"'C/"%*@'
3,'),"9'"D("4,3<"#@'34'(/"'9",374'%B'
/".#(/'"9)$.(3%4'.49'/".#(/'1"/.<3%)*'
2*%7*.&&",'.49'.,'(/"'1.,3,'B%*'
intervention strategies.
Other theoretical considerations
[#"34&.4E,'$%4$"2('%B'KD2#.4.(%*@'
X%9"#,c
'$%4(.34'"D2#.4.(3%4,'%B'."(3%#%7@I'
%4,"('%B',@&2(%&,I'2.(/%2/@,3%#%7@I'
$%)*,"'%B',3$?4",,'.49'(*".(&"4(I'(%'
"#.1%*.("'Z,2"$3+$',@,("&,'%B'?4%>#"97"'
and values centred in the different social
,"$(%*,'.49',)1=,"$(%*,'%B'(/"'/".#(/$.*"'
,@,("&E]
:'64'2%#3(3$.#="$%4%&3",'%B'
/".#(/I'B.$(%*,'$.("7%*3,347'.<.3#.13#3(@I'
.$$",,313#3(@I'.BB%*9.13#3(@'.49'.$$"2(.13#3(@'
still dominate.
X.4@'&%9"#,'.,,)&"'(/.('3493<39).#,'
"47.7"'34'.'*.(3%4.#'2*%$",,'%B'>"37/347'
(/"'1"4"+(,'.49'$%,(,'%B'1"/.<3%)*.#'
choices and select the course of action
>3(/'(/"'&%,('B.<%)*.1#"'$%,(=1"4"+('
*.(3%'l.,'34'(/"'-".#(/'W"#3"B'X%9"#I'(/"'
C/"%*@'%B'R#.44"9'W"/.<3%)*I'.49'(/"'
J%$3.#'U%743(3<"'C/"%*@mI'1)('.BB"$(3<"'
associations`
'/.<"'.#,%'1""4',/%>4'(%'
1"'34i)"4(3.#:'M4#3?"'(/","'Z$%4(34))&E'
(/"%*3",'l>/3$/'2#.$"'.4'3493<39).#'.#%47'
.'$%4(34))&'%B'.$(3%4'#3?"#3/%%9mI'Z,(.7"9E'
(/"%*3",I',)$/'.,'(/"'C*.4,(/"%*"(3$.#'
X%9"#'%B'W"/.<3%)*'U/.47"'l.#,%',""'
+7)*"'cm_
'/.<"'.*3,"4'B*%&'9%)1('(/.('
#34".*'&%9"#,'.*"'B)##@'$.2.1#"'%B'$.2()*347'
(/"'$%&2#"D'2*%$",,",'(/.(')49"*#3"'
9"$3,3%4,'(%'"47.7"'34'/".#(/'1"/.<3%)*,d
.
69".##@I'.,'-.),&.44=X)"#.'$%4$#)9",I'
Z.'$%4("D().#3,"9'.4.#@,3,'%B'/".#(/'
1"/.<3%)*,',/%)#9'l.m'1"'4"$",,.*3#@'
34("*93,$32#34.*@I'$%&134347'Z4.()*.#'
,$3"4$",E'>3(/'Z,%$3.#',$3"4$",E'.22*%.$/",O'
l1m'4%('B.3#'(%'$%4,39"*'(/.('(/"',()93"9'
Z$%4("D(,E'.*"'2.*('%B'.'/3,(%*3$.#'2*%$",,O'
l$m'$%&134"'Z&3$*%E'>3(/'Z&.$*%E'#"<"#,O'.49'
l9m'(*3.47)#.("'Q).#3(.(3<"'.49'Q).4(3(.(3<"'
34<",(37.(3%4'("$/43Q)",En
.
C%')49"*,(.49'1"/.<3%)*'.,,%$3.("9'>3(/'
(/"'.9%2(3%4'%B'("$/4%#%73",'%B'/".#(/I'
>"'4""9'(%'%<"*#.@'(/"%*3",'9"*3<"9'B*%&'
,%$3.#'.49'1"/.<3%)*.#',$3"4$"I'>3(/'
(/"%*3",'%B'),"*'"47.7"&"4('9*.>4'B*%&'
(/"'+"#9,'%B'64B%*&.(3%4'U%&&)43$.(3%4'
.49'C"$/4%#%7@:
Stage 4: ACTION
Dedicates considerable
time and energy; make
overt and viable changes;
developes strategies to
deal with barriers
Stage 3:
PREPARATION
Intends to take action
and makes small changes;
needs to set goals
and priorities
Stage 2:
CONTEMPLATION
Aware the problem exists
and serious evaluation
of options but not
committed to
take action
Stage 1:
No intention to
change, often unaware
of the problem
Stage 6:
EVALUATION
Assessment and feedback
to continue dynamic
change process
Stage 5:
ADAPTATION /
MAINTENANCE
Works to adapt and adjust
to facilitate maintenance
of change
PRE-CONTEMPLATION
Figure 3 Transtheoretical Model of Behaviour Change
Vodafone mHealth Solutions 19
Vodafone mHealth Solutions Insights Guide
Diffusion of Innovations Theory
V%7"*,E'03BB),3%4'%B'644%<.(3%4,'
C/"%*@'l.#,%',""'+7)*"']mp
is the most
34i)"4(3.#'34')49"*,(.49347'/%>'.4'
344%<.(3%4'34+#(*.(",'.'2%2)#.(3%4'l%*'4%(mI'
.49'2*%<39",'.'$%&2*"/"4,3<"',(*)$()*"'
B%*')49"*,(.49347'3493<39).#'.9%2(3%4'.49I'
$%##"$(3<"#@I'93BB),3%4:'6('B%$),",'%4'(/"'
conditions that increase or decrease the
#3?"#3/%%9'%B'.'4">'39".I'2*%9)$('%*'
2*.$(3$"'1"347'.9%2("9:'
V%7"*,'2*","4("9'B%)*',(.7",L'
(/"'344%<.(3%4'3(,"#BO'93BB),3%4'l%*'
$%&&)43$.(3%4m'(/*%)7/'(/"',%$3.#',@,("&O'
(3&"O'.49'$%4,"Q)"4$",:'-"'.*7)"9'(/.('
.4'344%<.(3%4'3,'Z.4'39".I'2*.$(3$"I'%*'%1Y"$('
(/.('3,'2"*$"3<"9'(%'1"'4">'1@'.4'3493<39).#'
%*'%(/"*')43('%B'.9%2(3%4EI'93BB),3%4'3,'
Z(/"'Z2*%$",,'1@'>/3$/'.4'344%<.(3%4'3,'
communicated through certain channels
%<"*'.'2"*3%9'%B'(3&"'.&%47'(/"'&"&1"*,'
%B'.',%$3.#',@,("&EI'.49'$%&&)43$.(3%4'3,'
Z(/"'2*%$",,'34'>/3$/'2.*(3$32.4(,'$*".("'
.49',/.*"'34B%*&.(3%4'>3(/'%4"'.4%(/"*'
(%'*".$/'.'&)().#')49"*,(.49347E:'
C/"'(/"%*@',)77",(,'(/.('1"$.),"'
34B%*&.(3%4'i%>,'(/*%)7/'4"(>%*?,I'
%2343%4'#".9"*,'34'(/.('4"(>%*?'2#.@'.'
*%#"'34'9"("*&34347'(/"'#3?"#3/%%9'(/.('
(/"'344%<.(3%4'>3##'1"'.9%2("9I'1)('
.993(3%4.#'34("*&"93.*3",'l$/.47"'.7"4(,'
.49'7.("?""2"*,m'.*"'.#,%'34i)"4(3.#:'
P3<"'$.("7%*3",'%B'.9%2("*'.*"'%)(#34"9'
>/3$/'B%##%>'.4'J=,/.2"9'93BB),3%4'$)*<"L'
344%<.(%*,I'".*#@'.9%2("*,I'".*#@'&.Y%*3(@I'
#.("'&.Y%*3(@I'.49'#.77.*9,:'
03BB),3%4'*",".*$/'/.,'B%$),"9'%4'+<"'
&.34'"#"&"4(,L'(/"'$/.*.$("*3,(3$,'%B'
.4'344%<.(3%4'>/3$/'&.@'34i)"4$"'3(,'
.9%2(3%4O'(/"'9"$3,3%4=&.?347'2*%$",,'
(/.('%$$)*,'>/"4'3493<39).#,'$%4,39"*'
(/"'.9%2(3%4O'(/"'$/.*.$("*3,(3$,'%B'
3493<39).#,'(/.('&.?"'(/"&'#3?"#@'(%'.9%2('
.4'344%<.(3%4O'(/"'$%4,"Q)"4$",'B%*'
3493<39).#,'.49',%$3"(@'%B'.9%2(347'(/"'
344%<.(3%4O'.49'$%&&)43$.(3%4'$/.44"#,'
),"9'34'(/"'.9%2(3%4'2*%$",,:'U#%,"#@'
#34?"9'(%'03BB),3%4'%B'644%<.(3%4,'C/"%*@'
3,'G"(>%*?'F4.#@,3,'.49'J%$3.#'G"(>%*?'
C/"%*@cb
'.49'U*3(3$.#'X.,,'C/"%*@31
.
0
100
75
50
25
Marketshare%
Innovators
2.5%
Early
Adopters
13.5%
Early
Majority
34%
Late
Majority
34%
Laggards
16%
Figure 4 Diffusion of Innovations Theory
X.*?"('2"4"(*.(3%4
f"<"#'%B'.9%2(3%4
''H%9.B%4"'&-".#(/'J%#)(3%4,''b
Vodafone mHealth Solutions Insights Guide
Technology Acceptance Model
C/"'C"$/4%#%7@'F$$"2(.4$"'X%9"#'3,'
%4"'%B'(/"'&%,('34i)"4(3.#'"D("4,3%4,'
%B'FYA"4E,'C/"%*@'%B'V".,%4"9'F$(3%4'.49'
C/"%*@'%B'R#.44"9'W"/.<3%)*:'0"<"#%2"9'1@'
0.<3,cI'cc
'3('3,'.4'34B%*&.(3%4',@,("&,'(/"%*@'
(/.('&%9"#,'/%>'),"*,'$%&"'(%'.$$"2('.49'
),"'.'("$/4%#%7@:'6('*"2#.$",'FYA"4E,'.((3()9"'
&".,)*",'>3(/'(>%'("$/4%#%7@'.$$"2(.4$"'
&".,)*",L'2"*$"3<"9'),"B)#4",,'l(/"'9"7*""'
(%'>/3$/'.'2"*,%4'1"#3"<",'(/.('),347'.'
2.*(3$)#.*',@,("&'>%)#9'"4/.4$"'/3,'%*'/"*'
Y%1'2"*B%*&.4$"mI'.49'2"*$"3<"9'".,"=%B=
),"'l(/"'9"7*""'(%'>/3$/'.'2"*,%4'1"#3"<",'
(/.('),347'.'2.*(3$)#.*',@,("&'>%)#9'1"'
B*""'B*%&'"BB%*(m:'C/"'&%9"#'.,,)&",'(/.('
>/"4',%&"%4"'B%*&,'.4'34("4(3%4'(%'.$(I'
(/"@'>3##'1"'B*""'(%'.$('>3(/%)('#3&3(.(3%4I'
>/"*".,'34'(/"'*".#'>%*#9I'(/"*"'>3##'1"'
<.*3%),'$%4,(*.34(,:';(/"*'&%9"#,'"D2#.34347'
.$$"2(.4$"'2"*$"2(3%4,'.49'1"/.<3%)*,'
.,,%$3.("9'>3(/'64B%*&.(3%4'C"$/4%#%7@'
34$#)9"'U%&2)("*'J"#B=KB+$.$@34
I'C.,?=
C"$/4%#%7@'P3(35
'.49'(/"'X%(3<.(3%4.#'
X%9"#36
.
United Theory of Acceptance and Use
'3.4"/5$'*'-6.7.8$%#"!.45"',6.'3.
Consumer Acceptance Technology
Recent studies have sought to integrate
,%&"'%B'(/"'2*3%*'&%9"#,:'H"4?.(",/37
"D.&34"9'"37/('%B'(/"'&%,('$%&&%4'
(/"%*"(3$.#'B*.&">%*?,'.49'&%9"#,'),"9'
(%'"D2#.34'3493<39).#'.9%2(3%4'.49'),"'%B'
("$/4%#%7@'.49'1*%)7/('(%7"(/"*'(/"3*'
&%,(',.#3"4('$/.*.$("*3,(3$,'(%'B%*&'.')43+"9'
(/"%*@I'M43("9'C/"%*@'%B'F$$"2(.4$"'.49'
M,"'%B'C"$/4%#%7@'l.#,%',""'+7)*"'`m:'
C/3,'2*","4(,'B%)*'?"@'9"("*&34.4(,'%B'),"'
l2"*B%*&.4$"'"D2"$(.4$@I'"BB%*('"D2"$(.4$@I'
,%$3.#'34i)"4$"'.49'B.$3#3(.(347'$%493(3%4,m'
and four moderators of individual use
l7"49"*I'.7"I'"D2"*3"4$"'.49'<%#)4(.*34",,m:'
J3&3#.*#@I'[)#<3>.(38
designed the Consumer
F$$"2(.4$"'%B'C"$/4%#%7@'B*.&">%*?'1@'
&"*7347'(>%'2*"<3%),#@')4*"#.("9'&%9"#,I'
(/"'C"$/4%#%7@'F$$"2(.4$"'X%9"#'.49'
(/"'R#".,)*"I'F*%),.#'.49'0%&34.4$"'
2.*.937&'%B'.BB"$('l9"<"#%2"9'.,'.'&%9"#'34'
"4<3*%4&"4(.#=2,@$/%#%7@'1@'X"/*.1.3439
I'
3(',)77",(,'(/.('.##'"&%(3%4.#'*",2%4,",'(%'
2/@,3$.#'.49',%$3.#'"4<3*%4&"4(,'$.4'1"'
$.2()*"9'>3(/'(/*""'93&"4,3%4,'%B'.BB"$(L'
2#".,)*"I'.*%),.#'.49'9%&34.4$"m:'
Sun and Zhang]b
'2*","4('.',@,("&.(3$'
.4.#@,3,'%B'(/"'"D2#.4.(%*@'.49',3().(3%4.#'
#3&3(.(3%4,'%B'"D3,(347'("$/4%#%7@'
.$$"2(.4$"',()93",:'C/"@'$.##'B%*'&%*"'
*",".*$/'34(%'(/"'3493<39).#'.49'$%4("D().#'
factors that are often neglected in
("$/4%#%7@'.$$"2(.4$"',()93",'1)('$.4'
1"'$*3(3$.#'34'(/"'.22#3$.(3%4'%B'(/"'
(/"%*"(3$.#'&%9"#,I'.49'39"4(3B@'("4'
&%9"*.(347'B.$(%*,'$%4,39"*"9'(%'1"'
34i)"4(3.#'l<%#)4(.*34",,I'(/"'4.()*"'%B'(.,?,'
.49'2*%B",,3%4,I'("$/4%#%73$.#'$%&2#"D3(@I'
(/"'2)*2%,"'%B'),347'("$/4%#%7@I'3493<39).#'
<,:'7*%)2'("$/4%#%73",I'7"49"*I'3493<39).#'
34("##"$().#'$.2.13#3(3",I'"D2"*3"4$"I'.7"'
.49'$)#()*.#'1.$?7*%)49m:
Adoption behaviours – barriers and
ways to overcome them
F,'(/"'+"#9'%B'&-".#(/'&.()*",I'%)*'
)49"*,(.49347'%B'.9%2(3%4'1"/.<3%)*,'
l1%(/'2%,3(3<"'.49'4"7.(3<"m'.,,%$3.("9'
>3(/'/".#(/'("$/4%#%7@')2(.?"'>3##'9"<"#%2'
34',$%2"'.49'4).4$":'C%'9.("I'*",".*$/'34'
(/3,'.*".'/.,'1""4'#3&3("9:'KD(*.2%#.("9'
B*%&'(/"'"D3,(347'#3("*.()*"I'(/"'B%##%>347'
1.**3"*,'(%')2(.?"',/%)#9'1"',""4'.,'.'
,(.*(347'2%34('B%*'B)()*"'>%*?:'F#(/%)7/'
&-".#(/'3,'%B("4'2%,3(3%4"9'%*'2"*$"3<"9'
.,'1"347'.'93,*)2(3<"'("$/4%#%7@'1@'
1%(/'/".#(/$.*"'2*%<39"*,'.49'*"$"3<"*,I'
34("*.$(3%4'%B("4'<.*3",'1"(>""4',(.?"/%#9"*'
7*%)2,:'!"'(/"*"B%*"'2*","4('(/"'9%&34.4('
1.**3"*,'B.$"9'1@'/".#(/$.*"'2*%<39"*,'
l1%(/'.,'3493<39).#,'.49'%*7.43,.(3%4,mI'
.49'(/%,"'B.$"9'1@'2.(3"4(,I'9",23("',%&"'
34"<3(.1#"'%<"*#.2:'!.@,'(%'%<"*$%&"'
(/","'1.**3"*,'.*"'(/"4',"('%)(:
J"<"*.#'Q)%(",'.*"'34$#)9"9'>/3$/'.*"'
.9.2("9'B*%&'(/"',(.?"/%#9"*'*",".*$/'
$%&&3,,3%4'1@'H%9.B%4"1
.
Figure 5 United Theory of Acceptance and Use of Technology
Performance
expectancy
Effort
expectancy
Social
influence
Facilitating
conditions
Behavioural
intention
Behaviour
Age
Experience
Gender
VoluntarinessofuseVoluntariness
Determinants
of use
Moderators of individual use
''H%9.B%4"'&-".#(/'J%#)(3%4,''e
Vodafone mHealth Solutions Insights Guide
Table 2 Barriers to health technology adoption – healthcare providers 41, 42, 43, 44, 45, 46, 47
Barrier )"#$%&%'$
Clinical issues 0%)1(,'.*3,347'%<"*'(/"'Q).#3(@'%B'$.*"'2*%<39"9'l.,,%$3.("9'>3(/'*3,?,'%B'#3(37.(3%4I'2.*(3$)#.*#@'34'(/"'MJFm
Cost / reimbursement -%>'(%'*"$%)2'34<",(&"4('.49'2.,,'%4'),"*'$%,('l",2"$3.##@'.'$%4$"*4'34'(/"'MJFm
Lack of evidence J$.4('"<39"4$"'.1%)('(/"'"BB"$(3<"4",,'%B'("$/4%#%7@'%*'/%>'&-".#(/'3&2*%<",'$#343$.#'%)($%&",I'
>%*?i%>'"($
Lack of
user-engagement
64.9"Q).("'2/@,3$3.4',)22%*('1.,"'.49'2/@,3$3.4=1.,"9'#".9"*,/32I'#3&3("9'34<%#<"&"4('34'9",374'%*'
3&2#"&"4(.(3%4I'$%4$"*4'.1%)('("$/4%#%7@
Organisational
structure
U%4$"*4,'.1%)('34("7*.(3%4'.49'34("*%2"*.13#3(@'%B'&-".#(/'34'$)**"4(',(*)$()*",
Privacy 6,,)",'%B'$%4+9"4(3.#3(@'.49'$%4,"4(
Security V"7.*9347'(*.4,&3,,3%4I',(%*.7"'.49'*"(*3"<.#'%B'$#343$.#'9.(.
Work load and
time management
64$*".,"9'(3&"',2"4('.49'*"#)$(.4$"'.1%)('Z%)(,39"'%B'%B+$"'/%)*,E'*",2%4,313#3(3",
9',:;'<.='!0*%&%"( f.$?'%B'2*%$",,",'.49'2*%$"9)*",'.*%)49'$%##"$(3%4I'%*7.43,.(3%4I'.4.#@,3,'%B'9.(.I'.49'/%>'(%'3&2#"&"4('
action needed
Clinical issues:
ZC/"'&%&"4('@%)E<"'7%('$%4(34)%),'
&%43(%*347'%4I'(/"*"'&37/('1"'.'#"7.#'
3&2#3$.(3%4'(/"*":'!/.('/.22"4,'3B'(/"'
4"(>%*?'7%",'9%>4'%*'@%)'7%'(%'.'2.*('%B'
(/"'/%,23(.#'>/"*"'3(E,'4%('.<.3#.1#"'.49'
,%&"(/347'>.,4E('23$?"9')2'2)*"#@'B%*'
(/.('*".,%4^'G%>'>/%E,'#3.1#"^'6,'3('(/"'
9.(.^'6,'3('(/"'$%&2.4@'(/.('&.?",'(/"'
9"<3$"^'6,'3('(/"'/%,23(.#'%*'(/"'$%&2.4@'
(/.('1)3#('(/"'/%,23(.#^'6,'3('(/"'9%$(%*'
.('(/"'"49^E
C/%)7/('f".9"*I'M[
Cost / reimbursement:
Z!"##I'6E9',.@'$%,(I')49"*,(.49347'%B'3(,'
)(3#3(@I'.4@(3&"'@%)'1*347'34',%&"(/347'
4">'5'2.*(3$)#.*#@'34'(/"'+"#9'%B'
("$/4%#%7@'5'$%4<34$347'2"%2#"'(/.('3(E,'
1*347347'1"(("*&"4(I'.4'.9<.4(.7"'(%'
(/"'>.@'(/.('(/"@E*"'9%347'(/347,I'(/.(E,'
.#>.@,'.'1.**3"*:E'
R/.*&.$")(3$.#I'MJ
ZC/"*"'3,'.'$%4$"2('$.##"9'$%,(=
%22%*()43(@'>/3$/'&".4,'(/.('(/"'
&%4"@'(/.('3,',2"4('%4',.43(.*@'3,,)",'3,'
(.?"4'B*%&'.4%(/"*'2#.$"v3B'@%)',2"49'
%4'("#"&"93$34"'.49'4%('34'.&1)#.4$",'
%*'"&"*7"4$@',@,("&,v3(E,'.'7*".('
*",2%4,313#3(@'(/"'>.@'@%)',2"49'&%4"@:E'
-%,23(.#I'J2.34
Lack of evidence:
ZC/"*"E,'Q)3("'.'B">'23#%(',()93",'Iv1)('
(/"'2*%1#"&'>3(/'.##'%B'(/%,"'3,'(/"@E*"'
<"*@',&.##',()93",:';*'"<"4'3B'(/"@'7%'
%4'.'@".*I'(/"@E*"'.'<"*@',"#"$('7*%)2'
%B'2.(3"4(,:'k%)'/.<"4E('9%4"'3('%4'
2%2)#.(3%4',$.#",',%'(*@347'(%'+49'.'
$%,('Y),(3+$.(3%4'B%*'(/.(vE'
C/%)7/('#".9"*I'M[
''H%9.B%4"'&-".#(/'J%#)(3%4,''
Vodafone mHealth Solutions Insights Guide
Organisational structure:
Z;4"'%B'(/"'*".#'$/.##"47",'B%*'),'3,'/%>'
>"'$.4'3&2*%<"'%)*',@,("&,',%'(/.('(/"@'
>%*?'&%*"'"B+$3"4(#@:'6(E,'.##'<"*@'>"##'
3&2*%<347'@%)*'1.$?'"49',@,("&,I'1)('
@%)E<"'7%('(%'1"'.1#"'(%'.$$",,'(/"&:'
C/"'?"@'2*%1#"&'B%*'),'3,'/%>'9%'@%)'
&.?"'(/","'43$"I',/34@I'4">',@,("&,'
.<.3#.1#"'(%'(/"'$#343$3.4,^'F49'%)*'?"@'
7%.#'3,'(%'&.?"'2.(3"4('34B%*&.(3%4I'*".#'
(3&"'2.(3"4('34B%*&.(3%4I'*"7.*9#",,'%B'
>/3$/',@,("&'3('$%&",'B*%&I'.<.3#.1#"'
B%*'(/"'$#343$3.4'.('(/"'2%34('%B'$.*":E'
-%,23(.#'X.4.7"*I'M[
Privacy:
Z!"'34$*".,"'34'.',3743+$.4('>.@'(/"'
*3,?'%B'4%('*",2"$(347'2"%2#"E,'*37/('(%'
2*3<.$@'.,'>"##'.,'2*3<.$@'%B'9.(.v(/"*"'
3,'4%'2*%2"*'*"7)#.(3%4'(%'2*%("$('9.(.'
.49'(/"'2.(3"4('34'(/"'B.$"'%B'(/"',2*".9'
%B'34B%*&.(3%4'(/*%)7/'("#"&"93$34":E'
G8;I'J2.34
Lack of user-engagement:
ZC/"'%4#@'(/347'(/.('(/","'2*%B",,3%4.#,'
,""'3,'(/.('(/"@'>3##'1"'%<"*1)*9"4"9:'
6(E,'$#".*'(/.('3B'(/"@'4%>'/.<"'ebb'
2.(3"4(,I'>3(/'("#"&"93$34"'(/"@'$%)#9'
/.<"'&.4@'&%*":E'
F$.9"&3$I'J2.34
Work load and time management:
Z6B'@%)',"4('%)('ebb'*"&349"*,I'4%>'
@%)E<"'7%('(%'*",2%49'(%'(/%,"'ebb'
*"2#3",:'K<"4'>3(/'"&.3#I'@%)'$.4',"49'
"&.3#,'(%'2.(3"4(,'>/%'.*"'%4'(/"3*'
&%13#",I'1)('3(E,'93B+$)#('1"$.),"'(/"4'
@%)',(.*('7"((347'(/"'"&.3#'Q)"*3",'
$%&347'34I'.49'@%)'$.4E(',3('.49'*",2%49'
(%'(/347,'"#"$(*%43$.##@'.##'(/"'(3&":'
X"93$.##@I'#"7.##@'@%)E*"'7%347'(%'*)4'
34(%'(*%)1#":'J%I'3(E,'7"((347'.*%)49'
(/%,"'$%4,(*.34(,:E'
8RI'J;MC-'FPV6UF
Z6B'.'#%('%B'2"%2#"'>"*"'),347'3(I'3('>%)#9'
*"Q)3*"'.4'"D(*.'"&2#%@""'(%'&.4.7"'
(/"'34B%*&.(3%4:E
8RI'J;MC-'FPV6UF
9',:;'<.='!0*%&%"(>
Z!/.('4""9,'(%'1"'9%4"'3,'(%'7.(/"*'
efforts to create a common information
,@,("&O'34',)$/'.'>.@'(/.('"<"*@'J2.43,/'
$3(3A"4'$%)#9'".,3#@'.49'*.239#@'#%$.("'.##'
(/"3*'$#343$.#'/3,(%*@'34'.'9.(.1.,"'.49'1@'
9%347',%'1"'$.2.1#"'(%',/.*"'>3(/',%&"'
%(/"*'9%$(%*,I'4%'&.(("*'>/"*"'@%)'>"*"'
.(I'J>3(A"*#.49'%*'X.9*39:E'
8RI'J2.34
''H%9.B%4"'&-".#(/'J%#)(3%4,''c
Vodafone mHealth Solutions Insights Guide
Table 3 Barriers to health technology adoption – patients48, 49, 50, 51, 52
Barrier )"#$%&%'$
Cost -%>'(%'B)49'93*"$('.49'.,,%$3.("9'$%,(,
Design of the
technology
U%&2#"D'34("*B.$"I'%1(*),3<"'("$/4%#%7@I'2/@,3$.#'.13#3(@'(%'),"'l$%493(3%4'%*'3&2.3*&"4(',2"$3+$m
Disruption to daily
routine and normal
healthcare practices
R"*$"3<"9'%*'.$().#'93,*)2(3%4:'U%&&%4'B".*'.&%47'2.(3"4(,'(/.(')(3#3,347'("$/4%#%7@'*3,?,'*"9)$347'%*'
#%%,347'93*"$('$%4(.$('>3(/'(/"3*'9%$(%*:
Lack of evidence F1%)('),"B)#4",,I'".,"=%*=),"I'.49'.$$",,313#3(@
Lack of knowledge G%'%*'#3&3("9'?4%>#"97"'.1%)('&-".#(/'2*%/313(,'343(3.#'2.(3"4('34("*.$(3%4
Lack of access F,'$%4,)&"*,I'2.(3"4(,'/.<"'#3((#"'349"2"49"4('.$$",,'(%'&-".#(/')4#",,'3('3,'93*"$(#@'*"$%&&"49"9'%*'
2*",$*31"9'l.#(/%)7/'.<.3#.13#3(@'.49'.$$",,'(%'1%(/'$#343$.#'.49'4%4=$#343$.#',&.*(2/%4",'.22,'3,'34$*".,347m
Level of technology
literacy
0373(.#'93<39"'.49'<.*3.1#"'#"<"#,'%B',?3##'l#"<"#'%B'(/*".('2"*$"3<"9'1@'4">'("$/4%#%7@m
Privacy !/%'/.,'.$$",,'(%'(/"3*'9.(.'l,"$)*3(@'3,'4%(',)$/'.'$%4$"*4'B%*'2.(3"4(,'>/%'*"7.*9"9'3('.,'("$/43$.#'3,,)"'
(/.(',/%)#9'1"',%#<"9'2*3%*'(%'("$/4%#%7@'*%##'%)(m
Reliability of the
technology
V3,?'%B'("$/43$.#'B.3#)*"'%*'"**%*'#".9347'(%'"#"<.("9'/".#(/'*3,?
Cost:
Z`bb'2%)49,'>3##'&".4',%&"(/347'(%'
&"I'1)('B%*',%&"%4"'"#,"'`bb'2%)49,'
&37/('1"'2"*$"3<"9'.,'.'#%('%B'&%4"@'
.49'3(E,'<"*@'/.*9'>3(/'(/","'$%,(347,:'
F49'>/.("<"*'>.@'@%)'#%%?'.('3('3B'@%)E*"'
(.#?347'.1%)('"Q)32&"4('.('.'/".<@'2*3$"'
3(E,'7%('1"'&".4,'(",("9'1"$.),"'(/"'
G.(3%4.#'-".#(/'J"*<3$"'
Y),('$.4E('.BB%*9'3(:E'
03.1"(3$'R.(3"4(I'M[
Disruption to normal healthcare
practices:
Z6'(/34?'9%$(%*,'>3##'/.<"'#%47"*'34("*<.#,'
1"(>""4'<3,3(,'1"$.),"'@%)E*"'&%*"'
$%<"*"9I'>/3$/'>%)#9'&.?"'&"'9%)1(I'
1"$.),"'6'#3?"'B.$"=(%=B.$"'$%4(.$('>3(/'
&@'9%$(%*I'1"347'.1#"'(%'("##'/3&'.1%)('
&@'2*%1#"&,:E'
03.1"(3$'R.(3"4(I'J2.34
Level of technology literacy:
ZF4@'9"<3$"'&),('1"'),"*=B*3"49#@:'k%)'
,/%)#94E('4""9'.'9"7*""'(%'),"'3(:'6(E,'+4"'
B%*'.'b'@".*'%#9I'1)('>"'9394E('7*%>')2'
>3(/'("$/4%#%7@'(/"'>.@'@%)47'2"%2#"'
939:'6'9%4E('?4%>'/%>'(%',"(')2'&@'0H0:E'
03.1"(3$'R.(3"4(I'qF
Privacy:
Z;4"'%B'(/"'1377",('/)*9#",'(/.('
@%)E*"'7%347'(%'/.<"'(%'7%'%<"*'3,'(/"'
.13#3(@'(%'"4,)*"'2.(3"4(,'(/.('(/"3*'9.(.'
3,'2*%("$("9I'(/.('3('3,'4%('1"347'),"9'
B%*'"D.&2#"I'1@'34,)*.4$"'$%&2.43",'
(%'2*"<"4('(/"&'B*%&'7"((347'34,)*.4$"'
1"$.),"'(/"@'/.<"'.'2.*(3$)#.*'
7"4"(3$'&.*?"*:E'
C/%)7/('f".9"*I'MJ
''H%9.B%4"'&-".#(/'J%#)(3%4,'']
Vodafone mHealth Solutions Insights Guide
Table 4 Ways to overcome barriers53, 54, 55, 56, 57, 58, 59, 60, 61, 62
How to overcome
the barrier
)"#$%&%'$
Complement/augment
normal practices
K4,)*"'("$/4%#%7@'.99,'<.#)"'.49',)22#"&"4(,'/".#(/$.*"'2*.$(3$",
Cost / reimbursement X.?"'3('$%,('"BB"$(3<"I'9"<"#%2'4">'1),34",,'&%9"#,
)0&0.(?"/%#/0&%'$( Collect targeted data that is required
Design and properties X.D3&3,"'(/"'),"*'"D2"*3"4$"'(/*%)7/'(.*7"("9'34("*B.$"'(/.('.##%>,'B%*'2"*,%4.#3,.(3%4I'$),(%&3,.(3%4'.49'
.9.2(3%4I'&.?"'3('9",3*.1#"
Evidence V37%*%),'"<.#).(3%4'.49'"<39"4$"=1.,"9'*",)#(,
Increase awareness,
knowledge base and
recognition
W)3#9'$%4,"4,),'.*%)49'>/.('3,'.<.3#.1#"I'>/"4I'>/@'.49'>/.('(/"'.9<.4(.7",'.*"'l),"*,'$.4'4%('.9%2('
("$/4%#%73",')4#",,'(/"@'?4%>'(/"@'.*"'.<.3#.1#"m:'V"9)$347'(/"'7.2'1"(>""4'(/"'2*"='.49'2%,(=),"'
2"*$"2(3%4,'%B'2.(3"4(,'.49'/".#(/$.*"'2*%<39"*,'3,'3&2%*(.4('.49'$%)#9'#".9'(%'/37/"*'.$$"2(.4$"'*.(",
Increase accessibility 64$*".,347'(/"'<3,313#3(@'%B'&-".#(/'3,'%4#@'2.*('%B'(/"'"Q).(3%4:'F<.3#.1#"'("$/4%#%73",'&),('1"'2.$?.7"9'
.49'%BB"*"9'34'>.@,'(/.('"4.1#"'$%4,)&"*,'(%'.$$",,'(/"&'93*"$(#@:
Organisational
support
M49"*234'("$/4%#%7@'>3(/',@,("&,'.49'2*%$",,",'(%',)22%*('%*7.43,.(3%4.#',(*)$()*",'34'>/3$/'3('>3##'
%2"*.("O'"4,)*"'34("7*.(3%4I'34("*%2"*.13#3(@'.49',(.49.*93,.(3%4
Overall, ensure the
2"$"#&(.'1&<"%-5.
the costs
F9%2(3%4'>3##'B%##%>'.4'J=,/.2"'93BB),3%4'$)*<"'(/.('4"$",,3(.(",',),(.34"9'"47.7"&"4('.49'$%&&3(&"4('
from the end users
Privacy J%#<"'#"7.#'.49'*"7)#.(%*@'3,,)",'.1%)('2*3<.$@'.49'$%4(*%#'%B'9.(.
Security J%#<"'("$/43$.#'3,,)",'.*%)49',"$)*3(@'%B'(*.4,&3,,3%4I',(%*.7"'.49'*"(*3"<.#'%B'$#343$.#'9.(.
Training C*.34'3493<39).#,'34'(/"'.22#3$.(3%4'.49'2*.$(3$.#3(3",'%B'(/"'("$/4%#%7@
User development K47.7"'.##',(.?"/%#9"*,'34'2*%9)$('9"<"#%2&"4('(%'"4,)*"'3(,'?"@'*"Q)3*"&"4(,'.*"'&"(I'3('3,'),"*'9*3<"4'
(/*%)7/'2.*(3$32.(3%4I'.49'3,',$.#.1#"
9',:;'<.='!0*%&%"( K4,)*"'34B%*&.(3%4'$%##"$(3%4I'.4.#@,3,I'.49'93,,"&34.(3%4'3,'"B+$3"4(
Applying behavioural theories in
technology and health
64'(/"'.9%2(3%4'.49')(3#3,.(3%4'%B'&-".#(/I'
1"/.<3%)*.#'.((3()9",'.*"'#3?"#@'(%'1"'&%*"'
3&2%*(.4('(%'2*%7*",,'(/.4'("$/4%#%7@'tc]u:'
F,'X.*(34,'tcu'$%4$#)9",I'&-".#(/'2"*',"'
3,'Z4%('"4%)7/'(%'3&2*%<"'/".#(/$.*"I',34$"'
3&2*%<347'$.*"I'%*',)22%*(347'3(I'3,'&%*"'(/.4'
Y),('73<347'2*%B",,3%4.#,'l.49'2.(3"4(,m'".,3"*'
.$$",,'(%'34B%*&.(3%4'.49'$%&&)43$.(3%4E:
6('3,'>39"#@'.$?4%>#"97"9'(/.('&-".#(/'
/.,'(/"'2%("4(3.#'(%'3&2*%<"'/".#(/'
%)($%&",I'1)('>"'&),('9"&%4,(*.("'
/%>'.49')49"*,(.49'>/@:'C/"'1.**3"*,'
39"4(3+"9'.,'2*%/313(347'(/"'*".9@'.9%2(3%4'
%B'&-".#(/'$.4'1"'93<39"9'34(%'+<"'34("*=
*"#.("9'$.("7%*3",L',%$3.#O'$#343$.#O'("$/43$.#O'
"$%4%&3$O'.49'%*7.43,.(3%4.#'%*'#%73,(3$.#'
l.#,%',""'+7)*"'_m:'
X"$/.43,&,'.49',(*.("73",'$.4'1"'2)('
34'2#.$"'(%'&343&3,"'(/"3*'3&2.$(L'"&2#%@347'
"BB"$(3<"'9",374'(/"%*@'>3##'*",)#('34'
34$*".,347#@'*"+4"9'.49'.22*%2*3.("'
34("*B.$",'1"347'9"<"#%2"9O'"&2#%@347'
%*7.43,.(3%4.#'$/.47"'(/"%*@'>3##'$*".("'
,(.1#"'34,(3()(3%4.#',@,("&,'.49'>%*?i%>,'
(/.('$.4'34$%*2%*.("'("$/4%#%7@'(%'3&2*%<"'
"B+$3"4$@O'"&2#%@347'(.*7"("9',%$3.#'
&.*?"(347'>3##'*.3,"'.>.*"4",,'%B'
(/"'("$/4%#%73",E'"D3,("4$":
C/"'2%("4(3.#'%B'&-".#(/'3,'"D("4,3<"'
.49',)22%*(,'.'B)49.&"4(.#'$/.47"'34'(/"'
>.@'(/.('-UR,'.49'2.(3"4(,'34("*B.$"'>3(/'
healthcare. Whilst changes are required for
-UR,'(%'1"'.1#"'(%'$%2"'>3(/'4">'/".#(/$.*"'
9"&.49,'.49',),(.34'(/"'Q).#3(@'%B'$.*"I'.,'.'
93,*)2(3<"'344%<.(%*I'(/"'B.$('3,'(/.('&-".#(/'
34(*%9)$",'$/.47"I'.49'$/.47"'&.@'
4"7.(3<"#@'3&2.$('3(,'.9%2(3%4'.49'$.),"'
4%4=)2(.?":'64'(/"'Q)%("'%4'(/"'4"D('2.7"I'
B%*'34,(.4$"I'$%4$"*4,'.1%)('"#3&34.(347'
$%##".7)",E'Y%1,'2*%/313('(/"'*".9@'.9%2(3%4'
of technological interventions.
Insight Guide 1 - Human Behaviour
Insight Guide 1 - Human Behaviour
Insight Guide 1 - Human Behaviour
Insight Guide 1 - Human Behaviour
Insight Guide 1 - Human Behaviour

More Related Content

Viewers also liked

Властивості функцій, повторення
Властивості функцій, повторенняВластивості функцій, повторення
Властивості функцій, повторенняTatyana Zubareva
 
Location call sheet
Location call sheet Location call sheet
Location call sheet jm9094
 
PROCESOS DE MANUFACTURA
PROCESOS DE MANUFACTURAPROCESOS DE MANUFACTURA
PROCESOS DE MANUFACTURAJoa_Reina
 
Insight Guide 2 - Politics & Economics
Insight Guide 2 - Politics & EconomicsInsight Guide 2 - Politics & Economics
Insight Guide 2 - Politics & EconomicsSarah Sanders
 
6логарифмы и их свойства
6логарифмы и их свойства6логарифмы и их свойства
6логарифмы и их свойстваTatyana Zubareva
 
اكمال دورة للدكتور عثمان باعثمان
اكمال دورة للدكتور عثمان باعثماناكمال دورة للدكتور عثمان باعثمان
اكمال دورة للدكتور عثمان باعثمانRayan Al Husini
 
They Looked Just Like Us
They Looked Just Like UsThey Looked Just Like Us
They Looked Just Like UsSimonBlog
 

Viewers also liked (14)

Parallel lines
Parallel lines Parallel lines
Parallel lines
 
Властивості функцій, повторення
Властивості функцій, повторенняВластивості функцій, повторення
Властивості функцій, повторення
 
Creativity Books
Creativity BooksCreativity Books
Creativity Books
 
Location call sheet
Location call sheet Location call sheet
Location call sheet
 
PROCESOS DE MANUFACTURA
PROCESOS DE MANUFACTURAPROCESOS DE MANUFACTURA
PROCESOS DE MANUFACTURA
 
Insight Guide 2 - Politics & Economics
Insight Guide 2 - Politics & EconomicsInsight Guide 2 - Politics & Economics
Insight Guide 2 - Politics & Economics
 
BSS Student Leaders TTT
BSS Student Leaders TTTBSS Student Leaders TTT
BSS Student Leaders TTT
 
6логарифмы и их свойства
6логарифмы и их свойства6логарифмы и их свойства
6логарифмы и их свойства
 
اكمال دورة للدكتور عثمان باعثمان
اكمال دورة للدكتور عثمان باعثماناكمال دورة للدكتور عثمان باعثمان
اكمال دورة للدكتور عثمان باعثمان
 
Colorful things
Colorful thingsColorful things
Colorful things
 
Q7
Q7Q7
Q7
 
They Looked Just Like Us
They Looked Just Like UsThey Looked Just Like Us
They Looked Just Like Us
 
Te llamo cristo
Te llamo cristoTe llamo cristo
Te llamo cristo
 
Cortona 2015
Cortona 2015 Cortona 2015
Cortona 2015
 

Similar to Insight Guide 1 - Human Behaviour

Effects of physical exercise in cerebrovascular mechanisms of adaptation to a...
Effects of physical exercise in cerebrovascular mechanisms of adaptation to a...Effects of physical exercise in cerebrovascular mechanisms of adaptation to a...
Effects of physical exercise in cerebrovascular mechanisms of adaptation to a...Enrike G. Argandoña
 
Christian Bason, MindLab Denmark - MaRS Global Leadership Series
Christian Bason, MindLab Denmark - MaRS Global Leadership SeriesChristian Bason, MindLab Denmark - MaRS Global Leadership Series
Christian Bason, MindLab Denmark - MaRS Global Leadership SeriesMaRS Discovery District
 
Evidence Farming: Implications for Open Architecture
Evidence Farming: Implications for Open ArchitectureEvidence Farming: Implications for Open Architecture
Evidence Farming: Implications for Open ArchitectureOpen mHealth
 
Pervasive 2011 Talk on Situated Glyphs
Pervasive 2011 Talk on Situated GlyphsPervasive 2011 Talk on Situated Glyphs
Pervasive 2011 Talk on Situated GlyphsFahim Kawsar
 
Module 1 - Sildenafil
Module 1 - SildenafilModule 1 - Sildenafil
Module 1 - SildenafilSam Pang
 
Methods of proper work out
Methods of proper work outMethods of proper work out
Methods of proper work outnavedgaur786
 
Marketing Collateral
Marketing CollateralMarketing Collateral
Marketing Collateralnreichstein
 
guia para la remineralizacion de aguas desaladas.PDF
guia para la remineralizacion de aguas desaladas.PDFguia para la remineralizacion de aguas desaladas.PDF
guia para la remineralizacion de aguas desaladas.PDFhome
 
guia para la remineralizacion de aguas desaladas.PDF
guia para la remineralizacion de aguas desaladas.PDFguia para la remineralizacion de aguas desaladas.PDF
guia para la remineralizacion de aguas desaladas.PDFhome
 
Bryley - 201 CMR17 Presentation -- 11-11-2009
Bryley  - 201 CMR17 Presentation -- 11-11-2009Bryley  - 201 CMR17 Presentation -- 11-11-2009
Bryley - 201 CMR17 Presentation -- 11-11-2009Bryley Systems Inc.
 
Evergreen trails master plan community meeting 1 boards
Evergreen trails master plan community meeting 1 boardsEvergreen trails master plan community meeting 1 boards
Evergreen trails master plan community meeting 1 boardsOV Consulting
 
Science Fiction Sensor Networks
Science Fiction Sensor NetworksScience Fiction Sensor Networks
Science Fiction Sensor NetworksDiego Pizzocaro
 
An Effort to Restore from Imperata Grassland to Secondary Forest in Samboja L...
An Effort to Restore from Imperata Grassland to Secondary Forest in Samboja L...An Effort to Restore from Imperata Grassland to Secondary Forest in Samboja L...
An Effort to Restore from Imperata Grassland to Secondary Forest in Samboja L...GPFLR
 
Trustfusion Presentation Ru&En
Trustfusion Presentation Ru&EnTrustfusion Presentation Ru&En
Trustfusion Presentation Ru&EnDaniil Pavlenko
 
Findes der millioner i velfærdsteknologi?
Findes der millioner i velfærdsteknologi?Findes der millioner i velfærdsteknologi?
Findes der millioner i velfærdsteknologi?Lakeside A/S
 

Similar to Insight Guide 1 - Human Behaviour (20)

Effects of physical exercise in cerebrovascular mechanisms of adaptation to a...
Effects of physical exercise in cerebrovascular mechanisms of adaptation to a...Effects of physical exercise in cerebrovascular mechanisms of adaptation to a...
Effects of physical exercise in cerebrovascular mechanisms of adaptation to a...
 
Christian Bason, MindLab Denmark - MaRS Global Leadership Series
Christian Bason, MindLab Denmark - MaRS Global Leadership SeriesChristian Bason, MindLab Denmark - MaRS Global Leadership Series
Christian Bason, MindLab Denmark - MaRS Global Leadership Series
 
Evidence Farming: Implications for Open Architecture
Evidence Farming: Implications for Open ArchitectureEvidence Farming: Implications for Open Architecture
Evidence Farming: Implications for Open Architecture
 
Mh11 sim
Mh11 simMh11 sim
Mh11 sim
 
Pervasive 2011 Talk on Situated Glyphs
Pervasive 2011 Talk on Situated GlyphsPervasive 2011 Talk on Situated Glyphs
Pervasive 2011 Talk on Situated Glyphs
 
Module 1 - Sildenafil
Module 1 - SildenafilModule 1 - Sildenafil
Module 1 - Sildenafil
 
Mastering Enterprise Risk Management Inside Your Organization
Mastering Enterprise Risk Management Inside Your OrganizationMastering Enterprise Risk Management Inside Your Organization
Mastering Enterprise Risk Management Inside Your Organization
 
Methods of proper work out
Methods of proper work outMethods of proper work out
Methods of proper work out
 
Marketing Collateral
Marketing CollateralMarketing Collateral
Marketing Collateral
 
guia para la remineralizacion de aguas desaladas.PDF
guia para la remineralizacion de aguas desaladas.PDFguia para la remineralizacion de aguas desaladas.PDF
guia para la remineralizacion de aguas desaladas.PDF
 
guia para la remineralizacion de aguas desaladas.PDF
guia para la remineralizacion de aguas desaladas.PDFguia para la remineralizacion de aguas desaladas.PDF
guia para la remineralizacion de aguas desaladas.PDF
 
Green grocersppt
Green grocerspptGreen grocersppt
Green grocersppt
 
Bryley - 201 CMR17 Presentation -- 11-11-2009
Bryley  - 201 CMR17 Presentation -- 11-11-2009Bryley  - 201 CMR17 Presentation -- 11-11-2009
Bryley - 201 CMR17 Presentation -- 11-11-2009
 
Evergreen trails master plan community meeting 1 boards
Evergreen trails master plan community meeting 1 boardsEvergreen trails master plan community meeting 1 boards
Evergreen trails master plan community meeting 1 boards
 
Vietnam Online Travel Behaviors
Vietnam Online Travel BehaviorsVietnam Online Travel Behaviors
Vietnam Online Travel Behaviors
 
Science Fiction Sensor Networks
Science Fiction Sensor NetworksScience Fiction Sensor Networks
Science Fiction Sensor Networks
 
An Effort to Restore from Imperata Grassland to Secondary Forest in Samboja L...
An Effort to Restore from Imperata Grassland to Secondary Forest in Samboja L...An Effort to Restore from Imperata Grassland to Secondary Forest in Samboja L...
An Effort to Restore from Imperata Grassland to Secondary Forest in Samboja L...
 
Trustfusion Presentation Ru&En
Trustfusion Presentation Ru&EnTrustfusion Presentation Ru&En
Trustfusion Presentation Ru&En
 
Findes der millioner i velfærdsteknologi?
Findes der millioner i velfærdsteknologi?Findes der millioner i velfærdsteknologi?
Findes der millioner i velfærdsteknologi?
 
Actions that vietnamese dislike
Actions that vietnamese dislikeActions that vietnamese dislike
Actions that vietnamese dislike
 

Insight Guide 1 - Human Behaviour

  • 1. Evaluating mHealth Adoption Barriers: Human Behaviour Vodafone mHealth Solutions Insights Guide mhealth.vodafone.com
  • 2. Vodafone mHealth Solutions 3 Vodafone mHealth Solutions Insights Guide Welcome !"#$%&"'(%'%)*'+*,('-".#(/'0"1.("'2)1#3$.(3%4'5'(/"' 64,37/(,'8)39":';)*'.3&'3,'(%'2*%<39"',%&"'"<39"4$"= 1.,"9',(3&)#),'(/.('>3##'"4$%)*.7"'.##'(/%,"'>%*?347' in the different areas of healthcare to consider the 344%<.(3%4'%22%*()43(3",'(/.('.*"'4%>'.<.3#.1#"'(%'(/"&:' !"'1"#3"<"'(/.('*".#'2*%7*",,'$.4'%4#@'1"'343(3.("9'>/"4' .##',(.?"/%#9"*,'#%%?'1"@%49'(*.93(3%4.#'/%*3A%4,'.49' share ideas that challenge the status quo so that together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our ideas in the months to come. FD"#'G"&"(A Head of Vodafone mHealth Solutions C/"'H%9.B%4"'-".#(/'0"1.("',"*3",'3,'2.*('%B'%)*'$%4(34)347'$%&&3(&"4(' (%'(/%)7/('#".9"*,/32'34'/".#(/$.*":'6('1*347,'(%7"(/"*',"43%*'2/.*&.I'2)1#3$' .49'2*3<.("'/".#(/',(.?"/%#9"*,'(%'#".*4I',/.*"'.49'9"1.("'%4'3,,)",'.49'4">' (/34?347'1*%)7/('B%*>.*9'1@'*"4%>4"9'(/%)7/('#".9"*,'.49'349),(*@'"D2"*(,:
  • 3. Vodafone mHealth Solutions 4 Vodafone mHealth Solutions Insights Guide Table of contents 3 Welcome 4 C.1#"'%B'$%4("4(, 5 J$%2"'.49'9"+43(3%4, 6 !/.('2.(3"4(,'.49'/".#(/$.*"'2*%B",,3%4.#,',.@ 8 F4'%<"*<3">'%B'&-".#(/'%22%*()43(@ 10 K<.#).(347'1"/.<3%)*'(%'&.*?"("9' mHealth services 14 F9%2(347'("$/4%#%7@L')49"*,(.49347'(/"' $/.##"47",'B%*'/".#(/$.*"'2*%B",,3%4.#, 16 M49"*,(.49347'/".#(/'2,@$/%#%7@' .49'(/"',$3"4$"'%B'1"/.<3%)* 26 Vodafone mHealth Solutions 26 References
  • 4. Vodafone mHealth Solutions 5 Vodafone mHealth Solutions Insights Guide Scope and !"#$%&%'$( N''&-".#(/L'.22#3$.(3%4'%B'&%13#"'.49' 4"(>%*?'("$/4%#%73",'(%'3&2*%<"' /".#(/$.*"'%)($%&",'%*'"B+$3"4$3",O' P%*'(/"',$%2"'%B'(/3,'*"2%*(I'>"' B%$),'%4'2.(3"4('.49'/".#(/$.*"' 2*%B",,3%4.#'$"4(*"9'&-".#(/',"*<3$",' including remote care and healthcare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
  • 5. Vodafone mHealth Solutions 6 Vodafone mHealth Solutions Insights Guide What patients and healthcare professionals say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takeholder Group What they want from mHealth Specialists C%'/"#2'&.4.7"'9.(.'.49'&.?"'(/"'1",('),"'%B'("$/4%#%7@ GPs C%'"&2%>"*'(/"3*'2.(3"4(,'.49'/"#2'(/"&'&.4.7"'$/*%43$' diseases Nurses C%'.$$",,'34,(*)$(3%4.#'34B%*&.(3%4'%*'2.(3"4('9"(.3#,'%4=(/"=7% Pharmacists C%'/"#2'(/"&'&.4.7"'2.(3"4('2*",$*32(3%4,I'"4,)*"'.$$)*.$@' .49'/"#2'>3(/'2.(3"4('$%&2#3.4$" Patients C%'1"(("*'&.4.7"'.49'(*.$?'(/"3*'3##4",,", Table 1 What HCPs and Patients say What patients have to say R.(3"4(,'$.4',""'(/"'1"4"+('%B'&-".#(/' 1"$.),"'3&2*%<"9'.$$",,'(%'34B%*&.(3%4' "4.1#",'(/"&'(%'1"$%&"'&%*"'.$(3<"#@' 34<%#<"9'34'(/"3*'%>4'$.*":'C/3,'3,' 2.*(3$)#.*#@'(*)"'B%*'(/%,"'>3(/'$/*%43$' $%493(3%4,',)$/'.,'93.1"(",'%*'/37/'1#%%9' 2*",,)*":'X%13#"'("$/4%#%7@'$.4'/"#2' them to monitor their condition outside .'/%,23(.#'"4<3*%4&"4(:'6('&".4,'&%*"' 2"%2#"'$.4'"4Y%@'.'4%*&.#'#3B"'1)('$.4' *".$(',>3B(#@'(%'*"$"3<"'(*".(&"4(',/%)#9' the need arise.
  • 6. Vodafone mHealth Solutions 7 Vodafone mHealth Solutions Insights Guide What healthcare professionals have to say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mproving quality of life ZFB("*'6'+*,('/.9'&@'+*,('/".*('.((.$?' B%*'(/"'(/*""'>""?,'1"(>""4'(/"'+*,(' %4"'.49'(/"',"$%49'%4"'6'/.9'(%'(.?"' &@'1#%%9'2*",,)*"'/.#B'.'9%A"4'(3&",' .'9.@'.('(/"'9%$(%*E,'%B+$"I'.49'6'$%)#9' /.<"'Y),('),"9'&@'2/%4"'(%'*"$%*9'3('.(' /%&"'34,(".9E' U.*93.$'R.(3"4(I'M[' Reassurance Z64'&@'/%,23(.#'7*%)2I'>"'7"('34'(%)$/' %<"*'(/"'64("*4"(:'C/"*"E,',%&"%4"'(/"*"' (%'.4,>"*'@%)*'Q)",(3%4,']'/%)*,'.'9.@I' either a doctor or a nutritionist. I can do 3('B*%&'/%&"'%*'>%*?I'.49'3('73<",'&"' 2".$"'%B'&349:E' 03.1"(3$'R.(3"4(I'J2.34 Discretion Z6'9%4E('>.4('%(/"*'2"%2#"'(%'B""#',%**@' B%*'&"'1"$.),"'6E&'.'93.1"(3$I',%'6'9%4E(' >.4(I'3B'6'(.?"'%)('.'$"##'2/%4"I'"<"*@%4"' (%'?4%>'Z%/I'(/"'2%%*'7)@'3,'.'93.1"(3$:E' 03.1"(3$'R.(3"4(I'J%)(/'FB*3$. Caring for patients Z6('>%)#9'1"'43$"'(%'1"',.('>3(/'(/"' 2.(3"4('.49'/.<"'.'2/%4"'(%'*"73,("*' >/.('@%)E*"'9%347I'>/.('@%)E<"'9%4"I' and have that recorded and logged. 6(',/%)#94E('1"'.'4)*,347'Y%1I',/%)#9'3(^ '6('(.?",'.1%)('(>%'/%)*,'.'9.@' >*3(347'(/"'4%(",:E G)*,"I'M[: Improved communication between professionals Z&-".#(/'>3##'1"'.4'.99"9'<.#)"'1"$.),"' (/"'7"4"*.#'2*.$(3(3%4"*'>3##'#".*4'.1%)(' 93BB"*"4('2.(/%#%73",'1@'*"$"3<347' 34B%*&.(3%4'B*%&'(/"',2"$3.#3,"9'9%$(%*:E' J2"$3.#3,(I'J2.34 C/"'B%##%>347'Q)%(.(3%4,'.*"'"D.&2#",'%B'(/"'&.34'1"4"+(,'>/3$/'>"*"'/37/#37/("9:
  • 7. Vodafone mHealth Solutions 8 Vodafone mHealth Solutions Insights Guide An overview of mHealth opportunity C/"'&-".#(/'&.*?"('3,',(3##'<"*@'@%)47' /%>"<"*'3('3,'$#".*'(/.('(/"'%22%*()43(@'B%*' ("$/4%#%7@'9*3<"4'/".#(/$.*"'3,'(/*3<347' as a result of a changing healthcare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of chronic disease is rising and the economic $%493(3%4,'.*"'$/.##"47347:'64'K)*%2"I'B%*' "D.&2#"I'(/"'%<"*=_`,I'>/%,"'/".#(/$.*"' $%,('1)*9"4'3,'B%)*'(3&",'(/.('%B'@%)47"*' .7",I'>3##'.$$%)4('B%*'.('#".,('`a'%B' (/"'2%2)#.(3%4'1@'b]b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cb'2"*'$"4(' %B'80R'1@'b]b:'C/"';KU0'3,'4%('B.*'1"/349' >3(/'$%,(,'*".$/347'cb'2"*'$"4('%B'(/"' &"93.4'80R'1@'bdb:'64'"&"*7347'&.*?"(,' ,)$/'.,'FB*3$.'>/"*"'.9)#('&%*(.#3(@'*.(",'.*"' %<"*']bb'2"*'eIbbb'2%2)#.(3%4,I'.#%47,39"' $%,(I'#.$?'%B'34B*.,(*)$()*"I'#3&3("9'.$$",,'(%' (*".(&"4(,'.49'2%%*'Q).#3(@'&"93$34",' .*"'(/"'$%*"'/".#(/$.*"'2*%1#"&,:' f%%?347'./".9'3('3,'/%2"9'(/.(',&.*("*' ("$/4%#%73",'>3##'/"#2'(%'3&2*%<"' $%&&)43$.(3%4,'1"(>""4'2.(3"4(,I' /".#(/$.*"'2*%<39"*,'.49'(/%,"'(/.('2.@'.49' &.4.7"'(/"',@,("&:'F,'.'*",)#('(/3,'/.,'(/"' 2%("4(3.#'(%'3&2*%<"'2.(3"4('B*""9%&'.49' 349"2"49"4$"I'*"9)$"'(/"'%<"*.##'$%,('.49' 3&2*%<"'2.(3"4('$.*":'C/3,'<3">'3,',)22%*("9' 1@'X$[34,"@'(/.('",(3&.(",'(/.('(/"'("#"= /".#(/'%*'&-".#(/'349),(*@'>3##'1"'>%*(/' %<"*'MJ'g`b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y Dr Tim JonesI'P%)49"*'.49'R*%7*.&&"'03*"$(%*'%B' P)()*"'F7"49.I'.'7#%1.#'%2"4'B%*",37/('343(3.(3<"'
  • 8. Vodafone mHealth Solutions 9 Vodafone mHealth Solutions Insights Guide 64'(/"'4"D('9"$.9"'("#"&"93$34"' $%44"$(3<3(@'>3##'2*%<39"']hd'&"93$.#' 9.(.',/.*347'1"(>""4'2.(3"4(,'.49' /".#(/$.*"'2*%B",,3%4,'>3(/'<39"%'#34?,I' >".*.1#"'&%43(%*347'"Q)32&"4('.49'34= /%&"',"4,%*,'(*.$?347'&%<"&"4(I'1%9@' ("&2"*.()*"'.49'%(/"*'<3(.#',374,:'C/"' $%4,"Q)"4$"'%B'(/3,'>3##'1"'(/.('2.(3"4(,' >3##'1"'.1#"'(%'*"(.34'(/"3*'349"2"49"4$"' B%*'#%47"*'.49',%'1"(("*'"4Y%@'#3B"'%)(,39"' (/"'&.34,(*".&'$.*"',@,("&:'J%&"' commentators as a result envisage a ,#%>=9%>4'34'(/"'*"$"4('7*%>(/'%B'4)*,347' /%&",'.,'.'7*".("*'2*%2%*(3%4'%B'(/"'"#9"*#@' remain at home. While some suggest that (/3,'34'()*4'$%)#9'&".4'34$*".,"9'2/@,3$.#' 3,%#.(3%4I'(/"'.&13(3%4'B%*'%(/"*,'3,'(%'),"' ("$/4%#%7@I'2.*(3$)#.*#@'&%13#"'("$/4%#%7@I' (%'2*"<"4('2"%2#"'B*%&'B""#347'#%4"#@:'64'.' >%*#9'>/"*"'%4'.<"*.7"'B.&3#@',)22%*('B%*' (/"'%#9"*'7"4"*.(3%4'>3##'$%4(34)"'(%'9"$#34"' .49'(/"'$%,('%B'2*%<39347'2"*,%4.#'$.*"*,' >3##'$%4(34)"'(%'*3,"I'"#9"*#@'2.(3"4(,'.49' (/%,"'>3(/'#%47'("*&'$/*%43$'93,".,",'.*"' 34$*".,347#@'#3?"#@'(%',""',%&"',("2'$/.47",' 34',)22%*('%<"*'(/"'4"D('B">'@".*,:' In addition to automated care there is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i)"4$"'%4'3493<39).#' 1"/.<3%)*'.,'(/"'&%*"'(*.93(3%4.#'2.(3"4(= /".#(/$.*"'2*%B",,3%4.#'*"#.(3%4,/32I',%' "D2"$('(%',""'&%*"'2.(3"4('9.(.'1"$%&347' &%*"'<3,31#"'.49'&%*"',/.*".1#"'.$*%,,' 2#.(B%*&,'.49',@,("&,'34'@".*,'(%'$%&": 6B'>"'$.4')(3#3,"'(/"'%22%*()43(@'(/.('(/"' )13Q)3(@'%B'&%13#"'$%&&)43$.(3%4'%BB"*,I' >"'$.4'1"(("*'B.$3#3(.("'(/"'9"#3<"*@'%B'&%*"' "B+$3"4('.49'"BB"$(3<"'/".#(/$.*":'dba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for healthcare innovation. F'7%%9'"D.&2#"'%B'/%>'&.()*"'&.*?"(,' .*"'#".*4347'B*%&'%(/"*,'$.4'1"'B%)49' 34'6493.'>/"*"'G.*.@.4.'-%,23(.#'/.,' ),"9'.'$%&134.(3%4'%B'1),34",,'&%9"#' .49'2*%$",,'344%<.(3%4'(%'#%>"*'(/"'$%,(' %B'$.*93.$',)*7"*@'.49'34'9%347',%'/.,' *"<%#)(3%43,"9'(/"'.$$",,I'<%#)&"'.49'*".$/' %B'3(,'B.$3#3(3",'(%'1"$%&"'%4"'%B'(/"'B.,(",(' 7*%>347'/".#(/$.*"'1),34",,",'34'(/"'>%*#9:' F$$%*9347'(%'(/"'!JjI'j.$?'f">34I'UK;'%B'(/"' F&"*3$.4'U%##"7"'%B'U.*93%#%7@I'(/"'#.*7"' 4)&1"*'%B'2.(3"4(,'2.,,347'(/*%)7/'(/"' G.*.@.4.'B.$3#3(3",'.##%>,'3493<39).#'9%$(%*,' (%'B%$),'%4'%4"'%*'(>%',2"$3+$'(@2",'%B' $.*93.$',)*7"*3",'.49',%'9"<"#%2'2.*(3$)#.*' ,?3##,:'SG.*.@.4.'/.,'4%('%4#@'1"$%&"'(/"' 1",('2#.$"'(%'/.<"'/".*(',)*7"*@'1)('3('/.,' .#,%'1"$%&"'(/"'7%=(%'B.$3#3(@'B%*'.##'.,23*347' $.*93.$',)*7"%4,'7#%1.##@T:' j.$?'f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he need to address the rationale for this 34"*(3.'3,'2*",,347'.49'3(',""&,'$#".*'(/.(' &%13#"'("$/4%#%7@'/.,'.'?"@'*%#"'(%'2#.@' in facilitating change. Z!"'.*"'34'.'2"*B"$(',(%*&:'k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sufferers the chance to live more $%&B%*(.1#@'.49'349"2"49"4(#@' .('/%&"'.49'2*%<39347'/".#(/$.*"' >%*?"*,'.$$",,'(%'34B%*&.(3%4',%' (/.('(/"@'$.4'(*".('&%*"'2.(3"4(,' &%*"'"BB"$(3<"#@:'
  • 9. ''H%9.B%4"'&-".#(/'J%#)(3%4,''eb Vodafone mHealth Solutions Insights Guide Evaluating behaviour to marketed mHealth services F,'&-".#(/'343(3.(3<",'"<%#<"'B*%&'23#%('(%' &.34,(*".&I'(/3,',"$(3%4'39"4(3+",',%&"' $%&&%4'.((*31)(",'%B'(/"'&%*"',)$$",,B)#' 343(3.(3<",'%2"*.(347'(%9.@'.$*%,,'.'4)&1"*' %B'$%)4(*3",'34'(/"'9"<"#%2"9'>%*#9:' A rapidly evolving space, favouring the newcomer &-".#(/'$%&134",'(/"'&%13#"I'6C'.49' /".#(/$.*"'349),(*3",I'>/3$/'.##'/.<"' 93BB"*"4('2#.@"*,I'2.@"*,I'$)#()*",I'$#%$?' ,2""9,'.49'.((3()9",'(%>.*9,',"$)*3(@I' 2*3<.$@'.49'Q).#3(@:'C/3,'9@4.&3$'.*".' B.<%)*,'4">$%&"*,I'.49'349""9'&%,('%B' (/"'$%&2.43",'*"B"*"4$"9'34'(/3,',"$(3%4' .*"'<"4()*"=1.$?"9',(.*(=)2,'>3(/'*.239#@' 7*%>347'),"*'1.,",'.49',(*%47'$.,/'2%,3(3%4,:' A space that covers both healthcare and wellness C/"'$#".*",('93,(34$(3%4'1"(>""4' 93BB"*"4('$%&2.43",'3,'1"(>""4'/".#(/' $.*"'.49'>"##4",,O'(/"'B%*&"*'("49'(%'1"' *"7)#.(%*@=.22*%<"9'&"93$.#'9"<3$",'.49' ,"*<3$",'),"9'1@'9%$(%*,I'>/3#"'(/"'#.(("*I' ,)$/'.,'$.#%*3"'$%)4("*,I'+(4",,'1)993",' .49',#""2'&%43(%*,I'.*"'(.*7"("9' at consumers. Wellness solutions 7"4"*.##@'),"'1"/.<3%)*'$/.47"'(%' 9"#3<"*'>"##4",,'7%.#,'l,)$/'.,'#%>"*347' $.#%*3",I'%*'3&2*%<347'.'`?'*)4'(3&"m' >/3#"'/".#(/$.*"',%#)(3%4,'.*"'%B("4'9.(.' 7.(/"*"*,'.,'2.*('%B'.'#.*7"*'$#343$.#' 2*%$",,'l,)$/'.,'/".*('&%43(%*,'.49'&%13#"' XV6,'lX.74"(3$'V",%4.4$"'6&.7347mm:' Tools for chronic disease management ,)$/'.,'93.1"(",I'/@2"*("4,3%4'.49' .,(/&.'("49'(%'9*.>'B*%&'1%(/'$.&2,I' .49'*"2*","4(',%&"'%B'(/"'&%,('"D$3(347' %22%*()43(3",'B%*'#%>"*347'$%,(,'.49' 3&2*%<347'2.(3"4('%)($%&",:' C/"'.((*31)(",'#3,("9'/"*"'.*"'$.("7%*3,"9' .$$%*9347'(%'.9%2(3%4I'"47.7"&"4('.49' 3&2.$('l.#,%',""'+7)*"em:'C/","'>%4E(' .22#@'"Q).##@'(%'.##'$%&2.43",I'/%>"<"*' &.4@',)$$",,B)#'$%&2.43",'"D/313('(/"' &.Y%*3(@'%B'(/","'.((*31)(",:' By Stephen Johnston, Founder and CEO of Fordcastle LLC >/3$/'/"#2,'9"<"#%2'$%&2.43",'(%'1)3#9'%22%*()43(@' .*%)49'&%13#"'("$/4%#%7@I'/".#(/$.*"'.49'#%47"<3(@' Figure 1 The common attributes of successful mHealth services IMPACTENGAGEMENT ADOPTION Simplicity Empatheticdesign Comprehensiveness Interactive Customerdelight Uservalue Joined-upsolutions Clincalandeconomicresults
  • 10. Vodafone mHealth Solutions 11 Vodafone mHealth Solutions Insights Guide F9%2(3%4' 1. Simplicity 8%%7#"E,'F49*%39'.49'F22#"E,'3;J'/.<"' &.9"'7*".(',(*39",'.('&.?347'$%&2#"DI' &)#(3=B".()*"9',&.*(2/%4",',3&2#"I'.49' /.<"'1""4'*">.*9"9'>3(/'.'$%&134"9'_na' &.*?"(',/.*"'7#%1.##@'34'oc'bee4 :'-%>"<"*I' (/"'&.Y%*3(@'%B'9"<3$",'34'2"%2#"E,'/.49,' 34'9"<"#%2"9'$%)4(*3",'.*"',(3##'Z9)&1EI'.49' /".#(/$.*"'2.(3"4(,'34'2.*(3$)#.*'.*"'#3?"#@' (%'1"'#",,'("$/',.<<@'(/.4'.<"*.7":'649""9I' %4"'*"$"4(',()9@'B%)49'(/.('%4#@'`a'%B' 2.(3"4(,'>3(/'$/*%43$'93,".,",'>"*"'64("*4"(' users at all5 'l#"('.#%4"'&%13#"'64("*4"('),"*,mI' >"##'1"#%>'(/"'.<"*.7"'.9)#('2"4"(*.(3%4' %B'dna6 . C"D('&",,.7347',"*<3$",'.*"'"BB"$(3<"'.(' 9"#3<"*347'1.,3$',"*<3$",I',34$"'(/"@'>%*?'%4' .#&%,('"<"*@'2/%4"'.49'(/"'*"$323"4('*".9,' p`a'%B'("D('&",,.7",'>3(/34'B%)*'&34)(",' of receiving. H%D3<.I'B%)49"9'34'bbeI'2*%<39",' C"D(]W.1@'(/.('9"#3<"*,'(/*""'("D(,'.'>""?' (%'2*%,2"$(3<"'&%(/"*,'.B("*'(/"@'*"73,("*' (/"3*'13*(/'9.("'),347'.',/%*('$%9":'C/"'("D(' &",,.7",'$%4(.34'"9)$.(3%4.#'$%4("4(I' *"&349"*,'.49',)*<"@,:'G%>'>3(/'c`?' ,)1,$*31"*,I'(/"',"*<3$"'3,'7*%>347'.('e`?' ),"*,'2"*'&%4(/I'.49',3743+$.4(#@I'%4#@' cca'%B'.##'),"*,'"<"*'*"73,("*"9'/.<"' cancelled the service. C/3,'Z,"('3('.49'B%*7"('3(E'$%4$"2('>%*?,'>"##O' 2.,,3<"',"*<3$",'("49'(%'*"(.34'),"*,'1"(("*' (/.4'(/%,"'$%4,(.4(#@'*"Q)3*347'9.(.'"4(*@:' X.4@'$.#%*3"'$%)4("*'.22,'/.<"'i%)49"*"9' B%*'(/3,'*".,%4I'>/"*".,'>"##4",,'9"<3$",' ,)$/'.,'(/"'!3(/347,'!3=P3'"4.1#"9'1.(/*%%&' ,$.#"I'(/"'P3(13('>".*.1#"'1%9@'&%43(%*'.49' (/"'q"%',#""2'(*.$?"*'.##'.)(%&.("'9.(.' $.2()*"'.49'"4(*@'.B("*'343(3.#',"(')2:' 2. Empathetic design X.*"?'R.>#%>,?3I'B%)49"*'%B'(/"'X%13#"' M,"*'KD2"*3"4$"'U%4B"*"4$"I'),"9'(/"'("*&' Z"&2.(/"(3$'9",374E'(%'9",$*31"'(/"'2*%$",,' %B'"4,)*347'9",374"*,'*".##@'9%'(.?"'(/"' needs of the end user into consideration. F('%4"'%B'(/"3*'>%*?,/%2',",,3%4,'%4' /".#(/$.*"I'2.*(3$32.4(,'34'.'1*.34,(%*&347' %4'&%13#"'/".#(/'9"<3$",'B%*'(/"'"#9"*#@' >"*"'73<"4'7#%<",'.49',/.9"9'7#.,,",'(%' 3##),(*.("'(/"'$/.##"47",'B.$"9'>/"4'2"%2#"' >3(/'<3,).#'.49'2/@,3$.#'3&2.3*&"4(,'/.9'(%' 34("*.$('>3(/'&%13#",:' C/"'j3(("*1)7'2/%4"'.49',"*<3$"'&.9"'1@' 8*".('U.##'3,'.'&%13#"',%#)(3%4'9",374"9' >3(/'(/"'4""9,'%B'.7347'),"*,'34'&349'5'>3(/' #.*7"'?"@,'.49',3&2#"',"*<3$"'%2(3%4,:'C/"@' offer a medication reminder service for an .993(3%4.#'&%4(/#@'$/.*7"'(/.('9"#3<"*,' *"7)#.*'<%3$"'*"&349"*,'(%',)1,$*31"*,'(%' (.?"'(/"3*'&"93$.(3%4:' 3. Comprehensiveness P%*',%&"'&-".#(/',%#)(3%4,I'(/"'?"@'(%' ,)$$",,'#3",'34'(/"3*'$%&2*"/"4,3<"4",,:' P%)49"9'34'eppnI'K2%$*.(",'3,'%4"'%B'(/"' B">'2)1#3$'$%&2.43",'#3,("9'/"*"'.49'/.<"' %<"*'.'9"$.9"E,'"D2"*3"4$"'$%##"$(347'.49' %*7.43,347'$%4("4('B%*'2/@,3$3.4,:'C/"3*'9*)7' *"B"*"4$"I'"9)$.(3%4.#'.49'$#343$.#',%#)(3%4,' .*"'34'),"'1@'e:c&'/".#(/$.*"'2*%B",,3%4.#,I' 34$#)9347'%<"*'/.#B'%B'(/"'9%$(%*,'34'(/"'MJI' >/%'*"#@'%4'3(,'$%&2*"/"4,3<"4",,: ;4'(/"'$%4,)&"*',39"I'(/"'3C*3.7"'.22'(/.(' /.,'1""4'9%>4#%.9"9'.#&%,('(/*""'&3##3%4' (3&",I',"",')2'(%'%4"'&3##3%4'&%4(/#@'),"*,' .49'1%.,(,'ebIbbb'l&%,(#@'2%,3(3<"m'*"<3">,' %4'F22#"E,'F22,(%*":'UK;'R"("*'-)9,%4I' X0I'/37/#37/(,'3(,'349),(*@=#".9347'$%4("4(' .77*"7.(3%4'$.2.13#3(3",'l34'.993(3%4'(%' ,(*%47'$),(%&"*',)22%*(m'.,'.'?"@',)$$",,' B.$(%*:'C/"@'2*%<39"'34B%*&.(3%4'.1%)(' ,@&2(%&,'.,'>"##'.,'34("7*.(3%4'34(%' /)49*"9,'%B'2.*(4"*'/".#(/$.*"'2*%<39"*,I' *",)#(347'34'>/.('3,'"BB"$(3<"#@'1"$%&347'.' White Pages of consumer health services. Engagement 4. Interactive R*%<39347'2"*,%4.#3,"9'B""91.$?'(/.('.##%>,' users to see the results of their actions &.?",'B%*'.'&%*"'"47.7347'"D2"*3"4$":' The Consumer Health Information U%*2%*.(3%4'lU-6Um'B%)49'(/.('.'Q).*("*'%B' .##',&.*(2/%4"'.22,'l4%('Y),('/".#(/'.22,m' >"*"'9*%22"9'.B("*'(/"'+*,('7%I'.49'(/*""= Q).*("*,'>"*"'4%'#%47"*'),"9'.B("*'(/"'("4(/' (*@:'V".,%4,'B%*'9*%22347'.4'.22'34$#)9"9' +49347'.'1"(("*'%4"'lc]:]amI'3(,'#.$?'%B' S),"*'B*3"49#34",,T'lc:_amI'%*'3('4%('1"347' "47.7347'"4%)7/'le`:nam:';B'.',)*<"@'%B' cp`'$%4,)&"*,I'.1%)('nba',.39'(/"@' >%)#9'1"'&%*"'&%(3<.("9'(%'),"'.4'.22' (/.('>%)#9'.4.#@,"'9.(.'(/"@'*"$%*9"9' .49'2*%<39"'B""91.$?7 . -".#(/$.*"'("$/4%#%7@'$%&2.4@' !"##0%$I'64$:')49"*,(.49,'(/3,:' C/"3*'i.7,/32'03.1"(",X.4.7"*® I'(/"'+*,(' &%13#"'93.1"(",'&.4.7"&"4(',%#)(3%4'(%' *"$"3<"'P0F'`eb['$#".*.4$"I'2*%<39",' ,3&2#"'.49'2*%<"4I'$#343$.#'.49'1"/.<3%)*.#' "<39"4$"=1.,"9'7)39.4$"'.1%)('/%>'(%' &.4.7"'7#)$%,"'#"<"#,I'&"93$.(3%4,I' .$(3<3(@I'93"('.49',"<"*.#'%(/"*'2.*.&"("*,' >/3$/'.BB"$('(%(.#'93.1"(",'>"##4",,:' U%&2.4@'R*",39"4('F4.49'6@"*',"",'3('.,' .'S&%13#"'<3*().#'$%.$/347',%#)(3%4T'(/.(' 2*%<39",'1.,3$'$#343$.#'.49'1"/.<3%)*.#' ,)22%*(I'"BB"$(3<"#@'2*%<39347'.4'34("*.$(3<"' $%.$/'34'2"%2#"E,'2%$?"(,:
  • 11. ''H%9.B%4"'&-".#(/'J%#)(3%4,''e Vodafone mHealth Solutions Insights Guide Z!"E<"',""4'&.4@'2*%7*.&&",'(/.('/.<"'1""4'7*.4('B)49"9:'C/"'7*.4('"49,'.49'(/"' 2*%7*.&&"'"49,:'J%'>"'.,?'2"%2#"'(%'(/34?'.1%)(',),(.34.13#3(@'.49'(%'$%&"')2'>3(/' .'1),34",,'2#.4'(/.('&.?",',"4,":'!/.(E,'(/"'9.(.'>"'4""9'(%'$%##"$('(%',/%>'(/"' 3&2.$('.49'>/.('.*"'(/"'3493$.(%*,'%B',)$$",,:'k%)E<"'7%('(%'1"'.1#"'(%'9"("*&34"'(/.(:' C"#"/".#(/'>3##'4%('1"',),(.34"9'%*'.9%2("9')4#",,'>"'$.4',/%>'(/.('3('3&2*%<",'/".#(/' %)($%&",'.49'*"9)$",'$%,(,:E' U#343$3.4I'MJ 5. Customer delight, even fun P)4$(3%4'/.,'7"4"*.##@'(*3)&2/"9'%<"*' B%*&'34'(/"'/".#(/$.*"'1),34",,I'>/3#"'34' (/"'$%4,)&"*'"#"$(*%43$,'.49'&%13#"',2.$"' .'<.,('.&%)4('%B'(3&"'3,',2"4('(/34?347' .1%)('),"*'"D2"*3"4$":' C/"'W%,(%4I'XF=1.,"9',(.*(=)2' P3(4",,[""2"*'/.,'.((*.$("9'_&'),"*,'(%'3(,' V)4[""2"*',"*<3$"'>3(/%)(',2"49347'.'$"4(' %4'.9<"*(3,347:'P%)49"*'r'UK;'j.,%4'j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ser value J&.*(',%#)(3%4,'9%'&%*"'(/.4'Y),(' *"2#3$.("'"D3,(347'2*%$",,",'%4',&.##' ,$*""4,I'(/"@'#%%?'B%*'>.@,'34'>/3$/'(/"' 2*%$",,'$.4'1"'9%4"'1"(("*I'9"#3<"*347' #.,(347'),"*'1"4"+(,'(/.(',3743+$.4(#@' %)(>"37/'.4@'$%,(,'34$)**"9:' FA)&3%E,'Z64,(.4('-".*('V.("E'.22'9"#3<"*,' Y),('>/.('3('2*%&3,",I'(.?347'(/"'/".*('*.("' B*%&'(/"'+47"*'34'Y),('.'B">',"$%49,:'6(' ),",'(/"'2/%4"E,'34=1)3#('$.&"*.'$%&134"9' >3(/'(/"'#37/('B*%&'(/"'i.,/'(%'(*.$?'$%#%)*' $/.47",'34'(/"',?34'(/.(',/%>'/".*('*.(":' C/3,'344%<.(3<"'.22*%.$/I'(%7"(/"*'>3(/'.4' attractive user interface has resulted in this .22'1"347'9%>4#%.9"9'eb'&3##3%4'(3&",'1@' ;$(%1"*'bebO'.('gb:pp'.'9%>4#%.9I'(/3,'/.,' 1"$%&"'%4"'%B'&-".#(/E,',)$$",,',(%*3",:' J%#)(3%4,'(/.('&.?"'B)##'),"'%B'(/"'&)#(3= B.$"("9'2%>"*'%B'(/"'&%13#"'$.4'9"#3<"*' even more value to users than those that Y),('*"2#3$.("'"D3,(347'%Bi34"'2*%$",,",:' C/3,'3,'",2"$3.##@'3&2%*(.4('>/"4'%4"' $%4,39"*,'(/"'&@*3.9'%B'"D3,(347'93,(*.$(3%4,' %4'(/"'2/%4"'(/.('.*"'.#*".9@'$%&2"(347' B%*'(/"'),"*E,'.(("4(3%4I',)$/'.,'?""2347')2' >3(/',%$3.#'4"(>%*?,I'$%4,)&347'&"93.'%*' 2#.@347'7.&",: 7. Clinical and economic results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lK&"*7"4$@' X"93$.#'J"*<3$",m'(%',)*7"*@'1@')2'(%'e`' &34)(",I'.49'*"9)$",'(/"'.<"*.7"'(3&"' ,2"4('34'/%,23(.#'B%##%>347'.'/".*('.((.$?' 1@'.#&%,('.'9.@:' F',$3"4(3+$',()9@'*"2%*("9'34'(/"'J"2("&1"*' bee'"93(3%4'%B'(/"'Y%)*4.#'%B'(/"'F&"*3$.4' 03.1"(",'F,,%$3.(3%4I',/%>,'(/.('!"##0%$E,' 03.1"(",X.4.7"*® '9"#3<"*"9'.'e:pa'9"$#34"' %<"*'.'@".*'34'(/"'?"@'93.1"(",'&"(*3$' lFeU'5'8#@$.("9'/."&%7#%134mI'$%&2.*"9' (%'b:da'34'(/"'(",('7*%)2:'!3(/'".$/'ea' 34$*".,"'34'(/"'FeU'#"<"#'*"2*","4(347'.' s]ba'34$*".,"9'*3,?'%B'&3$*%'.49'&.$*%' <.,$)#.*'$%&2#3$.(3%4,'B%*'93.1"(",'2.(3"4(,I' .49'.4'.<"*.7"'&%4(/#@'$%,('%B'%<"*'gcbbI' *",)#(,',)$/'.,'(/","'&.?"'3('&%*"'#3?"#@' (/.('2/@,3$3.4'.49'*"7)#.(%*,'>3##'*.239#@' .9%2('.49'"&1*.$"'(/","',"*<3$",:'
  • 12. Vodafone mHealth Solutions 13 Vodafone mHealth Solutions Insights Guide 8. Joined-up solutions J)$$",,B)#',"*<3$",'("49'(%'1"'34("7*.("9' 34(%'%(/"*'.,2"$(,'%B'(/"'2.(3"4(E,'#3B"' .49'(/"'/".#(/$.*"',@,("&:'C/3,'"D2#.34,' (/"'4""9'B%*'S,%#)(3%4,'.,'%22%,"9'(%' ("$/4%#%73",TI'.$$%*9347'(%'j%"'J&3(/'B*%&' West Wireless Health Institute. X3$*%,%B('-".#(/'H.)#(E,'J".4'G%#.4',.@,I' SC/"'>%*#9'9%",4E('4""9'%4"'&%*"'3,%#.("9' ,3#%'%B'9.(.'B%*'(*.$?347'>/.("<"*:'&-".#(/' ,"*<3$",'/.<"'(%'"D3,('>3(/34'(/"'$%4("D(' %B'(/"'B%*&.#'.49'34B%*&.#'$.*"'(".&:T' C/"'-".#(/'H.)#('2#.(B%*&'$%44"$(,'cbb' .22#3$.(3%4,'.49'db'/%&"'$.*"'9"<3$",I' .49'$%##.1%*.(",'>3(/'.'7*%>347'4)&1"*' %B'/".#(/$.*"'2*%<39"*,:' P3(4",,[""2"*'%BB"*,'Y%34"9=)2',%#)(3%4,' $%&347'B*%&'(/"'>"##4",,'2"*,2"$(3<":' C/"@'*"$"4(#@'#.)4$/"9'.'-".#(/'8*.2/'FR6' (/.(',)22%*(,'.4'"$%,@,("&'%B'(/3*9'2.*(@' 9"<"#%2"*,'(/.('34("7*.("'>3(/'(/"'2#.(B%*&' .49',/.*"'.B+#3.("'*"<"4)",:'R.*(4"*,' 34$#)9"'&.4@'%B'(/"'&%*"'2*%&3,347' &-".#(/'9"<3$",I',)$/'.,',#""2'(*.$?"*' q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i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
  • 13. Vodafone mHealth Solutions 14 Vodafone mHealth Solutions Insights Guide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and effectiveness. C/3,',"$(3%4'$%4,39"*,'(/"'2*.$(3$.#'*".,%4,' 1"/349'(/"',#%>"*'(/.4'"D2"$("9'.9%2(3%4' of digital health technologies and discusses "D2"*3"4$",'B*%&'%(/"*',"$(%*,'(/.('$%)#9' 2%("4(3.##@'/"#2'$*".("'>39"',$.#"'.9%2(3%4: Creating a better customer-centric experience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f"(E,',.@'@%)'4""9'(%'+49' .'$.*93%#%73,('$#%,"'(%'G">'k%*?I'(/"4' @%)'$.4'+49'&%*"'(/.4'`bb'2%,,31#"'Gk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y Fonny Schenck, UK;'.('F$*%,,'-".#(/I'.4' international management $%4,)#(.4$@'B%*'9373(.#' innovation in life sciences Adopting technology: understanding the challenges for healthcare professionals
  • 14. Vodafone mHealth Solutions 15 Vodafone mHealth Solutions Insights Guide )49"*,(.49'3(,'1"4"+(,:'649""9'34'.'>.@' ("$/4%#%73,(,'/.<"'1""4'93,(*.$("9'1@'(/"' $%4$"2('%B'("$/4%#%7@'5'.49'34,(".9'%B' >%*?347'(%>.*9,'1"(("*',"*<3$",'/.<"',2"4(' (%%'&)$/'(3&"'(*@347'(%'1)3#9'.'$#"<"*"*' ,@,("&:'F3*J(*32'UK;'F#.4'R%*("#.'"D2#.34"9' (/3,'34'(/"'$%4("D('%B'K#"$(*%43$'X"93$.#' V"$%*9,I'KXV,L'SKXV,'.*"'2#.(B%*&,I'C/"' ,.&"'>.@'(/.('@%)*'$%&2)("*'/.,'.4' t%2"*.(347',@,("&u'5'KXV,'.*"'(/"';J:' k%)'1"4"+('B*%&'(/"'.22,'(/.('@%)'2)('%4' (%2'%B'(/"';JI'>/3#"'@%)'9%4E('1"4"+(',%' much from the OSeb :T';B'$%)*,"'>3(/%)(' (/"';2"*.(347'J@,("&'(/"'.22,'>%)#9'4%(' >%*?'1)(',(3##I'(/"'2%34('4""9,'(%'1"'&.9":' &-".#(/'("$/4%#%7@'2*%<39"*,'>%)#9'9%' >"##'(%'1".*'(/3,'34'&349'>/"4'$%4,39"*347' 2*%9)$('344%<.(3%4,: Right place, right technology, right doctor and right patient 64'(/"'B)()*"'/".#(/$.*"'>3##'1"'9"#3<"*"9' through a multitude of channels and it 3,'$#".*'(/.('&%13#"'9"<3$",'>3##'/.<"'.' 93,(34$('*%#"'(%'2#.@'34'(/3,:'W)('&%13#"' 9"<3$",'.*"'4%('(/"'%4#@'%2(3%4I'%(/"*' 9"<3$",'%*'$/.44"#,',/%)#9'.49'>3##'1"' ),"9'>/"4'&%*"'.22*%2*3.(": G%('%4#@'9%'$"*(.34'9"<3$",'+('$"*(.34' $%4("D(,'1"(("*I'(/"',"*<3$",'2*%<39"9' on these devices should integrate as ,".&#",,#@'.,'2%,,31#"'>3(/'(/"'4%*&.#' >%*?'2.(("*4,'%B'(/"'/".#(/$.*"'2*%B",,3%4.#' .49'2.(3"4(:'P.3#)*"'(%'.$/3"<"'(/3,'/.,'34' (/"'2.,('#"9'(%',3743+$.4('+4.4$3.#' 34<",(&"4('>3(/%)('.4@'&.("*3.#'7.34: mHealth technologists need to consider /%>'1",('(%'+('(/"3*',"*<3$"'34(%'(/"' 2.(3"4(,E'9.3#@'#3<",'%*'(/"'2/@,3$3.4,E' 4%*&.#'>%*?i%>:'C/"'?"@'Q)",(3%4'(/"@' ,/%)#9'.,?'3,'/%>'$.4'>"'&.?"'(/"3*'#3<",' ".,3"*I'.49'4%('&%*"'93B+$)#(^' Understanding pricing and reimbursement dynamics C/"'34("*4"('/.,'*.93$.##@'(*.4,B%*&"9' 2*3$347'&%9"#,'.49'&.4@'%*7.43,.(3%4,' .*"'1.((#347'(%'.9.2('(%'(/3,:'64$*".,347#@' SB*""&3)&T'&%9"#,'$%&134"9'>3(/' advertising have great success. There .*"'.##',%*(,'%B'>.@,'%B'.9%2(347'.' B*""&3)&'.22*%.$/:'P%*'"D.&2#"I'34'/3,' 1%%?'SP*""L'(/"'P)()*"'%B'.'V.93$.#'R*3$"T' U/*3,'F49"*,%4'9",$*31",'/%>'2*.$(3$"' &.4.7"&"4(',%B(>.*"'3,'73<"4'.>.@'1@' (/"'U.#3B%*43.4'$%&2.4@'R*.$(3$"'P),3%4:' C/"'2/@,3$3.4,'.*"'73<"4'(/"'B*""'<"*,3%4'%B' (/"',%B(>.*"'>3(/'.9,'%*'$.4'1)@'.4'.9=B*""' <"*,3%4'B%*'ebb'MJ0'2"*'&%4(/:'F993(3%4.#' <.#)"'3,'$*".("9'1@',"##347'.4%43&3,"9' 2.(3"4('$/.*(,'(%'&"93$.#'.,,%$3.(3%4,' B%*'*",".*$/'2)*2%,",:'ebbIbbb'&"93$.#' 2*%B",,3%4.#,'.*"'$)**"4(#@'),347'(/"' ,"*<3$"'.49'(/"'4)&1"*'3,'7*%>347I'>3(/' c`b'4">'),"*,'"<"*@'9.@11 . J(.49.*9'/".#(/$.*"'2*.$(3$"'3,' ,%&">/.('93BB"*"4('(%'(/3,:'64'9"<"#%2"9' "$%4%&3",'$%&&%4'2*.$(3$"'3,'(%'*"#@'%4' *"3&1)*,"&"4('B*%&'(/"'7%<"*4&"4(I'34' >/3$/'$.,"'(/"'("$/4%#%7@'3,'$%4,39"*"9' l4".*#@m'B*""'B%*'(/"'"49'),"*:'64'&%,(' $%)4(*3",I'9%$(%*,'.*"'2.39'1.,"9'%4'(/"' 4)&1"*'%B'2.(3"4(,'(/"@'(*".('%*'&""(' in the consulting room. If doctors are *">.*9"9'34'(/3,'>.@'3('3,'<"*@'$#".*'>/@' (/"@'.*"'*"(3$"4('34'.9%2(347'("$/4%#%73",' (/.('*"9)$"'B.$"=(%=B.$"'34("*.$(3%4,:'P*%&' (/.('2"*,2"$(3<"I'349""9L'!/.('(%'(/"&'3,' (/"'1"4"+('%B'*"&%("'&%43(%*347^' An interesting recent initiative from F),(*.#3.')49"*,$%*",'(/"'3&2%*(.4$"' %B'*"3&1)*,"&"4(h34$"4(3<",'34'(/"' .9%2(3%4'%B'4">'("$/4%#%73",L',34$"' j)#@'bee'.49'B%*'(/"'4"D('B%)*'@".*,I' (/"'F),(*.#3.4'7%<"*4&"4('3,'.$(3<"#@' 2*%&%(347'("#"/".#(/'1@'2*%<39347'1%4),",' (%'/".#(/$.*"'2*%B",,3%4.#,'(/.('.9%2(' ("#"/".#(/'("$/4%#%7@'.49'(/.('2.*(3$32.("' 34'<39"%=$%4,)#(,'>3(/'2.(3"4(,: U*%,,347'(/"'l&-".#(/m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
  • 15. Vodafone mHealth Solutions 16 Vodafone mHealth Solutions Insights Guide Understanding health psychology and the science of behaviour Introduction -.<347'"<.#).("9'.'4)&1"*'%B'&-".#(/' ,"*<3$",'%4'(/"'1.,3,'%B',)$$",,'34'),"*' .9%2(3%4I'(/3,'#.,(',"$(3%4'%B'(/"'*"2%*(' .3&,'(%'$%4("D().#3,"'(/"'$)**"4(',(.("' of mHealth through relevant academic #3("*.()*"'%4'),"*'.9%2(3%4'1"/.<3%)*: C/"*"'3,'.'7*%>347'$%*2),'%B'#3("*.()*"' 9%$)&"4(347'(/"'9"<"#%2&"4('%B'93BB"*"4(' mHealth technologies. Alongside technical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xisting theories -".#(/=*"#.("9'1"/.<3%)*'3,'/37/#@'$%&2#"D' and efforts to understand and account B%*'3493<39).#'.49'$%##"$(3<"'1"/.<3%)*' and its determinants continue across &)#(32#"'93,$32#34",:'0*.>347'%4'(/"%*"(3$.#' B*.&">%*?,'B*%&'.4(/*%2%#%7@I'/".#(/' 2,@$/%#%7@I',%$3%#%7@'.49'$)#()*.#' "239"&3%#%7@I'(/"'B%##%>347'2*","4(,'.'1*3"B' %)(#34"'%B',"#"$("9'(/"%*3",'%B'1"/.<3%)*' .,'(/"@'*"#.("'(%'/".#(/$.*"'2*.$(3$",'.49' /".#(/',@,("&'*",2%4,": The Health Belief Model P3*,('9"<"#%2"9'34'(/"'ep`b,'1@',%$3.#' 2,@$/%#%73,(,'-%$/1.)&I'V%,"4,(%$?'.49' ["7"#,eIec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l$%493(3%4,'(/.('&-".#(/'("$/4%#%73",' /.<"'.99*",,"9m:'W"#3"B'.49'/".#(/' &%(3<.(3%4'.*"',""4'(%'1"'$%493(3%4"9' 1@',%$3%=9"&%7*.2/3$'<.*3.1#",'.49' (/"'2,@$/%#%73$.#'$/.*.$("*3,(3$,'%B' (/"'3493<39).#:'C/"'&%9"#'/.,'1""4' ),"9'"D("4,3<"#@'34'9"("*&34347'/".#(/' 2*%&%(3%4'.$(3<3(3",14 :'-%>"<"*I'3('B.3#,'(%' 34$%*2%*.("'B".()*",',)$/'.,'(/"'34i)"4$"' %B'2*"<3%),'"D2"*3"4$"I'.9<.4(.7",'%B'&.#= .9.2(3<"'1"/.<3%)*I'1"/.<3%)*.#'34("4(3%4' .49'2"*$"3<"9'$%4(*%#: By Dr Juliet BedfordI'P%)49"*'.49'03*"$(%*'%B'F4(/*%#%73$.I' .'*",".*$/'1.,"9'$%4,)#(.4$@'+*&',2"$3.#3,347'34'(/"' .22#3"9'.4(/*%2%#%7@'%B'/".#(/$.*"
  • 16. Vodafone mHealth Solutions 17 Vodafone mHealth Solutions Insights Guide Theory of Planned Behaviour F4'"D("4,3%4'%B'(/"'C/"%*@'%B'V".,%4"9' F$(3%4I'B%*&)#.("9'1@'FYA"4'.49'P3,/1"34' 34'epnb15 I'>/3$/',%)7/('(%'",(3&.("' (/"'93,$*"2.4$@'1"(>""4'.((3()9"' .49'1"/.<3%)*I'(/"'C/"%*@'%B'R#.44"9' W"/.<3%)*'l.#,%',""'+7)*"'m16 '2*"93$(,' 9"#31"*.("'1"/.<3%)*.#'34("4(3%4'),347' (/*""'$%4,(*)$(,L'1"/.<3%)*.#'1"#3"B,I' 4%*&.(3<"'1"#3"B,'.49'$%4(*%#'1"#3"B,:' N''W"/.<3%)*.#'1"#3"B,'l.((3()9",'(%>.*9,' (/"'1"/.<3%)*m'.*"'9"("*&34"9'1@'(/"' 4%(3%4'(/.('.',2"$3+$'1"/.<3%)*'>3##'/.<"' a concrete consequence. N''G%*&.(3<"'1"#3"B,'l(/"',)1Y"$(3<"'4%*&m' .*"'$%4$"*4"9'>3(/'<3">,'.1%)('/%>' 2"%2#"'5'(/"'3493<39).#E,',%$3.#'4"(>%*?' 5'>3##'*"7.*9'(/"'1"/.<3%)*'34'Q)",(3%4I' 2#),'2"*,%4.#'&%(3<.(3%4'(%'B)#+#'(/"' "D2"$(.(3%4'%B'%(/"*,:' N''U%4(*%#'1"#3"B,'l2"*$"3<"9'1"/.<3%)*.#' $%4(*%#m'*"B"*'(%'.4'3493<39).#E,' 2"*$"2(3%4'%B'(/"3*'.13#3(@'(%'2"*B%*&'.' 73<"4'1"/.<3%)*I'1"#3"B'.1%)('.$$",,'(%' the resources needed in order to .$(',)$$",,B)##@:' C/","'2*"93$(%*,'#".9'(%'34("4(3%4I'(/"' 2*"$)*,%*'%B'1"/.<3%)*:'64'7"4"*.#I'(/"' &%*"'B.<%)*.1#"'(/"'.((3()9"'.49'(/"' ,)1Y"$(3<"'4%*&I'(/"'7*".("*'(/"'2"*$"3<"9' $%4(*%#I'(/"',(*%47"*'.'2"*,%4E,'34("4(3%4' (%'2"*B%*&'(/"'1"/.<3%)*'34'Q)",(3%4:'C/"' .9<.4(.7"'%B'(/"'2*.$(3$.#'.22#3$.(3%4'%B' (/3,'(/"%*@'3,'(/.('3('(.?",'34(%'.$$%)4(' &%(3<.(3%4.#'.,2"$(,'%B'2"*,%4.#'$%4(*%#' .49'(/"'34i)"4$"'%B',%$3.#'4"(>%*?,I'1)(' 3('$.4'1"'#3&3("9'1@'.4'%<"*="&2/.,3,'%B' 2,@$/%#%73$.#'B.$(%*,'>/3#,(')49"*=<.#)347' structural forces such as the reduced .<.3#.13#3(@'%B'*",%)*$",'%*'2%%*'.$$",,: Healthcare Utilisation Model 0"<"#%2"9'1@'F49"*,%4'.49'G">&.417 34'(/"'epdb,I'(/3,',%$3%=1"/.<3%)*.#' &%9"#'7*%)2,'(/*""'$#),("*,'%B'B.$(%*,' (/.('$.4'34i)"4$"'/".#(/'1"/.<3%)*'34'.' #%73$',"Q)"4$"L' N'2*"93,2%,347 N'"4.1#347' N need factors C/3,'&%9"#'>.,'9"<"#%2"9'(%'34<",(37.("' (/"'),"'%B'13%&"93$.#'/".#(/',"*<3$",I' .#(/%)7/'#.("*'<"*,3%4,'>"*"'"D("49"9' to include other healthcare sectors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l%*'#.$?'%B'3(m'B".,31#":'6('2"*&3(,'(/"' ",(.1#3,/&"4('%B'$%**"#.(3%4,'>3(/'7%%9' 2*"93$(.13#3(@I'1)('4%(',2"$3+$.(3%4'%B' /%>'.49'>/@'(/"'93BB"*"4('B.$(%*,'.BB"$(' (/"*.2")(3$',"#"$(3%4: Behavioural attitude Subjective norms Perceived behavioural control Intention Behaviour Figure 2 Theory of Planned Behaviour
  • 17. Vodafone mHealth Solutions 18 Vodafone mHealth Solutions Insights Guide Social Cognitive Theory P*%&'(/"'ep_b,'%4>.*9,I'W.49)*.b' has 9"<"#%2"9',%$3.#'$%743(3<"'(/"%*@'(%' "D2#.34'/%>'2"%2#"'.$Q)3*"'.49'&.34(.34' $"*(.34'1"/.<3%)*.#'2.(("*4,:'W.,"9'%4' (/"'".*#3"*'C/"%*@'%B'J%$3.#'f".*4347e' (/*""'9%&34.4('B.$(%*,'>"*"',""4'(%' 1"'$%4,(.4(#@'34i)"4$347'".$/'%(/"*L' "4<3*%4&"4('l,%$3.#'.49'2/@,3$.#mI' 2"%2#"'.49'1"/.<3%)*:' Bandura suggested that individuals are $.2.1#"'%B'#".*4347'4%('Y),('B*%&'(/"3*'%>4' "D2"*3"4$",I'1)('<3$.*3%),#@I'B*%&'(/%,"' .*%)49'(/"&:'[4%>4'.,';1,"*<.(3%4.#' f".*4347I'(/"'2*%$",,'3,'*"7)#.("9'1@'B%)*' ,)1'B)4$(3%4,L' N'.(("4(3%4.#'2*%$",,",' N'*"("4(3%4'2*%$",,",' N'2*%9)$(3%4'2*%$",,",' N'&%(3<.(3%4.#'2*%$",,",' f34?"9'(%'(/3,'3,',"#B="B+$.$@'l1"/.<3%)*.#' $.2.13#3(@mI'(/"'Z1"#3"B,'34'%4"E,'$.2.13#3(3",' (%'%*7.43,"'.49'"D"$)("'(/"'$%)*,",' %B'.$(3%4'*"Q)3*"9'(%'2*%9)$"'73<"4' .((.34&"4(,E :'J%$3.#'U%743(3<"'C/"%*@' 3,'),"9'"D("4,3<"#@'34'(/"'9",374'%B' /".#(/'"9)$.(3%4'.49'/".#(/'1"/.<3%)*' 2*%7*.&&",'.49'.,'(/"'1.,3,'B%*' intervention strategies. Other theoretical considerations [#"34&.4E,'$%4$"2('%B'KD2#.4.(%*@' X%9"#,c '$%4(.34'"D2#.4.(3%4,'%B'."(3%#%7@I' %4,"('%B',@&2(%&,I'2.(/%2/@,3%#%7@I' $%)*,"'%B',3$?4",,'.49'(*".(&"4(I'(%' "#.1%*.("'Z,2"$3+$',@,("&,'%B'?4%>#"97"' and values centred in the different social ,"$(%*,'.49',)1=,"$(%*,'%B'(/"'/".#(/$.*"' ,@,("&E] :'64'2%#3(3$.#="$%4%&3",'%B' /".#(/I'B.$(%*,'$.("7%*3,347'.<.3#.13#3(@I' .$$",,313#3(@I'.BB%*9.13#3(@'.49'.$$"2(.13#3(@' still dominate. X.4@'&%9"#,'.,,)&"'(/.('3493<39).#,' "47.7"'34'.'*.(3%4.#'2*%$",,'%B'>"37/347' (/"'1"4"+(,'.49'$%,(,'%B'1"/.<3%)*.#' choices and select the course of action >3(/'(/"'&%,('B.<%)*.1#"'$%,(=1"4"+(' *.(3%'l.,'34'(/"'-".#(/'W"#3"B'X%9"#I'(/"' C/"%*@'%B'R#.44"9'W"/.<3%)*I'.49'(/"' J%$3.#'U%743(3<"'C/"%*@mI'1)('.BB"$(3<"' associations` '/.<"'.#,%'1""4',/%>4'(%' 1"'34i)"4(3.#:'M4#3?"'(/","'Z$%4(34))&E' (/"%*3",'l>/3$/'2#.$"'.4'3493<39).#'.#%47' .'$%4(34))&'%B'.$(3%4'#3?"#3/%%9mI'Z,(.7"9E' (/"%*3",I',)$/'.,'(/"'C*.4,(/"%*"(3$.#' X%9"#'%B'W"/.<3%)*'U/.47"'l.#,%',""' +7)*"'cm_ '/.<"'.*3,"4'B*%&'9%)1('(/.(' #34".*'&%9"#,'.*"'B)##@'$.2.1#"'%B'$.2()*347' (/"'$%&2#"D'2*%$",,",'(/.(')49"*#3"' 9"$3,3%4,'(%'"47.7"'34'/".#(/'1"/.<3%)*,d . 69".##@I'.,'-.),&.44=X)"#.'$%4$#)9",I' Z.'$%4("D().#3,"9'.4.#@,3,'%B'/".#(/' 1"/.<3%)*,',/%)#9'l.m'1"'4"$",,.*3#@' 34("*93,$32#34.*@I'$%&134347'Z4.()*.#' ,$3"4$",E'>3(/'Z,%$3.#',$3"4$",E'.22*%.$/",O' l1m'4%('B.3#'(%'$%4,39"*'(/.('(/"',()93"9' Z$%4("D(,E'.*"'2.*('%B'.'/3,(%*3$.#'2*%$",,O' l$m'$%&134"'Z&3$*%E'>3(/'Z&.$*%E'#"<"#,O'.49' l9m'(*3.47)#.("'Q).#3(.(3<"'.49'Q).4(3(.(3<"' 34<",(37.(3%4'("$/43Q)",En . C%')49"*,(.49'1"/.<3%)*'.,,%$3.("9'>3(/' (/"'.9%2(3%4'%B'("$/4%#%73",'%B'/".#(/I' >"'4""9'(%'%<"*#.@'(/"%*3",'9"*3<"9'B*%&' ,%$3.#'.49'1"/.<3%)*.#',$3"4$"I'>3(/' (/"%*3",'%B'),"*'"47.7"&"4('9*.>4'B*%&' (/"'+"#9,'%B'64B%*&.(3%4'U%&&)43$.(3%4' .49'C"$/4%#%7@: Stage 4: ACTION Dedicates considerable time and energy; make overt and viable changes; developes strategies to deal with barriers Stage 3: PREPARATION Intends to take action and makes small changes; needs to set goals and priorities Stage 2: CONTEMPLATION Aware the problem exists and serious evaluation of options but not committed to take action Stage 1: No intention to change, often unaware of the problem Stage 6: EVALUATION Assessment and feedback to continue dynamic change process Stage 5: ADAPTATION / MAINTENANCE Works to adapt and adjust to facilitate maintenance of change PRE-CONTEMPLATION Figure 3 Transtheoretical Model of Behaviour Change
  • 18. Vodafone mHealth Solutions 19 Vodafone mHealth Solutions Insights Guide Diffusion of Innovations Theory V%7"*,E'03BB),3%4'%B'644%<.(3%4,' C/"%*@'l.#,%',""'+7)*"']mp is the most 34i)"4(3.#'34')49"*,(.49347'/%>'.4' 344%<.(3%4'34+#(*.(",'.'2%2)#.(3%4'l%*'4%(mI' .49'2*%<39",'.'$%&2*"/"4,3<"',(*)$()*"' B%*')49"*,(.49347'3493<39).#'.9%2(3%4'.49I' $%##"$(3<"#@I'93BB),3%4:'6('B%$),",'%4'(/"' conditions that increase or decrease the #3?"#3/%%9'%B'.'4">'39".I'2*%9)$('%*' 2*.$(3$"'1"347'.9%2("9:' V%7"*,'2*","4("9'B%)*',(.7",L' (/"'344%<.(3%4'3(,"#BO'93BB),3%4'l%*' $%&&)43$.(3%4m'(/*%)7/'(/"',%$3.#',@,("&O' (3&"O'.49'$%4,"Q)"4$",:'-"'.*7)"9'(/.(' .4'344%<.(3%4'3,'Z.4'39".I'2*.$(3$"I'%*'%1Y"$(' (/.('3,'2"*$"3<"9'(%'1"'4">'1@'.4'3493<39).#' %*'%(/"*')43('%B'.9%2(3%4EI'93BB),3%4'3,' Z(/"'Z2*%$",,'1@'>/3$/'.4'344%<.(3%4'3,' communicated through certain channels %<"*'.'2"*3%9'%B'(3&"'.&%47'(/"'&"&1"*,' %B'.',%$3.#',@,("&EI'.49'$%&&)43$.(3%4'3,' Z(/"'2*%$",,'34'>/3$/'2.*(3$32.4(,'$*".("' .49',/.*"'34B%*&.(3%4'>3(/'%4"'.4%(/"*' (%'*".$/'.'&)().#')49"*,(.49347E:' C/"'(/"%*@',)77",(,'(/.('1"$.),"' 34B%*&.(3%4'i%>,'(/*%)7/'4"(>%*?,I' %2343%4'#".9"*,'34'(/.('4"(>%*?'2#.@'.' *%#"'34'9"("*&34347'(/"'#3?"#3/%%9'(/.(' (/"'344%<.(3%4'>3##'1"'.9%2("9I'1)(' .993(3%4.#'34("*&"93.*3",'l$/.47"'.7"4(,' .49'7.("?""2"*,m'.*"'.#,%'34i)"4(3.#:' P3<"'$.("7%*3",'%B'.9%2("*'.*"'%)(#34"9' >/3$/'B%##%>'.4'J=,/.2"9'93BB),3%4'$)*<"L' 344%<.(%*,I'".*#@'.9%2("*,I'".*#@'&.Y%*3(@I' #.("'&.Y%*3(@I'.49'#.77.*9,:' 03BB),3%4'*",".*$/'/.,'B%$),"9'%4'+<"' &.34'"#"&"4(,L'(/"'$/.*.$("*3,(3$,'%B' .4'344%<.(3%4'>/3$/'&.@'34i)"4$"'3(,' .9%2(3%4O'(/"'9"$3,3%4=&.?347'2*%$",,' (/.('%$$)*,'>/"4'3493<39).#,'$%4,39"*' (/"'.9%2(3%4O'(/"'$/.*.$("*3,(3$,'%B' 3493<39).#,'(/.('&.?"'(/"&'#3?"#@'(%'.9%2(' .4'344%<.(3%4O'(/"'$%4,"Q)"4$",'B%*' 3493<39).#,'.49',%$3"(@'%B'.9%2(347'(/"' 344%<.(3%4O'.49'$%&&)43$.(3%4'$/.44"#,' ),"9'34'(/"'.9%2(3%4'2*%$",,:'U#%,"#@' #34?"9'(%'03BB),3%4'%B'644%<.(3%4,'C/"%*@' 3,'G"(>%*?'F4.#@,3,'.49'J%$3.#'G"(>%*?' C/"%*@cb '.49'U*3(3$.#'X.,,'C/"%*@31 . 0 100 75 50 25 Marketshare% Innovators 2.5% Early Adopters 13.5% Early Majority 34% Late Majority 34% Laggards 16% Figure 4 Diffusion of Innovations Theory X.*?"('2"4"(*.(3%4 f"<"#'%B'.9%2(3%4
  • 19. ''H%9.B%4"'&-".#(/'J%#)(3%4,''b Vodafone mHealth Solutions Insights Guide Technology Acceptance Model C/"'C"$/4%#%7@'F$$"2(.4$"'X%9"#'3,' %4"'%B'(/"'&%,('34i)"4(3.#'"D("4,3%4,' %B'FYA"4E,'C/"%*@'%B'V".,%4"9'F$(3%4'.49' C/"%*@'%B'R#.44"9'W"/.<3%)*:'0"<"#%2"9'1@' 0.<3,cI'cc '3('3,'.4'34B%*&.(3%4',@,("&,'(/"%*@' (/.('&%9"#,'/%>'),"*,'$%&"'(%'.$$"2('.49' ),"'.'("$/4%#%7@:'6('*"2#.$",'FYA"4E,'.((3()9"' &".,)*",'>3(/'(>%'("$/4%#%7@'.$$"2(.4$"' &".,)*",L'2"*$"3<"9'),"B)#4",,'l(/"'9"7*""' (%'>/3$/'.'2"*,%4'1"#3"<",'(/.('),347'.' 2.*(3$)#.*',@,("&'>%)#9'"4/.4$"'/3,'%*'/"*' Y%1'2"*B%*&.4$"mI'.49'2"*$"3<"9'".,"=%B= ),"'l(/"'9"7*""'(%'>/3$/'.'2"*,%4'1"#3"<",' (/.('),347'.'2.*(3$)#.*',@,("&'>%)#9'1"' B*""'B*%&'"BB%*(m:'C/"'&%9"#'.,,)&",'(/.(' >/"4',%&"%4"'B%*&,'.4'34("4(3%4'(%'.$(I' (/"@'>3##'1"'B*""'(%'.$('>3(/%)('#3&3(.(3%4I' >/"*".,'34'(/"'*".#'>%*#9I'(/"*"'>3##'1"' <.*3%),'$%4,(*.34(,:';(/"*'&%9"#,'"D2#.34347' .$$"2(.4$"'2"*$"2(3%4,'.49'1"/.<3%)*,' .,,%$3.("9'>3(/'64B%*&.(3%4'C"$/4%#%7@' 34$#)9"'U%&2)("*'J"#B=KB+$.$@34 I'C.,?= C"$/4%#%7@'P3(35 '.49'(/"'X%(3<.(3%4.#' X%9"#36 . United Theory of Acceptance and Use '3.4"/5$'*'-6.7.8$%#"!.45"',6.'3. Consumer Acceptance Technology Recent studies have sought to integrate ,%&"'%B'(/"'2*3%*'&%9"#,:'H"4?.(",/37 "D.&34"9'"37/('%B'(/"'&%,('$%&&%4' (/"%*"(3$.#'B*.&">%*?,'.49'&%9"#,'),"9' (%'"D2#.34'3493<39).#'.9%2(3%4'.49'),"'%B' ("$/4%#%7@'.49'1*%)7/('(%7"(/"*'(/"3*' &%,(',.#3"4('$/.*.$("*3,(3$,'(%'B%*&'.')43+"9' (/"%*@I'M43("9'C/"%*@'%B'F$$"2(.4$"'.49' M,"'%B'C"$/4%#%7@'l.#,%',""'+7)*"'`m:' C/3,'2*","4(,'B%)*'?"@'9"("*&34.4(,'%B'),"' l2"*B%*&.4$"'"D2"$(.4$@I'"BB%*('"D2"$(.4$@I' ,%$3.#'34i)"4$"'.49'B.$3#3(.(347'$%493(3%4,m' and four moderators of individual use l7"49"*I'.7"I'"D2"*3"4$"'.49'<%#)4(.*34",,m:' J3&3#.*#@I'[)#<3>.(38 designed the Consumer F$$"2(.4$"'%B'C"$/4%#%7@'B*.&">%*?'1@' &"*7347'(>%'2*"<3%),#@')4*"#.("9'&%9"#,I' (/"'C"$/4%#%7@'F$$"2(.4$"'X%9"#'.49' (/"'R#".,)*"I'F*%),.#'.49'0%&34.4$"' 2.*.937&'%B'.BB"$('l9"<"#%2"9'.,'.'&%9"#'34' "4<3*%4&"4(.#=2,@$/%#%7@'1@'X"/*.1.3439 I' 3(',)77",(,'(/.('.##'"&%(3%4.#'*",2%4,",'(%' 2/@,3$.#'.49',%$3.#'"4<3*%4&"4(,'$.4'1"' $.2()*"9'>3(/'(/*""'93&"4,3%4,'%B'.BB"$(L' 2#".,)*"I'.*%),.#'.49'9%&34.4$"m:' Sun and Zhang]b '2*","4('.',@,("&.(3$' .4.#@,3,'%B'(/"'"D2#.4.(%*@'.49',3().(3%4.#' #3&3(.(3%4,'%B'"D3,(347'("$/4%#%7@' .$$"2(.4$"',()93",:'C/"@'$.##'B%*'&%*"' *",".*$/'34(%'(/"'3493<39).#'.49'$%4("D().#' factors that are often neglected in ("$/4%#%7@'.$$"2(.4$"',()93",'1)('$.4' 1"'$*3(3$.#'34'(/"'.22#3$.(3%4'%B'(/"' (/"%*"(3$.#'&%9"#,I'.49'39"4(3B@'("4' &%9"*.(347'B.$(%*,'$%4,39"*"9'(%'1"' 34i)"4(3.#'l<%#)4(.*34",,I'(/"'4.()*"'%B'(.,?,' .49'2*%B",,3%4,I'("$/4%#%73$.#'$%&2#"D3(@I' (/"'2)*2%,"'%B'),347'("$/4%#%7@I'3493<39).#' <,:'7*%)2'("$/4%#%73",I'7"49"*I'3493<39).#' 34("##"$().#'$.2.13#3(3",I'"D2"*3"4$"I'.7"' .49'$)#()*.#'1.$?7*%)49m: Adoption behaviours – barriers and ways to overcome them F,'(/"'+"#9'%B'&-".#(/'&.()*",I'%)*' )49"*,(.49347'%B'.9%2(3%4'1"/.<3%)*,' l1%(/'2%,3(3<"'.49'4"7.(3<"m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l1%(/'.,'3493<39).#,'.49'%*7.43,.(3%4,mI' .49'(/%,"'B.$"9'1@'2.(3"4(,I'9",23("',%&"' 34"<3(.1#"'%<"*#.2:'!.@,'(%'%<"*$%&"' (/","'1.**3"*,'.*"'(/"4',"('%)(: J"<"*.#'Q)%(",'.*"'34$#)9"9'>/3$/'.*"' .9.2("9'B*%&'(/"',(.?"/%#9"*'*",".*$/' $%&&3,,3%4'1@'H%9.B%4"1 . Figure 5 United Theory of Acceptance and Use of Technology Performance expectancy Effort expectancy Social influence Facilitating conditions Behavioural intention Behaviour Age Experience Gender VoluntarinessofuseVoluntariness Determinants of use Moderators of individual use
  • 20. ''H%9.B%4"'&-".#(/'J%#)(3%4,''e Vodafone mHealth Solutions Insights Guide Table 2 Barriers to health technology adoption – healthcare providers 41, 42, 43, 44, 45, 46, 47 Barrier )"#$%&%'$ Clinical issues 0%)1(,'.*3,347'%<"*'(/"'Q).#3(@'%B'$.*"'2*%<39"9'l.,,%$3.("9'>3(/'*3,?,'%B'#3(37.(3%4I'2.*(3$)#.*#@'34'(/"'MJFm Cost / reimbursement -%>'(%'*"$%)2'34<",(&"4('.49'2.,,'%4'),"*'$%,('l",2"$3.##@'.'$%4$"*4'34'(/"'MJFm Lack of evidence J$.4('"<39"4$"'.1%)('(/"'"BB"$(3<"4",,'%B'("$/4%#%7@'%*'/%>'&-".#(/'3&2*%<",'$#343$.#'%)($%&",I' >%*?i%>'"($ Lack of user-engagement 64.9"Q).("'2/@,3$3.4',)22%*('1.,"'.49'2/@,3$3.4=1.,"9'#".9"*,/32I'#3&3("9'34<%#<"&"4('34'9",374'%*' 3&2#"&"4(.(3%4I'$%4$"*4'.1%)('("$/4%#%7@ Organisational structure U%4$"*4,'.1%)('34("7*.(3%4'.49'34("*%2"*.13#3(@'%B'&-".#(/'34'$)**"4(',(*)$()*", Privacy 6,,)",'%B'$%4+9"4(3.#3(@'.49'$%4,"4( Security V"7.*9347'(*.4,&3,,3%4I',(%*.7"'.49'*"(*3"<.#'%B'$#343$.#'9.(. Work load and time management 64$*".,"9'(3&"',2"4('.49'*"#)$(.4$"'.1%)('Z%)(,39"'%B'%B+$"'/%)*,E'*",2%4,313#3(3", 9',:;'<.='!0*%&%"( f.$?'%B'2*%$",,",'.49'2*%$"9)*",'.*%)49'$%##"$(3%4I'%*7.43,.(3%4I'.4.#@,3,'%B'9.(.I'.49'/%>'(%'3&2#"&"4(' action needed Clinical issues: ZC/"'&%&"4('@%)E<"'7%('$%4(34)%),' &%43(%*347'%4I'(/"*"'&37/('1"'.'#"7.#' 3&2#3$.(3%4'(/"*":'!/.('/.22"4,'3B'(/"' 4"(>%*?'7%",'9%>4'%*'@%)'7%'(%'.'2.*('%B' (/"'/%,23(.#'>/"*"'3(E,'4%('.<.3#.1#"'.49' ,%&"(/347'>.,4E('23$?"9')2'2)*"#@'B%*' (/.('*".,%4^'G%>'>/%E,'#3.1#"^'6,'3('(/"' 9.(.^'6,'3('(/"'$%&2.4@'(/.('&.?",'(/"' 9"<3$"^'6,'3('(/"'/%,23(.#'%*'(/"'$%&2.4@' (/.('1)3#('(/"'/%,23(.#^'6,'3('(/"'9%$(%*' .('(/"'"49^E C/%)7/('f".9"*I'M[ Cost / reimbursement: Z!"##I'6E9',.@'$%,(I')49"*,(.49347'%B'3(,' )(3#3(@I'.4@(3&"'@%)'1*347'34',%&"(/347' 4">'5'2.*(3$)#.*#@'34'(/"'+"#9'%B' ("$/4%#%7@'5'$%4<34$347'2"%2#"'(/.('3(E,' 1*347347'1"(("*&"4(I'.4'.9<.4(.7"'(%' (/"'>.@'(/.('(/"@E*"'9%347'(/347,I'(/.(E,' .#>.@,'.'1.**3"*:E' R/.*&.$")(3$.#I'MJ ZC/"*"'3,'.'$%4$"2('$.##"9'$%,(= %22%*()43(@'>/3$/'&".4,'(/.('(/"' &%4"@'(/.('3,',2"4('%4',.43(.*@'3,,)",'3,' (.?"4'B*%&'.4%(/"*'2#.$"v3B'@%)',2"49' %4'("#"&"93$34"'.49'4%('34'.&1)#.4$",' %*'"&"*7"4$@',@,("&,v3(E,'.'7*".(' *",2%4,313#3(@'(/"'>.@'@%)',2"49'&%4"@:E' -%,23(.#I'J2.34 Lack of evidence: ZC/"*"E,'Q)3("'.'B">'23#%(',()93",'Iv1)(' (/"'2*%1#"&'>3(/'.##'%B'(/%,"'3,'(/"@E*"' <"*@',&.##',()93",:';*'"<"4'3B'(/"@'7%' %4'.'@".*I'(/"@E*"'.'<"*@',"#"$('7*%)2' %B'2.(3"4(,:'k%)'/.<"4E('9%4"'3('%4' 2%2)#.(3%4',$.#",',%'(*@347'(%'+49'.' $%,('Y),(3+$.(3%4'B%*'(/.(vE' C/%)7/('#".9"*I'M[
  • 21. ''H%9.B%4"'&-".#(/'J%#)(3%4,'' Vodafone mHealth Solutions Insights Guide Organisational structure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rivacy: Z!"'34$*".,"'34'.',3743+$.4('>.@'(/"' *3,?'%B'4%('*",2"$(347'2"%2#"E,'*37/('(%' 2*3<.$@'.,'>"##'.,'2*3<.$@'%B'9.(.v(/"*"' 3,'4%'2*%2"*'*"7)#.(3%4'(%'2*%("$('9.(.' .49'(/"'2.(3"4('34'(/"'B.$"'%B'(/"',2*".9' %B'34B%*&.(3%4'(/*%)7/'("#"&"93$34":E' G8;I'J2.34 Lack of user-engagement: ZC/"'%4#@'(/347'(/.('(/","'2*%B",,3%4.#,' ,""'3,'(/.('(/"@'>3##'1"'%<"*1)*9"4"9:' 6(E,'$#".*'(/.('3B'(/"@'4%>'/.<"'ebb' 2.(3"4(,I'>3(/'("#"&"93$34"'(/"@'$%)#9' /.<"'&.4@'&%*":E' F$.9"&3$I'J2.34 Work load and time management: Z6B'@%)',"4('%)('ebb'*"&349"*,I'4%>' @%)E<"'7%('(%'*",2%49'(%'(/%,"'ebb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efforts to create a common information ,@,("&O'34',)$/'.'>.@'(/.('"<"*@'J2.43,/' $3(3A"4'$%)#9'".,3#@'.49'*.239#@'#%$.("'.##' (/"3*'$#343$.#'/3,(%*@'34'.'9.(.1.,"'.49'1@' 9%347',%'1"'$.2.1#"'(%',/.*"'>3(/',%&"' %(/"*'9%$(%*,I'4%'&.(("*'>/"*"'@%)'>"*"' .(I'J>3(A"*#.49'%*'X.9*39:E' 8RI'J2.34
  • 22. ''H%9.B%4"'&-".#(/'J%#)(3%4,''c Vodafone mHealth Solutions Insights Guide Table 3 Barriers to health technology adoption – patients48, 49, 50, 51, 52 Barrier )"#$%&%'$ Cost -%>'(%'B)49'93*"$('.49'.,,%$3.("9'$%,(, Design of the technology U%&2#"D'34("*B.$"I'%1(*),3<"'("$/4%#%7@I'2/@,3$.#'.13#3(@'(%'),"'l$%493(3%4'%*'3&2.3*&"4(',2"$3+$m Disruption to daily routine and normal healthcare practices R"*$"3<"9'%*'.$().#'93,*)2(3%4:'U%&&%4'B".*'.&%47'2.(3"4(,'(/.(')(3#3,347'("$/4%#%7@'*3,?,'*"9)$347'%*' #%%,347'93*"$('$%4(.$('>3(/'(/"3*'9%$(%*: Lack of evidence F1%)('),"B)#4",,I'".,"=%*=),"I'.49'.$$",,313#3(@ Lack of knowledge G%'%*'#3&3("9'?4%>#"97"'.1%)('&-".#(/'2*%/313(,'343(3.#'2.(3"4('34("*.$(3%4 Lack of access F,'$%4,)&"*,I'2.(3"4(,'/.<"'#3((#"'349"2"49"4('.$$",,'(%'&-".#(/')4#",,'3('3,'93*"$(#@'*"$%&&"49"9'%*' 2*",$*31"9'l.#(/%)7/'.<.3#.13#3(@'.49'.$$",,'(%'1%(/'$#343$.#'.49'4%4=$#343$.#',&.*(2/%4",'.22,'3,'34$*".,347m Level of technology literacy 0373(.#'93<39"'.49'<.*3.1#"'#"<"#,'%B',?3##'l#"<"#'%B'(/*".('2"*$"3<"9'1@'4">'("$/4%#%7@m Privacy !/%'/.,'.$$",,'(%'(/"3*'9.(.'l,"$)*3(@'3,'4%(',)$/'.'$%4$"*4'B%*'2.(3"4(,'>/%'*"7.*9"9'3('.,'("$/43$.#'3,,)"' (/.(',/%)#9'1"',%#<"9'2*3%*'(%'("$/4%#%7@'*%##'%)(m Reliability of the technology V3,?'%B'("$/43$.#'B.3#)*"'%*'"**%*'#".9347'(%'"#"<.("9'/".#(/'*3,? Cost: Z`bb'2%)49,'>3##'&".4',%&"(/347'(%' &"I'1)('B%*',%&"%4"'"#,"'`bb'2%)49,' &37/('1"'2"*$"3<"9'.,'.'#%('%B'&%4"@' .49'3(E,'<"*@'/.*9'>3(/'(/","'$%,(347,:' F49'>/.("<"*'>.@'@%)'#%%?'.('3('3B'@%)E*"' (.#?347'.1%)('"Q)32&"4('.('.'/".<@'2*3$"' 3(E,'7%('1"'&".4,'(",("9'1"$.),"'(/"' G.(3%4.#'-".#(/'J"*<3$"' Y),('$.4E('.BB%*9'3(:E' 03.1"(3$'R.(3"4(I'M[ Disruption to normal healthcare practices: Z6'(/34?'9%$(%*,'>3##'/.<"'#%47"*'34("*<.#,' 1"(>""4'<3,3(,'1"$.),"'@%)E*"'&%*"' $%<"*"9I'>/3$/'>%)#9'&.?"'&"'9%)1(I' 1"$.),"'6'#3?"'B.$"=(%=B.$"'$%4(.$('>3(/' &@'9%$(%*I'1"347'.1#"'(%'("##'/3&'.1%)(' &@'2*%1#"&,:E' 03.1"(3$'R.(3"4(I'J2.34 Level of technology literacy: ZF4@'9"<3$"'&),('1"'),"*=B*3"49#@:'k%)' ,/%)#94E('4""9'.'9"7*""'(%'),"'3(:'6(E,'+4"' B%*'.'b'@".*'%#9I'1)('>"'9394E('7*%>')2' >3(/'("$/4%#%7@'(/"'>.@'@%)47'2"%2#"' 939:'6'9%4E('?4%>'/%>'(%',"(')2'&@'0H0:E' 03.1"(3$'R.(3"4(I'qF Privacy: Z;4"'%B'(/"'1377",('/)*9#",'(/.(' @%)E*"'7%347'(%'/.<"'(%'7%'%<"*'3,'(/"' .13#3(@'(%'"4,)*"'2.(3"4(,'(/.('(/"3*'9.(.' 3,'2*%("$("9I'(/.('3('3,'4%('1"347'),"9' B%*'"D.&2#"I'1@'34,)*.4$"'$%&2.43",' (%'2*"<"4('(/"&'B*%&'7"((347'34,)*.4$"' 1"$.),"'(/"@'/.<"'.'2.*(3$)#.*' 7"4"(3$'&.*?"*:E' C/%)7/('f".9"*I'MJ
  • 23. ''H%9.B%4"'&-".#(/'J%#)(3%4,''] Vodafone mHealth Solutions Insights Guide Table 4 Ways to overcome barriers53, 54, 55, 56, 57, 58, 59, 60, 61, 62 How to overcome the barrier )"#$%&%'$ Complement/augment normal practices K4,)*"'("$/4%#%7@'.99,'<.#)"'.49',)22#"&"4(,'/".#(/$.*"'2*.$(3$", Cost / reimbursement X.?"'3('$%,('"BB"$(3<"I'9"<"#%2'4">'1),34",,'&%9"#, )0&0.(?"/%#/0&%'$( Collect targeted data that is required Design and properties X.D3&3,"'(/"'),"*'"D2"*3"4$"'(/*%)7/'(.*7"("9'34("*B.$"'(/.('.##%>,'B%*'2"*,%4.#3,.(3%4I'$),(%&3,.(3%4'.49' .9.2(3%4I'&.?"'3('9",3*.1#" Evidence V37%*%),'"<.#).(3%4'.49'"<39"4$"=1.,"9'*",)#(, Increase awareness, knowledge base and recognition W)3#9'$%4,"4,),'.*%)49'>/.('3,'.<.3#.1#"I'>/"4I'>/@'.49'>/.('(/"'.9<.4(.7",'.*"'l),"*,'$.4'4%('.9%2(' ("$/4%#%73",')4#",,'(/"@'?4%>'(/"@'.*"'.<.3#.1#"m:'V"9)$347'(/"'7.2'1"(>""4'(/"'2*"='.49'2%,(=),"' 2"*$"2(3%4,'%B'2.(3"4(,'.49'/".#(/$.*"'2*%<39"*,'3,'3&2%*(.4('.49'$%)#9'#".9'(%'/37/"*'.$$"2(.4$"'*.(", Increase accessibility 64$*".,347'(/"'<3,313#3(@'%B'&-".#(/'3,'%4#@'2.*('%B'(/"'"Q).(3%4:'F<.3#.1#"'("$/4%#%73",'&),('1"'2.$?.7"9' .49'%BB"*"9'34'>.@,'(/.('"4.1#"'$%4,)&"*,'(%'.$$",,'(/"&'93*"$(#@: Organisational support M49"*234'("$/4%#%7@'>3(/',@,("&,'.49'2*%$",,",'(%',)22%*('%*7.43,.(3%4.#',(*)$()*",'34'>/3$/'3('>3##' %2"*.("O'"4,)*"'34("7*.(3%4I'34("*%2"*.13#3(@'.49',(.49.*93,.(3%4 Overall, ensure the 2"$"#&(.'1&<"%-5. the costs F9%2(3%4'>3##'B%##%>'.4'J=,/.2"'93BB),3%4'$)*<"'(/.('4"$",,3(.(",',),(.34"9'"47.7"&"4('.49'$%&&3(&"4(' from the end users Privacy J%#<"'#"7.#'.49'*"7)#.(%*@'3,,)",'.1%)('2*3<.$@'.49'$%4(*%#'%B'9.(. Security J%#<"'("$/43$.#'3,,)",'.*%)49',"$)*3(@'%B'(*.4,&3,,3%4I',(%*.7"'.49'*"(*3"<.#'%B'$#343$.#'9.(. Training C*.34'3493<39).#,'34'(/"'.22#3$.(3%4'.49'2*.$(3$.#3(3",'%B'(/"'("$/4%#%7@ User development K47.7"'.##',(.?"/%#9"*,'34'2*%9)$('9"<"#%2&"4('(%'"4,)*"'3(,'?"@'*"Q)3*"&"4(,'.*"'&"(I'3('3,'),"*'9*3<"4' (/*%)7/'2.*(3$32.(3%4I'.49'3,',$.#.1#" 9',:;'<.='!0*%&%"( K4,)*"'34B%*&.(3%4'$%##"$(3%4I'.4.#@,3,I'.49'93,,"&34.(3%4'3,'"B+$3"4( Applying behavioural theories in technology and health 64'(/"'.9%2(3%4'.49')(3#3,.(3%4'%B'&-".#(/I' 1"/.<3%)*.#'.((3()9",'.*"'#3?"#@'(%'1"'&%*"' 3&2%*(.4('(%'2*%7*",,'(/.4'("$/4%#%7@'tc]u:' F,'X.*(34,'tcu'$%4$#)9",I'&-".#(/'2"*',"' 3,'Z4%('"4%)7/'(%'3&2*%<"'/".#(/$.*"I',34$"' 3&2*%<347'$.*"I'%*',)22%*(347'3(I'3,'&%*"'(/.4' Y),('73<347'2*%B",,3%4.#,'l.49'2.(3"4(,m'".,3"*' .$$",,'(%'34B%*&.(3%4'.49'$%&&)43$.(3%4E: 6('3,'>39"#@'.$?4%>#"97"9'(/.('&-".#(/' /.,'(/"'2%("4(3.#'(%'3&2*%<"'/".#(/' %)($%&",I'1)('>"'&),('9"&%4,(*.("' /%>'.49')49"*,(.49'>/@:'C/"'1.**3"*,' 39"4(3+"9'.,'2*%/313(347'(/"'*".9@'.9%2(3%4' %B'&-".#(/'$.4'1"'93<39"9'34(%'+<"'34("*= *"#.("9'$.("7%*3",L',%$3.#O'$#343$.#O'("$/43$.#O' "$%4%&3$O'.49'%*7.43,.(3%4.#'%*'#%73,(3$.#' l.#,%',""'+7)*"'_m:' X"$/.43,&,'.49',(*.("73",'$.4'1"'2)(' 34'2#.$"'(%'&343&3,"'(/"3*'3&2.$(L'"&2#%@347' "BB"$(3<"'9",374'(/"%*@'>3##'*",)#('34' 34$*".,347#@'*"+4"9'.49'.22*%2*3.("' 34("*B.$",'1"347'9"<"#%2"9O'"&2#%@347' %*7.43,.(3%4.#'$/.47"'(/"%*@'>3##'$*".("' ,(.1#"'34,(3()(3%4.#',@,("&,'.49'>%*?i%>,' (/.('$.4'34$%*2%*.("'("$/4%#%7@'(%'3&2*%<"' "B+$3"4$@O'"&2#%@347'(.*7"("9',%$3.#' &.*?"(347'>3##'*.3,"'.>.*"4",,'%B' (/"'("$/4%#%73",E'"D3,("4$": C/"'2%("4(3.#'%B'&-".#(/'3,'"D("4,3<"' .49',)22%*(,'.'B)49.&"4(.#'$/.47"'34'(/"' >.@'(/.('-UR,'.49'2.(3"4(,'34("*B.$"'>3(/' healthcare. Whilst changes are required for -UR,'(%'1"'.1#"'(%'$%2"'>3(/'4">'/".#(/$.*"' 9"&.49,'.49',),(.34'(/"'Q).#3(@'%B'$.*"I'.,'.' 93,*)2(3<"'344%<.(%*I'(/"'B.$('3,'(/.('&-".#(/' 34(*%9)$",'$/.47"I'.49'$/.47"'&.@' 4"7.(3<"#@'3&2.$('3(,'.9%2(3%4'.49'$.),"' 4%4=)2(.?":'64'(/"'Q)%("'%4'(/"'4"D('2.7"I' B%*'34,(.4$"I'$%4$"*4,'.1%)('"#3&34.(347' $%##".7)",E'Y%1,'2*%/313('(/"'*".9@'.9%2(3%4' of technological interventions.